See personalized New Product recommendations! Get personalized New Product recommendations! Register or Login for personalized New Product recommendations!

Holiday Notification: Cayman Chemical will be closed Monday, May 28, 2012, in observance of the Memorial Day holiday. More…
Please feel free to continue placing orders via our website or via fax at 734-971-3640. You may send an email to customer service at custserv@caymanchem.com , or to technical support at techserv@caymanchem.com which we will respond to the next business day. Cayman will resume regular business hours and shipping schedules on Tuesday, May 29, 2012. Thank you for your patience and understanding.

Research Area · Neuroscience

· See all 100+ product categories

Item Number Product Sizes & Pricing CAS Purity Image Exclusive Introduction Date Mojo Plain Text Name Synonyms Keywords Interest
10976 10-HDA 14113-05-4 ≥98% 2011-10-13 79.840110497237 10-hda fatty acids royal jelly lifespan MMP RA, rheumatoid arthritis VEGF angiogenesis antitumor neurogenesis collagen 79.840110497237
33400 (±)10-HDoHE 90780-50-0 ≥98% 13.941282228361 -10-hdohe 10-hydroxy Docosahexaenoic Acid racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)10-HDoHEs (+/-)HDoHEs neurochemistry 13.941282228361
10008598 11(12)-EET Ethanolamide - ≥98% 2007-01-16 26.410596685083 11-12-eet-ethanolamide 11(12)-EpETrE Ethanolamide AEA endocannabinoids Arachidonoyl ethanolamides CYP450 cytochromes metabolism neurochemistry anxiety depression 14,15-EET 14,15-EpETrE 14,15-EET-EA 14,15-EET-ethanolamide 14,15-epetre-ea 14,15-ethanolamide anandamides lipids neurotransmitters cannabinergic cannabinoids CBs FAAH inhibitor fatty acids hydrolases cbs synthetic 26.410596685083
10010101 11-cis Vaccenyl Acetate Exclusive 6186-98-7 >98% ✓ 2007-08-06 66.514051565377 11-cis-vaccenyl-acetate d. melanogaster pheromones olfactory receptors mating male female specific insects flys fruit flies Or67d odorant hydrocarbon 865721-11-5 66.514051565377
33450 (±)11-HDoHE 87018-59-5 ≥98% 12.417691068139 -11-hdohe 11-hydroxy Docosahexaenoic Acid racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)11-HDoHEs (+/-)HDoHEs neurochemistry 12.417691068139
10009897 (−)-11-nor-9-carboxy-Δ9-THC (solution) 56354-06-4 ≥98% 2010-11-11 11.018646408839 -11-nor-9-carboxy-9-thc-solution THC metabolites Delta9-THC Δ9-THC tetrahydrocannabinols marijuana cannabinoids cbs synthetic 10915 11.018646408839
10009473 1,2-dipalmitoyl-sn-glycero-3-PC 63-89-8 >98% 2007-01-19 6.177437845303 1-2-dipalmitoyl-sn-glycero-3-pc L-dipalmitoyl Lecithin; L-DPPC; 1,2-dipalmitoyl-sn-glycero-3-Phosphatidylcholine antigens phosphatidylcholines zwitterionic phosphoglycerides proteoliposomes liposomal enzymes g-glutamyl gamma-glutamyl .gamma.-glutamyl transpeptidase erythrocytes immunotherapy immunotherapies GSLs glycosphingolipids phospholipids polyenylphosphatidylcholine 6.177437845303
90377 13-Docosenamide 112-84-5 ≥98% 2.449281767955 13-docosenamide Erucamide; Armoslip E CSF sleep fatty acids neurochemistry neuroscience 2.449281767955
33500 (±)13-HDoHE 90780-53-3 ≥98% 12.803142265193 -13-hdohe 13-hydroxy Docosahexaenoic Acid racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)13-HDoHEs (+/-)HDoHEs neurochemistry 12.803142265193
10008599 14(15)-EET Ethanolamide - ≥95% 2006-08-07 22.645801104972 14-15-eet-ethanolamide 14(15)-EpETrE Ethanolamide; 14(15)-Epoxy Eicosatrienoyl Ethanolamide CYP450 cytochrome P450 metabolites AEA arachidonoyl ethanolamides anandamide lipids neurotransmitter cannibinergic cannabinoid CB1 CB2 receptors enzymatic metabolism FAAH fatty acid amide hydrolases endocannabinoid neurochemistry anxiety depression neuroscience 14,15-EET 14,15-EpETrE 14,15-EET-EA 14,15-EET-ethanolamide 14,15-epetre-ea 14,15-ethanolamide cbs synthetic cannabinoids 22.645801104972
11206 1,4-Dibenzylpiperazine (hydrochloride) New 2298-55-7 ≥98% 2012-02-23 7.829794509491 1-4-dibenzylpiperazine-hydrochloride DBZP NSC128882 EINECS 239-574-4 1034-11-3 hydrochloride HCl dihydrochloride forensics piperazines phenylpiperazines designer drugs 5-HT serotonin dopamine BZP stimulants inhibits inhibitors inhibition monoamine MDBP NSC-128882 NSC 12882 7.829794509491
11112 1-(4-Fluorobenzyl) piperazine (hydrochloride) New 199672-06-5 ≥98% 2012-02-20 2.456760235297 1-4-fluorobenzyl-piperazine-hydrochloride 70931-28-1 forensics piperazines phenylpiperazines designer drugs 5-HT serotonins BZP monoamines MDBP hydrochloride HCl 2.456760235297
33550 (±)14-HDoHE 87042-40-8 ≥98% 17.599931491713 -14-hdohe 14-hydroxy Docosahexaenoic Acid racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)14-HDoHEs (+/-)HDoHEs neurochemistry 14-hdha 17.599931491713
10010132 15-deoxy-Δ12,14-Prostaglandin J2-2-glycerol ester - ≥98% (isomer mixture) 2008-06-09 19.581055862492 15-deoxy-12-14-prostaglandin-j2-2-glycerol-ester 15-deoxy-Δ12,14-PGJ2-2-glycerol ester PPARgamma PPAR.gamma. PPARg PGD2 PGJ2 lipolysis prostaglandins adipocyte endocannabinoid metabolism diabetes obesity nuclear receptors COX-2 COX2 2-AG 2AG cannabinoids cbs synthetic 19.581055862492
10169 15(S)-HETE Ethanolamide 161744-53-2 ≥98% 19.370883977900 15-s-hete-ethanolamide 15(S)-HAEA neurotransmitters ethanolamides fatty acids endocannabinoids CB receptors amide hydrolases FAAH neurochemistry neuroscience ethanolamines 15HETE cannabinoids cbs synthetic 19.370883977900
10174 16(17)-EpDPE - ≥90% 2004-01-14 34.388830570902 16-17-epdpe 16,17-epoxy Docosapentaenoic Acid; 16,17 EDP epoxides epoxygenases cytochrome P450 (±)16,17-EpDPEs (+/-)16,17-EpDPEs fatty acids (+/-)16(17)EpDPEs 16(17)EETs eicosatrienoic neurochemistry 16,17-EDP 16,17EDP 34.388830570902
33600 (±)16-HDoHE 90780-51-1 ≥98% 12.159311694291 -16-hdohe 16-hydroxy Docosahexaenoic Acid racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)16-HDoHEs (+/-)HDoHEs neurochemistry 12.159311694291
33650 (±)17-HDoHE 90780-52-2 ≥98% 18.841629834254 -17-hdohe 17-hydroxy Docosahexaenoic Acid racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)17-HDoHEs (+/-)HDoHEs neurochemistry 18.841629834254
14810 17-phenyl trinor Prostaglandin E2 38315-43-4 >98% 59.319171270718 17-phenyl-trinor-prostaglandin-e2 17-phenyl trinor PGE2 agonists EP1 EP3 prostaglandins receptors 17-phenyl-trinor-PGE2 59.319171270718
10004238 17-phenyl trinor Prostaglandin E2 serinol amide - ≥95% 2004-05-13 25.834298342541 17-phenyl-trinor-prostaglandin-e2-serinol-amide 17-phenyl trinor PGE2-SA agonists EP1 EP3 prostaglandins receptors 17-phenyl-trinor-PGE2 analogs 17-phenyl-PGE2SA 17-phenyl-PGE2-SA amides cannabinoids Cbs sythetic 25.834298342541
10004237 17-phenyl trinor Prostaglandin F2α serinol amide - ≥98% 2004-03-15 6.814792817679 17-phenyl-trinor-prostaglandin-f2-serinol-amide 17-phenyl trinor PGF2α-SA; Bimatoprost serinol amide analogs agonists receptors 17-phenyl-PGF2.alpha.SA 17-phenyl-PGF2alphaSA 17-phenyl-PGF2a-SA prostaglandins cannabinoids CBs synthetic 6.814792817679
10005099 17(R)-HDoHE Exclusive 155976-53-7 ≥98% ✓ 2005-01-05 25.056148382005 17-r-hdohe 17(R)-hydroxy Docosahexaenoic Acid resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry 25.056148382005
10009799 17(S)-HDoHE - ≥98% 2007-03-12 13.789244935543 17-s-hdohe 17(S)-hydroxy Docosahexaenoic Acid resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry 17(s)-hdohe 13.789244935543
10175 19(20)-EpDPE - ≥98% 2004-01-14 40.950773480663 19-20-epdpe 19,20-epoxy Docosapentaenoic Acid; 19,20 EDP metabolites epoxides epoxygenases cytochrome P450 (±)19,20-EpDPEs (+/-)19,20-EpDPEs fatty acids (+/-)19(20)EpDPEs 19(20)EETs eicosatetraenoic 19,20-EETs neurochemistry 19,20-EDP 19,20EDP 40.950773480663
62150 1-Arachidonoyl Glycerol Exclusive 35474-99-8 >95% (as a 9:1 mixture of the 1-AG and 2-AG) ✓ 9.454548802946 1-arachidonoyl-glycerol 1-AG cannabinoids glycerol anandamides fatty acids neurochemistry neuroscience 9.454548802946
362152 1-Arachidonoyl Glycerol-d5 - ≥99% deuterated forms (d1-d5) 36.490704419889 1-arachidonoyl-glycerol-d5 1-AG-d5 deuterium isotopes GC/MS endocannabinoids anandamides 1AG-d5 GC-MS mass spectrometry LC/MS LC-MS deuterated standards 1-AG-d5 internal fatty acids cannabinoids cbs synthetic 36.490704419889
11205 1-(m-Trifluoromethylphenyl) piperazine (hydrochloride) New 76835-14-8 ≥98% 2012-02-21 4.482171419508 1-m-trifluoromethylphenyl-piperazine-hydrochloride TFMPP EINECS 239-574-4 NSC128882 NSC-12882 STK397247 AG-E-03624 T-6427 LS-184023 15532-75-9 forensics piperazine phenylpiperazine designer drugs 5-HT serotonin dopamine MDMA BZP party pills powders seizures metabolism rats 4.482171419508
11687 1'-Naphthoyl Indole New 109555-87-5 ≥98% 2012-05-01 100.035968650112 1-naphthoyl-indole indol-3-yl 1-naphthyl ketones synthetic cannabinoids CBs receptors CB1 central CB2 peripheral napthoylindole indoles herbals blends recreational cannabimimetics N-alkyl chains forensics designer drugs incense 100.035968650112
11204 1-(p-Fluorophenyl) piperazine (hydrochloride) New 64090-19-3 ≥98% 2012-02-20 4.805978985297 1-p-fluorophenyl-piperazine-hydrochloride pFPP; NSC 149515 NSC149515 NSC-149515 SBB003383 16141-90-5 forensics piperazine phenylpiperazine designer drugs 5-HT serotonin hydrochloride HCl 4.805978985297
33750 (±)20-HDoHE 90906-41-5 ≥98% 15.101024401473 -20-hdohe 20-hydroxy Docosahexaenoic Acid racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)20-HDoHEs (+/-)HDoHEs neurochemistry 15.101024401473
10008602 20-HETE Ethanolamide - ≥98% 2006-09-26 42.358876611418 20-hete-ethanolamide 20-hydroxy AEA; 20-hydroxy Arachidonoyl Ethanolamide hydroxy fatty acids omega-oxidation .omega.-oxidation w-oxidation cytochrome P450 CYP450 arachidonic HETEs metabolites P-450 vasoconstrictors vasoconstriction ethanolamides cannabinoids cbs synthetic 42.358876611418
10009501 20-hydroxy N-Arachidonoyl Taurine - >95% 2008-04-23 14.306108041743 20-hydroxy-n-arachidonoyl-taurine metabolism metabolites CYP450 20-HETE taurines vasoconstrictors TRPV1 TRPV4 FAAH 14.306108041743
10009962 2-(14,15-Epoxyeicosatrienoyl) Glycerol 848667-56-1 ≥95% 2008-04-03 39.494825046040 2-14-15-epoxyeicosatrienoyl-glycerol 2-14,15-EG 2-AG CYP450 metabolism mitogens cancers kidneys endocannabinoids cannabinoids cbs synthetic 39.494825046040
9001133 2,3-Methylenedioxymethcathinone (hydrochloride) New - ≥98% 2012-01-26 35.088433376594 2-3-methylenedioxymethcathinone-hydrochloride 2,3-MDMC forensics phenethylamines cathinones designer drugs amphetamines bath salts party pills plants food hydrochloride HCl 35.088433376594
11463 2,3-Pentylone isomer (hydrochloride) New - ≥98% 2012-02-27 37.046086359592 2-3-pentylone-isomer-hydrochloride designer drugs amphetamines phenethylamines bath salts party pills powders hydrochloride HCl forensics isomers 37.046086359592
9000683 25-hydroxy Vitamin D3 New 19356-17-3 ≥98% 2012-01-12 62.289278752437 25-hydroxy-vitamin-d3 RO 8-8892; Rovimix Hy-D; U 32070E; 25-hydroxy Cholecalciferol 25631-40-7 calcidiol calcifediol calderol dedrogyl didrogyl hidroferol Hy-D Ro 8-8892 Rovimix Hy-D U 32070E U-32070E U32070E 25-OH cholecalciferol 25-OH vitamin D3 25-hydroxyvitamin D3 phosphorus metabolism neuromuscular inflammatory intermediates receptors livers kidneys plasma serum 62.289278752437
9001128 25I-NBOMe New 1043868-97-8 ≥98% 2012-02-06 100.146936810764 25i-nbome 919797-19-6 serotonin 5-HT2A hallucinogenic frontal cortex agonists forensic sciences phenethylamines neuroscience receptors brains memory schizophrenia hallucinogenic drugs 25I-NMBOMe 100.146936810764
64970 2-APB 524-95-8 >98% 59.117366482504 2-apb receptors inositol-1,4,5-triphosphates calcium signalling ins(1,4,5)IP3 blocked inositols antagonists Ca2+ neurochemistry neuroscience 59.117366482504
62160 2-Arachidonoyl Glycerol 53847-30-6 >95% (as a 9:1 mixture of the 2-AG and 1-AG) 43.426339384372 2-arachidonoyl-glycerol 2-AG endocannabinoids anandamides 2AG fatty acids CB1 neuroscience neurochemistry endocrinology cannabinoids cbs synthetic 43.426339384372
362162 2-Arachidonoyl Glycerol-d5 - ≥99% deuterated forms (d1-d5) 47.930980662983 2-arachidonoyl-glycerol-d5 2-AG-d5 deuterium isotopes GC/MS endocannabinoids anandamides 2AG-d5 GC-MS mass spectrometry LC/MS LC-MS deuterated standards 2-AG-d5 internal fatty acids lipids neurochemistry neuroscience endocrinology cannabinoids cbs synthetic 47.930980662983
362160 2-Arachidonoyl Glycerol-d8 - ≥99% deuterated forms (d1-d8) 84.020801104972 2-arachidonoyl-glycerol-d8 2-AG-d8 deuterium isotopes GC/MS endocannabinoids anandamides 2AG-d8 GC-MS mass spectrometry LC/MS LC-MS deuterated standards internal neurochemistry neuroscience endocrinology cannabinoids cbs synthetic 84.020801104972
62165 2-Arachidonyl Glycerol ether 222723-55-9 >98% 32.466556169429 2-arachidonyl-glycerol-ether Noladin; 2-AG ether endocannabinoids 2AG anandamides CB1 receptor selective selectivity agonists stable 2-AG-ether analogs fatty acids neurochemistry neuroscience lipids cannabinoids cbs synthetic 32.466556169429
10395 2C-E New 71539-34-9 ≥95% 2012-01-11 30.809779871310 2c-e 2,5-Dimethoxy-4-ethylphenethylamine forensics designer drugs phenethylamines serotonin norepinephrine dopamine monoamines oxidase inhibitors 2Cs psychoactive metabolism 4-ethyl-2,5-dimethoxy-phenethylamine 4-ethyl-2,5-dimethoxy-β-phenethylamine 2ce 30.809779871310
9000787 2-chloro-3-Deazaadenosine 40656-71-1 ≥98% 2011-06-29 1.173011049723 2-chloro-3-deazaadenosine 2-CADO; NSC 158900; 6-Amino-2-chloropurine riboside adenosine receptors analogs agonists seizures neuroscience NSC158900 NSC-158900 neurotransmission A1 A2A A2B A3 G protein-coupled 2-chloroadenosine 2CA 2-CA 2 CA CADO 1.173011049723
11113 2C-I (hydrochloride) New 64584-32-3 ≥98% 2012-01-17 35.745325722822 2c-i-hydrochloride forensics designer drugs phenethylamines serotonin norepinephrine dopamine monoamine oxidase inhibitors hydrochloride HCl psychoactive metabolism 2CI 2C I 35.745325722822
11199 2-Ethylethcathinone (hydrochloride) New - ≥98% 2012-02-10 7.436028289606 2-ethylethcathinone-hydrochloride 2-EEC forensics phenethylamines amphetamines cathinones designer drugs ethcathinones hydrochloride HCl 2EEC 2 EEC 7.436028289606
9001081 2-Ethylmethcathinone (hydrochloride) New - ≥98% 2012-02-13 18.143856848266 2-ethylmethcathinone-hydrochloride 2-EMC designer drugs forensics amphetamines phenethylamines cathinones hydrochloride HCl stumulants entactogens mephedrone 2 EMC 2EMC 4-MMC 4 MMC 4MMC bath salts plants food tablets 18.143856848266
11419 2-Fluoroamphetamine (hydrochloride) New 1626-69-3 ≥98% 2012-02-07 45.961968629073 2-fluoroamphetamine-hydrochloride 2-FA 1716-60-5 designer drugs amphetamines phenethylamines bath salts monoamine neurotransmitters isomers 4-FA 4 FA 2 FA forensics hydrochloride HCl 45.961968629073
11229 2-Fluoroethcathinone (hydrochloride) Exclusive New - ≥98% ✓ 2012-01-27 30.894157483765 2-fluoroethcathinone-hydrochloride 2-FEC forensics phenethylamine cathinones designer drugs amphetamines hydrochloride HCl bath salts plants food pills 30.894157483765
11420 2-Fluoromethamphetamine (hydrochloride) Exclusive New - ≥98% ✓ 2012-02-09 39.954189325844 2-fluoromethamphetamine-hydrochloride 2-FMA methamphetamines forensic science stimulant 4-fluoromethamphetamine 4-FMA MDMA amphetamines 4FMA FMAs 39.954189325844
62260 2-Linoleoyl Glycerol Exclusive 3443-82-1 >98% ✓ 18.476045777426 2-linoleoyl-glycerol 2-LG CB1 glycerols 2LG cannabinoids 2-Linoleoyl-Glycerol reuptake endocannabinoids receptors congeners fatty acids neurochemistry neuroscience lipids cannabinoids cbs synthetic 18.476045777426
9001186 2-Methoxymethcathinone (hydrochloride) New - ≥98% 2012-02-06 31.157286619093 2-methoxymethcathinone-hydrochloride 2-MMC forensics phenethylamines amphetamines cathinones designer drugs isomers methedrone party pills bath salts hydrochloride HCl bronchodilator receptors agonists methoxyphenamine 2MMC 2 MMC 31.157286619093
90055 (±)-2-Methyl Arachidonoyl-2'-Fluoroethylamide 166100-39-6 >95% 20.331703499079 -2-methyl-arachidonoyl-2-fluoroethylamide O-689; 2-Methyl-2'-fluoro Anandamide; 2-methyl-2'-fluoro AEA anandamides ethanolamides AEA cannabinoids receptors CB1 binding affinity faah fatty acid hydrolases .DELTA.9-THC .DELTA.9THC DELTA9-THC DELTA9THC D9-THC D9THC tetrahydrocannabidiol selective analogs neurochemistry neuroscience fluoromethanandamide 20.331703499079
11221 2-Methylethcathinone (hydrochloride) New - ≥98% 2012-02-29 32.915391834472 2-methylethcathinone-hydrochloride 2-MEC forensics phenethylamines cathinones designer drugs amphetamines hydrochloride HCl 4-MEC 9001069 9001098 psychoactive 32.915391834472
11223 2-Methylmethcathinone (hydrochloride) New 1246815-51-9 ≥98% 2012-02-09 28.746543352722 2-methylmethcathinone-hydrochloride 2-MMC forensics science phenethylamines cathinones designer drugs amphetamines bath salts mephedrone 3MMC 4MMC MMCs 4-MMC 1246911-71-6 HCl cathinones 28.746543352722
9001188 2-Methyl-α-pyrrolidinobutiophenone (hydrochloride) New - ≥98% 2012-02-27 28.450942938118 2-methyl-pyrrolidinobutiophenone-hydrochloride 2-MPBP forensics phenethylamines amphetamines cathinones designer drugs 2 MPBP 4-MPBP 4 MPBP party pills powders isomers hydrochloride HCl 28.450942938118
10007980 3,4-DAA - ≥95% 2006-08-09 1.842265193370 3-4-daa Trp tryptophan Multiple Sclerosis MS T helper-1 TH1 cytokines EAE encephalomyelitis inflammation immunity autoimmune autoimmunity cells cytokines 1.842265193370
10515 3,4-Dihydroxymethamphetamine (trifluoroacetate salt) Exclusive New - ≥95% ✓ 2012-05-02 88.661196842730 3-4-dihydroxymethamphetamine-trifluoroacetate-salt DHMA; HHMA 438625-59-3 15398-87-5 MDMA metabolism amphetamines forensics ecstasy CYP2D6 COMT HMMA catecholamine hypothalamic vasopressin oxytocin serotonergic neurotoxicity trifluoroacetate salts 88.661196842730
11128 3,4-Dimethoxymethamphetamine (hydrochloride) New 70932-18-2 ≥97% 2012-02-20 24.461015629855 3-4-dimethoxymethamphetamine-hydrochloride 3,4-DMMA 33236-61-2 52370-71-5 HCl hydrochloride analogs forensics methamphetamines designer drugs amphetamines ecstasy MDMA phenethylamines serotonin norepinephrine dopamine 5-HT noradrenalin methylenedioxymethamphetamine 24.461015629855
11228 3,4-Dimethylethcathinone (hydrochloride) New - ≥95% 2012-01-23 17.434146196736 3-4-dimethylethcathinone-hydrochloride 3,4-DMEC hydrochloride HCl forensics phenethylamines cathinones designer drugs amphetamines psychoactive 17.434146196736
9001098 3,4-Dimethylmethcathinone (hydrochloride) New 1081772-06-6 ≥98% 2012-01-19 44.825842270628 3-4-dimethylmethcathinone-hydrochloride 3,4-DMMC 1082110-00-6 forensics phenethylamines cathinones designer drugs amphetamines hydrochloride HCl 4-methylmethcathinone 4-MMC 4 MMC 4MMC psychoactive bath salts plants food research 3,4 DMMC 3,4DMMC 44.825842270628
10397 3-amino Benzamide 3544-24-9 ≥98% 2011-10-07 2.107037223058 3-amino-benzamide 3-(Aminocarbonyl) Aniline; 3-Carboxamidoaniline poly(ADP-ribose) polymerases PARPs DNA repairs DNA strands breaks apoptosis inflammation atherosclerosis neruogenesis cancers angiogenesis signaling cellular responses inhibits inhibitor inhibition telomere shortening shortens stimulates mediated mediates PARP-mediated 2.107037223058
10918 (±)3-epi CP 47,497-C8-homolog - ≥98% 2011-05-06 9.598423751790 -3-epi-cp-47-497-c8-homolog (±)-trans-CAY10596 (±)-3-epi CP 47,497-C8 analogs trans-CAY10596 cannabinoids analogs receptors by-product standards (+)-CP 47,497-C8 CB2 CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 13802 9.598423751790
13802 (±)3-epi CP 47,497-C8-homolog (solution) Exclusive - ≥98% ✓ 2010-08-04 9.270452402875 -3-epi-cp-47-497-c8-homolog-solution (±)-trans-CAY10596 (±)-3-epi CP 47,497-C8 analogs trans-CAY10596 cannabinoids analogs receptors by-product standards (+)-CP 47,497-C8 CB2 CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 10918 9.270452402875
11198 3-Ethylethcathinone (hydrochloride) New - ≥98% 2012-01-24 10.521614835789 3-ethylethcathinone-hydrochloride 3-EEC 3EEC EECs forensics phenethylamines amphetamines cathinones designer drugs ethcathinones psychoactive 10.521614835789
9001082 3-Ethylmethcathinone (hydrochloride) New - ≥98% 2012-01-27 24.225759184927 3-ethylmethcathinone-hydrochloride 3-EMC designer drugs forensics hydrochloride HCl stimulants entactogen amphetamines phenethylamines cathinones mephedrone bath salts plants food tablets 24.225759184927
9001191 3-Fluoroamphetamine (hydrochloride) New 1716-59-2 ≥98% 2012-02-07 53.541097069440 3-fluoroamphetamine-hydrochloride 3-FA 1626-71-7 designer drugs amphetamines phenethylamines bath salts isomers 3 FA 4-FA 4 FA monoamine neurotransmitters hydrochloride HCl 53.541097069440
11230 3-Fluoroethcathinone (hydrochloride) New - ≥98% 2012-02-03 30.150779803396 3-fluoroethcathinone-hydrochloride 3-FEC forensics phenethylamine cathinones designer drugs amphetamines bath salts plants food pills hydrochloride HCl 30.150779803396
9001185 3-Fluoromethamphetamine (hydrochloride) New - ≥98% 2012-02-10 44.888826616684 3-fluoromethamphetamine-hydrochloride 3-FMA designer drugs amphetamines phenethylamines bath salts 4 FMA 4FMA stimulants methamphetamines powders isomers hydrochloride HCl forensics 3FMA 3 FMA 44.888826616684
10730 3-Fluoromethcathinone (hydrochloride) - ≥98% 2011-04-26 51.741855430261 3-fluoromethcathinone-hydrochloride 3-FMC flephedrones cathinones analogs designer drugs plant feeders forensic analysis CMF-3 1049677-77-1 51.741855430261
9001187 3-Methoxymethcathinone (hydrochloride) New - ≥98% 2012-03-06 35.315411656060 3-methoxymethcathinone-hydrochloride 3-MMC forensics phenethylamines amphetamines cathinones designer drugs MMC 3MMC MMMA HCl methedrone bath salts party pills hydrochloride 35.315411656060
11222 3-Methylethcathinone (hydrochloride) New - ≥98% 2012-02-06 30.307522270377 3-methylethcathinone-hydrochloride 3-MEC forensics phenethylamines cathinones designer drugs amphetamines 3MEC 3 MEC hydrochloride HCl 30.307522270377
11224 3-Methylmethcathinone (hydrochloride) New 1246816-62-5 ≥97% 2012-02-03 31.276075269567 3-methylmethcathinone-hydrochloride 3-MMC 1246911-86-3 forensics phenethylamines cathinones designer drugs amphetamines synthetic bath salts powders mephedrone 3 MMC 4-MMC 4 MMC 4-methylmethcathinone 31.276075269567
9001189 3-Methyl-α-pyrrolidinobutiophenone (hydrochloride) New - ≥98% 2012-02-14 23.207766908327 3-methyl-pyrrolidinobutiophenone-hydrochloride 3-MPBP forensics phenethylamines amphetamines cathinones designer drugs 3 MPBP 3MPBP isomers party pills powders metabolism hydrochloride HCl 23.207766908327
90312 4,5-dehydro Docosahexaenoic Acid - ≥98% 25.332228360957 4-5-dehydro-docosahexaenoic-acid 4,5-dehydro Cervonic Acid; 4,5-dehydro DHA w-3 fatty acids omega-3 .omega.-3 n-3 analogs acetylene 5-LO 5-lipoxygenases inhibits inhibitors 25.332228360957
90314 4(5)-EpDPE methyl ester 121818-29-9 ≥98% 28.196648250460 4-5-epdpe-methyl-ester 4,5-epoxy Docosapentaenoic Acid methyl ester; 4,5-EDP methyl ester cytochrome P450 metabolites epoxide epoxygenase neurochemistry 28.196648250460
11231 4-Fluoroethcathinone (hydrochloride) New - ≥98% 2012-01-16 30.365141241109 4-fluoroethcathinone-hydrochloride 4-FEC forensics phenethylamine cathinones designer drugs amphetamines psychoactive plants feeder capsules analogs ehtyl groups methyl amino flephedrone 4 FMC 4 FEC 30.365141241109
9001146 4-Fluoroisocathinone (hydrochloride) Exclusive New - ≥98% ✓ 2012-03-28 59.945131336918 4-fluoroisocathinone-hydrochloride 4-FIC designer drugs forensics cathinones phenethylamines hydrochloride HCl 59.945131336918
9001070 4-Fluoromethamphetamine (hydrochloride) 52063-62-4 ≥98% 2011-08-08 39.286209668883 4-fluoromethamphetamine-hydrochloride 4-FMA methamphetamines forensic sciences stimulants 4 fluoromethamphetamine 4FMA FMA MDMA amphetamines 4-fluoroamphetamine 351-03-1 39.286209668883
10859 4-Fluoromethcathinone (hydrochloride) 7589-35-7 ≥98% 2011-05-31 55.123920806166 4-fluoromethcathinone-hydrochloride 4-FMC; Flephedrone flephedrones 4-FMC cathionones analogs 4 FMC 4FMC derivatives drugs plants feeders forensics 447-40-5 4-fluoroephedrone hcl 55.123920806166
33200 (±)4-HDoHE 90906-40-4 ≥98% 16.977554648090 -4-hdohe 4-hydroxy Docosahexaenoic Acid racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)4-HDoHEs (+/-)HDoHEs neurochemistry 16.977554648090
11312 4-hydroxy DIPT (hydrochloride) New 63065-90-7 ≥95% 2012-05-16 90.000000000000 4-hydroxy-dipt-hydrochloride 4-OH DIPT 132328-45-1 hallucinogens tryptamine forensics science psilocin mushrooms psilocybe panaeolus natural hydrochloride HCl 4-HO DIPT 4-hydroxy-DIPT 4-OH-DIPT 90.000000000000
11148 4-hydroxy MET New 77872-41-4 ≥98% 2012-05-16 90.000000000000 4-hydroxy-met Metocin; 4-OH MET psychoactive tryptamines forensics science psilocin mushrooms psilocybe panaeolus natural 4-HO-MET 4-hydroxy-MET 4-OH-MET 90.000000000000
11552 4-hydroxy MIPT New 77872-43-6 ≥98% 2012-05-21 153.444444444445 4-hydroxy-mipt 4-OH MIPT hallucinogens tryptamines forensics science psilocin serotonergic LSD mushrooms psychoactive mescaline psychedelics 4-HO-MIPT 4-OH-MIPT 153.444444444445
13265 4-hydroxy Nonenal Alkyne Exclusive 1011268-23-7 ≥98% ✓ 2010-06-16 136.023106200123 4-hydroxy-nonenal-alkyne Click Tag™ 4-HNE alkyne lipids peroxidation inflammation neurodegeneration atherosclerosis diabetes cancers click chemistry Click Tag™ 4-HNEs alkynes IT 136.023106200123
9000895 4-methoxy DMT Exclusive 3965-97-7 ≥98% ✓ 2011-11-21 40.646844689994 4-methoxy-dmt 4-MeO DMT; 4-methoxy-N,N-Dimethyltryptamine hallucinogen DMT dimethyltryptamine 5-HT receptors agonists 5-hydroxytryptamine behavior neuroscience forensics 4-OMe DMT 4 OMe DMT 4OMe DMT tryptamine 40.646844689994
9001069 4-Methylethcathinone (hydrochloride) Exclusive 1266688-86-1 ≥98% ✓ 2011-07-18 67.383227647416 4-methylethcathinone-hydrochloride 4-MEC; 4-methyl-N-ethyl Cathinone forensic sciences designer drugs methamphetamines 4methylethcathinone 4 methylethcathinones mephedrones cathinones analogs MDMA amphetamines plant feeders 1225617-18-4 67.383227647416
10801 4-Methylmethcathinone (hydrochloride) 1189726-22-4 ≥98% 2011-06-17 36.971516916490 4-methylmethcathinone-hydrochloride 4-MMC; 4-Methylephedrone; Mephedrone designer drugs methcathinone cathinones methamphetamine bath salts plants food feeder forensics psychoactive analysis hallucinogen meow bounce bubbles mad cow 4MMC MMC methylephedrone 1189805-46-6 4-methyl-methcathinone 36.971516916490
9001190 4-Methyl-α-pyrrolidinobutiophenone (hydrochloride) New 1214-15-9 ≥98% 2012-02-17 24.209813254137 4-methyl-pyrrolidinobutiophenone-hydrochloride 4-MPBP; F 1938 732180-91-5 forensics phenethylamines amphetamines cathinones designer drugs 4-methyl-α-pyrrolidinobutyrophenone 4 MPBP 4MPBP synthetic party pills powders metabolism F-1938 F1938 24.209813254137
10448 4'-Methyl-α-pyrrolidinohexanophenone (hydrochloride) - ≥98% 2011-10-21 24.901178637201 4-methyl-pyrrolidinohexanophenone-hydrochloride MPHP 34138-58-4 designer drugs forensics pyrovalerone bath salts MPPP PPP α-PPP α PPP psychostimulant toxic liver damage rabdomyloysis 24.901178637201
13140 4-(n-nonyl) Benzeneboronic Acid 256383-45-6 ≥98% 2009-11-04 6.628153775322 4-n-nonyl-benzeneboronic-acid fatty acids amide hydrolase FAAH endocannabinoids arachidonoyl ethanolamides AEA inhibitors inhibit monoacylglycerol lipase MAGL 2-arachidonoyl glycerol 2-AG 2AG 2 AG inhibition cannabinoids cbs synthetic 6.628153775322
11093 4-Quinolone-3-Carboxamide CB2 Ligand New 1314230-69-7 ≥98% 2012-01-30 29.832711699173 4-quinolone-3-carboxamide-cb2-ligand 4Q3C CB2 Ligand CB1 CB2 cannabinoid CBs central peripheral receptors inverse agonists antinociception AM630 analgesic pain osteoporosis synthetic ligands mice analgesic AM 630 AM-630 29.832711699173
11094 4-Quinolone-3-Carboxamide Furan CB2 Agonist New 1314230-75-5 ≥98% 2012-02-28 32.235202229476 4-quinolone-3-carboxamide-furan-cb2-agonist 4Q3C CB2 Agonist cannabinoids CBs agonists receptors CB1 CB2 AM630 pain neuroscience osteoporosis inflammation anti-inflammatory bones research peripheral AM630 AM 630 AM-630 32.235202229476
10008596 5(6)-EET Ethanolamide - ≥95% 2006-10-20 9.080923441200 5-6-eet-ethanolamide 5(6)-EpETrE Ethanolamide epoxides epoxygenases 5,6-EETs cytochrome P450 (+/-)5(6)-EpETrEs (+/-)5,6-EpETrEs fatty acids esters ethanolamides metabolites AEA anandamides arachidonoyl neurotransmitters cannabinergic endocannabinoids CB1 CB2 receptors central peripheral FAAH hydrolases metabolism lipoxygenases inhibition (±)5(6)-Epoxy eicosatrienoyl 14,15-EET 14,15-EpETrE 14,15-EET-EA 14,15-EET-ethanolamide 14,15-epetre-ea 14,15-ethanolamide cannabinoids cbs synthetic 9.080923441200
11134 5-APB (hydrochloride) Exclusive New 286834-80-8 ≥95% ✓ 2012-01-13 27.040298507463 5-apb-hydrochloride 5-(2-aminopropyl)benzofuran 6-APB benzofurans amphetamines phenethylamines MDA 5-APDB forensics designer drugs analogs stimulants entactogens 1-benzofuran-5yl-propan-2-amine 27.040298507463
13803 (±)5-epi CP 55,940 - ≥98% 2010-08-04 8.949804118533 -5-epi-cp-55-940 (±)-5-trans-CP 55,940 (±)-CP 55,940 cannabinoids analogs receptors pains analgesics by-products standards Δ9-THC delta-tetrahydrocannabidiol CP 55940 CP44950 CP-55940 CP55,940 8.949804118533
11035 5-IAI (hydrochloride) New - ≥98% 2011-12-09 16.607995033359 5-iai-hydrochloride 5-iodo-2-Aminoindan 132367-76-1 phenethylamines phenylethylamines forensics indans indanes analogs MDMA rats serotonin hi hydrochloride hcl AI 5IAI psychoactive alkaloids 3,4-methylenedioxymethamphetamine 16.607995033359
10729 5-methoxy DALT 928822-98-4 ≥95% 2011-04-05 90.911305340699 5-methoxy-dalt N,N-Diallyl-5-Methoxytryptamine tryptamines neuroscience forensics designer drugs 5-MeO-DALT MeO TRYPTAMINE, n,n-DIALLYL-5-METHOXY N,N-DIALLYL-5-METHOXYTRYPTAMINE INDOLE, 3-[2-(DIALLYLAMINO)ETHYL]-5-METHOXY 3-[2-(DIALLYLAMINO)ETHYL]-5-METHOXYINDOLE 5-Methoxy-DALT 5-MeO-DALT DALT 5-meo-dalt meo 5meo meodalt 90.911305340699
11480 5-methoxy DMT New 1019-45-0 ≥98% 2012-03-20 53.411546961326 5-methoxy-dmt 5-methoxy-N,N-Dimethyltryptamine; 5-MeO-DMT hallucinogenic indolealkylamine serotonin 5-HT receptors regulated scheduled psychoactives party pills monoamines oxidases inhibitors inhibits inhibition pharmacological toxilogical forensics tryptamines dimethyltryptamines 5-hydroxytryptamines agonists MAOs MAOIs N,N-Dimethyl-5-methoxytryptamine 53.411546961326
11482 5-methoxy MiPT New 96096-55-8 ≥98% 2012-04-09 153.444444444445 5-methoxy-mipt 5-MeO MiPT tryptamine monoamines inhibitors inhibits inhibition serotonin 5-HT dopamine norepinephrine forensics designer drugs 5 methoxy MiPT psychedelic rats brains synaptosomes 153.444444444445
90195 5(Z),8(Z),11(Z)-Eicosatrienoic Acid Ethanolamide 169232-04-6 ≥98% 8.987233319167 5-z-8-z-11-z-eicosatrienoic-acid-ethanolamide Mead Acid Ethanolamide cannabinoids neurotransmitter CB1 CB2 receptors ligands acids ethanolamides eicosatrienoyl fatty acids neurochemistry neuroscience ethanolamines 8.987233319167
10009315 6-Aminonicotinamide 329-89-5 ≥98% 2008-11-21 1.353038674033 6-aminonicotinamide 6-AN; NSC 21206; SR 4388 inhibitors inhibits inhibition 6-phosphoguconate dehydrogenase cancers ATPs oxidative injury neurodegeneration cardiovascular 1.353038674033
10010670 7-Aminoclonazepam-d4 - ≥99% deuterated product 2009-04-17 7.863259668508 7-aminoclonazepam-d4 seizures myotonic atonic epilepsy receptors acids deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 7.863259668508
33300 (±)7-HDoHE 90780-55-5 ≥98% 15.674330110497 -7-hdohe 7-hydroxy Docosahexaenoic Acid racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)7-HDoHEs (+/-)HDoHEs neurochemistry 15.674330110497
81340 7-Nitroindazole 2942-42-9 >98% 7.855365254757 7-nitroindazole nitric oxide synthases inhibitors nNOS eNOS iNOS inhibits anti-nociceptive antinociceptive neurochemistry 7.855365254757
10006878 8,12-iso-iPF2α-VI-d11 Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2005-09-01 7.929696132596 8-12-iso-ipf2-vi-d11 8,12-epi-iPF2α-VI-d11 GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry analogs internal standards isoprostanes prostaglandins free-radical lipid peroxidation stero- regioisomers arachidonic acids 8-isoprostane 8-epi-PGF2.alpha. iPF2.alpha.-III oxidative stress Type VI class internal lactones facilitates extraction and purification neurochemistry neuroscience 7.929696132596
10008597 8(9)-EET Ethanolamide - ≥98% 2007-07-05 17.391712707182 8-9-eet-ethanolamide 8(9)-EpETrE Ethanolamide AEA endocannabinoids arachidonoyl ethanolamide CYP450 cytochrome P450 metabolism ethanolamides hypertension cannabinoids cbs synthetic 17.391712707182
10010109 8-DY547-cGMP - ≥98% 2008-10-23 774.385911602210 8-dy547-cgmp CNGA2 channels activators fluorescences cyclic nucleotides 774.385911602210
33350 (±)8-HDoHE 90780-54-4 ≥98% 12.271558471454 -8-hdohe 8-hydroxy Docosahexaenoic Acid racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)8-HDoHEs (+/-)HDoHEs neurochemistry 12.271558471454
316350 8-iso Prostaglandin F2α-d4 211105-40-7 ≥99% deuterated forms (d1- d4) 101.686063535911 8-iso-prostaglandin-f2-d4 15-F2t-Isoprostane-d4; iPF2α-III-d4; 8-epi PGF2α-d4; 8-Isoprostane-d4 GC/MS deuterium isotopes 8-isoprostanes 8-epi-PGF2.alpha.-d4 8-epi-PGF2alpha-d4 8-iso-PGF2.alpha.-d4 8-iso-PGF2alpha-d4 internal standards prostaglandins mass spectrometry LC/MS GC-MS LC-MS deuterated 8-iso-PGF2a-d4 8-epi-PGF2a-d4 ipf2a neurochemistry 316351 101.686063535911
10005764 8-iso Prostaglandin F2α Ethanolamide - >98% 2004-09-24 34.617771639042 8-iso-prostaglandin-f2-ethanolamide 8-Isoprostane Ethanolamide; 8-epi PGF2α Ethanolamide; 8-iso PGF2α Ethanolamide; iPF2α-III Ethanolamide ethanolamides prostaglandins anandamides AEA COX-2 cox2 cyclooxygenases synthases isoprostanes 8-epi-PGF2alpha 8-iso-PGF2alpha arachidonoyl prostamides congeners decomposition standards non-enzymatic iPF2a-III PGHS2 PGHS-2 ethanolamines 714966-38-8 cannabinoids cbs sythetic 34.617771639042
516351 8-Isoprostane EIA Kit - 1077.174254143646 8-isoprostane-eia-kit iPF2α-III EIA Kit; 8-epi Prostaglandin F2α EIA Kit; 8-iso Prostaglandin F2α EIA Kit; 8-Isoprostane ELISA Kit solid plates oxidative injury stress reactive oxygen species 8-isoprostanes 8-epi-PGF2.alpha. 8-epi-PGF2alpha 8-iso-PGF2.alpha. 8-iso-PGF2alpha prostaglandins free radicals ROS peroxidation lipids measures kits eias enzyme immunoassays ELISAs assays 1077.174254143646
516360 8-Isoprostane Express EIA Kit - 2009-10-26 167.372591662480 8-isoprostane-express-eia-kit 8-epi Prostaglandin F2α Express EIA Kit; iPF2α-III Express EIA Kit; 8-Isoprostane Express ELISA Kit; 8-iso Prostaglandin F2α Express EIA Kit solid plates oxidative injury stress reactive oxygen species 8-isoprostanes 8-epi-PGF2.alpha. 8-epi-PGF2alpha 8-iso-PGF2.alpha. 8-iso-PGF2alpha prostaglandins free radicals ROS peroxidation lipids measures kits eias enzyme immunoassays ELISAs 167.372591662480
90375 9-Octadecenamide 301-02-0 ≥98% 4.665646408840 9-octadecenamide Oleamide; cis-9-Octadecenamide CSF sleep 9Z-octadecenamide fatty acids neurochemistry neuroscience 4.665646408840
10012588 A-803467 944261-79-4 ≥98% 2009-02-14 0.165745856354 a-803467 Nav1.8 sodium channels neuropathic pain inflammatory blockers inhibitors inhibits inhibition TTX-resistance TTX-R 0.165745856354
10092 Adenosine Receptor A2A Blocking Peptide - 2009-04-03 189.773494475138 adenosine-receptor-a2a-blocking-peptide A2AR blocking peptides Western blots immunoblotting ARA2A 189.773494475138
10005254 AFMK 52450-38-1 >98% 2004-10-28 2.108149171270 afmk melatonin metabolites metabolism radicals scavengers neurotransmitters eukaryotes circadean rhythms antioxidants plasma synthesis endocrinology neurochemistry 2.108149171270
13203 Agomelatine 138112-76-2 ≥98% 2009-11-06 1.596353591160 agomelatine Valdoxan® melatonin circadian rhythm MT1 MT2 serotonin 5-HT noradrenaline dopamine antidepressant anti-depressant S20098 S-20098 S 20098 1.596353591160
11566 AKB48 Exclusive New 1345973-53-6 ≥98% ✓ 2012-04-30 346.902866392707 akb48 APINACA cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetics AKB 48 AKB-48 JWH018 JWH18 JWH 018 adamantyl carboxamide JWH-018 JWH 18 JWH-18 peripheral central 9001193 11564 STS-135 STS 135 STS135 346.902866392707
10011546 AL 34662 210580-75-9 ≥98% 2008-11-12 45.421248618784 al-34662 AL 34497 serotonins 5-HTs 5HT 5-hydroxy trptamine IOPs intraocular pressure glaucoma ophthalmology lower 5-hydroxytrptamine 45.421248618784
10005223 AM1172 251908-92-6 >98% 2004-09-01 24.112353433011 am1172 cannabinoids neurotransmitters inhibitors AEA lipids CB1 CB2 receptors anandamide hydrolysis fatty acids inhibits arachidonoyl ethanolamides reuptake FAAH-resistant amide hydrolases neuroscience neurochemistry cannabinoids cbs synthetic 24.112353433011
9001055 AM1220 137642-54-7 ≥98% 2011-10-11 95.776710483354 am1220 [1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl]-1-naphthalenyl-methanone AM-2201 AM 2201 AM-1220 AM 1220 cannabinoids CB1 CB2 CBs receptors pains forensic science forensics 95.776710483354
11583 AM1220 azepane isomer Exclusive New - ≥98% ✓ 2012-05-15 154.933505217925 am1220-azepane-isomer cannabinoids CB1 herbals spices forensics cannabimimetics receptors agonists neurosciences CBs CB2 central peripheral AM-1220 AM 1220 isomers 154.933505217925
9001094 AM1235 Exclusive New 335161-27-8 ≥98% ✓ 2012-04-20 126.136499386126 am1235 cannabinoids CBs herbals incense receptors agonists CB1 CB2 forensics AM-1235 AM 1235 synthetic 126.136499386126
10010118 AM1241 444912-48-5 ≥97% 2007-08-29 98.893354337934 am1241 CB1 CB2 cannabinoids receptors agonists antagonists antinociception AM630 AM251 AM-1241 AM 1241 cannabinoids cbs synthetic AM1243 AM-1243 1243 98.893354337934
11282 AM1248 Exclusive New 335160-66-2 ≥98% ✓ 2012-02-06 65.101985322061 am1248 CBs cannabinoids synthetic agonist AM-1248 AMs 1248 forensic sciences receptors CB1 CB2 1-pentyl-3-(1-adamantoyl)indole AM679 AM-679 679 herbal blends smart products 65.101985322061
11194 AM2201 2-hydroxyindole metabolite Exclusive New - ≥98% ✓ 2012-05-15 102.711743400859 am2201-2-hydroxyindole-metabolite forensic sciences isomers cannabinoids CB1 CB2 urinary metabolites CBs central peripheral receptors AM-2201 AM 2201 102.711743400859
11192 AM2201 6-hydroxyindole metabolite Exclusive New - ≥98% ✓ 2012-02-28 64.736433003919 am2201-6-hydroxyindole-metabolite cannabinoids CBs CB1 CB2 receptors pain forensic science neuroscience metabolites AM-2201 AM 2201 synthetic central peripheral P450 P-450 cytochromes blood urine 64.736433003919
11193 AM2201 7-hydroxyindole metabolite Exclusive New - ≥98% ✓ 2012-01-16 66.198490982941 am2201-7-hydroxyindole-metabolite forensics sciences AM-2201 AM 2201 isomers cannabinoids receptors pain CBs CB1 CB2 metabolites urinary urine metabolism synthetic central peripheral 66.198490982941
9001031 AM2201 N-(2-fluoropentyl) isomer Exclusive New - ≥95% ✓ 2011-12-15 85.204461174323 am2201-n-2-fluoropentyl-isomer forensics AM-2201 AM 2201 isomers cannabinoids receptors pain CBs CB1 CB2 synthetic isomers fluorine pentyl chains synthetic central peripheral 85.204461174323
9001029 AM2201 N-(4-fluoropentyl) isomer Exclusive - ≥98% ✓ 2011-08-11 89.033418511995 am2201-n-4-fluoropentyl-isomer forensics sciences AM-2201 AM 2201 isomers cannabinoids receptors pain CBs CB1 CB2 central peripheral 89.033418511995
10203 AM2201 N-(4-hydroxypentyl) metabolite Exclusive - ≥98% ✓ 2011-10-11 122.314144531919 am2201-n-4-hydroxypentyl-metabolite AM-2201 AM 2201 cannabinoids cannabimimetic metabolites CB1 CB2 CBS receptors forensics synthetics smoking urinary urine potent synthetic 122.314144531919
11457 AM2201 N-(4-hydroxypentyl) metabolite-d5 Exclusive New - ≥99% deuterated forms (d1-d5) ✓ 2012-03-13 109.116260245029 am2201-n-4-hydroxypentyl-metabolite-d5 cannabinoids central peripheral metabolites CB1 CB2 receptors pain forensic sciences synthetics smoking urinary urine potent CBs AM2201 AM-2201 deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry standards 109.116260245029
11503 AM2232 New 335161-19-8 ≥95% 2012-03-29 93.166883692332 am2232 cannabinoids CBs CB1 CB2 central peripheral receptors forensics herbals incense agonists AM-2232 AM 2232 AMS 93.166883692332
11008 AM2233 444912-75-8 ≥98% 2011-10-24 109.136584896401 am2233 769958-75-0 forensic science cannabinoid receptors CB1 agonists WIN 55,212-2 WIN 55212-2 radioligands neuroscience 109.136584896401
11584 AM2233 azepane isomer Exclusive New - ≥98% ✓ 2012-05-08 163.905113566605 am2233-azepane-isomer cannabinoids CBs CB1 herbals spices forensics cannabimimetics agonists receptors neuroscience AM 2233 AM-2233 isomer 11008 163.905113566605
71670 AM251 183232-66-8 >98% 97.388179650992 am251 cannabinoids receptors antagonists CB1 analogs selective SR-141716-A AM-251 SR141716A neuroscience neurochemistry endocrinology 97.388179650992
13452 AM3102 Exclusive 213182-22-0 ≥98% ✓ 2009-08-11 40.003752932898 am3102 KDS-5104 OEA PPARs PPARα KDS5104 antiobesity anti-obesity CB1 CB2 endocannabinoids obesity cannabinoids inhibitors agonists receptors cbs synthetic 40.003752932898
90060 AM404 183718-77-6 >98% 33.186357081109 am404 N-(4-hydroxyphenyl)-Arachidonoyl Amide; 4-HPA cannabinoids neurotransmitter inhibitors AEA lipids CB1 CB2 receptors anandamide hydrolysis fatty acids neuroscience neurochemistry 33.186357081109
10006974 AM630 164178-33-0 ≥98% 2009-02-09 47.443079312365 am630 Iodopravadoline neurochemistry neuroscience cannabinoids CB1 CB2 antagonist inverse agonist antinociception pain receptors 47.443079312365
11504 AM679 Exclusive New 335160-91-3 ≥98% ✓ 2012-04-27 108.225876043367 am679 ams AM-679 AM 679 central peripheral receptors cannabinoids CBs CB1 CB2 incense agonists forensics spices designer drugs synthetic 108.225876043367
10567 AM694 Exclusive 335161-03-0 ≥95% ✓ 2011-01-31 60.006351580004 am694 cannabinoids CB1 CB2 receptors pain JWH neuroscience AM-694 AM 694 60.006351580004
10869 AM694 4-iodo isomer Exclusive - ≥97% ✓ 2011-06-21 41.204834254143 am694-4-iodo-isomer cannabinoids CBs cannabimimetics CB1 CB2 pain spices forensics synthetic receptors agonists AM-694 AM 694 analogs neuroscience 41.204834254143
10005098 AMC Arachidonoyl Amide - >98% 2004-08-31 15.040994475138 amc-arachidonoyl-amide 7-amino-4-methyl Coumarin-Arachidonamide; AMC-AA fatty acid amides hydrolases FAAH anandamides fluorescence coumarin 15.040994475138
11001 Anatabine 2743-90-0 ≥95% 2011-11-10 0.160220994475 anatabine alkaloids solanaceae tobacco Alzheimer’s diseases amyloid beta Aβ β-secretase BACE-1 NF-κB inflammation urine nicotine transcription proteins SHSY-5Y cells 0.160220994475
13523 Apelin-13 217082-58-1 ≥95% 2010-06-29 36.988508287293 apelin-13 ligands APJ receptors central nervous system cardiovascular functions fluid homeostasis neurosciences hypertension diabetes metabolic syndrome insulin HIV aids Peptide Factors Paracrine Paracrine Protein Factors Paracrine Peptide Factors Growth Factors 36.988508287293
13524 Apelin-36 252642-12-9 ≥95% 2011-04-04 34.961381215469 apelin-36 agonists receptors APJ cardiovascular functions fluids homeostasis hypertension insulin sensitivity apelin-17 apelins 17 13 36 apelin-13 HIV infections peptides mature G protein-coupled GPCR c-protein coupled 34.961381215469
10008617 Arachidonic Acid Leelamide - ≥95% 2006-09-27 14.271160220994 arachidonic-acid-leelamide AA cannabinoids central peripheral CB1 CB2 CP55940 PDK pyruvates dehydrogenases kinases anti-inflammatory inflammation phospholipases PLA2 inhibits inhibitors inhibition cannabinoids cbs sythetic 14.271160220994
10007904 Arachidonoyl-1-thio-Glycerol Exclusive - ≥98% ✓ 2006-01-24 17.398674033149 arachidonoyl-1-thio-glycerol 1-S-Arachidonoyl-1-mercapto-2,3-propanediol cannabinoids monoacylglycerols monoglycerol monoglyceride anandamides fatty acids neurochemistry neuroscience chromogenic substrates lipases 2-arachidonoyls 2-AG agonists central CB1 nervous system CNS rat brains MGL hydrolyzes arachidonic acids thioesters analogs thiols DTNB Ellman's reagents yellow cannabinoids cbs synthetic 17.398674033149
91054 Arachidonoyl 2'-Chloroethylamide 220556-69-4 >96% 26.423195211786 arachidonoyl-2-chloroethylamide 2'-chloro-AEA; ACEA agonists selective CB1 receptors AEA arachidonoyl ethanolamides cannabinoids selectivity hypothermia FAAH fatty acid amide hydrolases neurochemistry neuroscience thc tetrahydrocannabinoids ethanolamines 26.423195211786
90054 Arachidonoyl-2'-Fluoroethylamide 166100-37-4 >98% 4.681927886013 arachidonoyl-2-fluoroethylamide 2'-fluoro Anandamide; 2'-fluoro AEA anandamides cannabinoids neurotransmitters ligands AEA lipids CB1 CB2 receptors neurochemistry neuroscience 4.681927886013
10007295 Arachidonoyl amide 85146-53-8 >98% 2006-01-18 6.976716653512 arachidonoyl-amide Arachidonamide; Arachidonic Acid amide anandamides arachidonoyl ethanolamides AEA endogenous endocannabinoids CB1 CB2 receptors cellular uptake hydrolysis bonds enzymes fatty acids hydrolases FAAH N,N-dimethyl analogs human inhibits inhibition rat glial gap junction cell-cells communications neurochemistry hydroxyethyl moiety transporter astrocytoma neuroscience cannabinoids inhibitors 6.976716653512
91053 Arachidonoyl Cyclopropylamide 229021-64-1 >98% 21.903535911602 arachidonoyl-cyclopropylamide ACPA cannabinoids receptors CB1 agonists AEA FAAH fatty acid hydrolases substrates selective analogs anandamide arachiodonyl ethanolamides neurochemistry neuroscience thc tetrahydrocannabinoids ethanolamines 21.903535911602
90050 Arachidonoyl Ethanolamide 94421-68-8 ≥98% 44.704675456451 arachidonoyl-ethanolamide Anandamide; AEA cannabinoids neurotransmitter ligands lipids CB1 CB2 receptors AEA fatty acids neuroscience neurochemistry ethanolamines ethanolamides endocrinology 44.704675456451
10011178 Arachidonoyl Ethanolamide-d4 946524-40-9 ≥99% deuterated forms (d1-d4) 2008-03-04 40.586823204420 arachidonoyl-ethanolamide-d4 AEA-d4; Anandamide-d4 deuterium GC/MS internal isotopes standards ethanolamides LC/MS mass spectrometry cannabinoids fatty acids deuterated neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic 40.586823204420
390050 Arachidonoyl Ethanolamide-d8 - ≥99% deuterated forms (d1-d8) 42.214751381215 arachidonoyl-ethanolamide-d8 Anandamide-d8; AEA-d8 deuterium GC/MS internal isotopes standards ethanolamides GC-MS LC/MS LC-MS mass spectrometry cannabinoids deuterated fatty acids neurochemistry neuroscience ethanolamines endocrinology 42.214751381215
10007270 Arachidonoyl Ethanolamide Lipid Maps MS Standard 94421-68-8 ≥98% 2009-02-18 7.096138971526 arachidonoyl-ethanolamide-lipid-maps-ms-standard AEA; Anandamide cannabinoids neurotransmitter ligands lipids CB1 CB2 receptors AEA fatty acids neuroscience neurochemistry ethanolamines ethanolamides endocrinology MS mass spectrometry standards 7.096138971526
10180 Arachidonoyl Ethanolamide Phosphate 183323-26-4 >98% 2004-08-19 21.402127071823 arachidonoyl-ethanolamide-phosphate AEA-P; Anandamide Phosphate endocannabinoids neurotransmitters ligands lipids CB1 CB2 receptors fatty acids phosphates anandamides LPA lysophosphatidic ethanolamines ethanolamides cannabinoids cbs synthetic 21.402127071823
90051 Arachidonoyl Glycine 179113-91-8 >98% 11.477701657458 arachidonoyl-glycine NAGly; N-Arachidonyl Glycine cannabinoids ligands lipids CB1 receptors AEA anandamides ethanolamides fatty acids neurochemistry neuroscience 11.477701657458
10007531 Arachidonoyl Glycine-d8 - ≥99% deuterated forms (d1-d8) 2005-09-13 17.205649171270 arachidonoyl-glycine-d8 N-Arachidonyl Glycine-d8; NAGly-d8 deuterium GC/MS internal isotopes standards GC-MS LC/MS LC-MS mass spectrometry deuterated cannabinoids ligands lipids CB1 receptors AEA anandamides ethanolamides fatty acids neurochemistry neuroscience 17.205649171270
90059 Arachidonoyl m-Nitroaniline Exclusive - >98% ✓ 4.586458563535 arachidonoyl-m-nitroaniline AmNA FAAH substrates anandamides hydrolases colorimetric cannabinoids fatty acids meta-nitroaniline aea nitroanilines nitroanalines neurochemistry neuroscience 4.586458563535
10007294 Arachidonoyl-N-methyl amide 156910-29-1 >98% 2006-01-18 6.545398579321 arachidonoyl-n-methyl-amide acids anandamides arachidonoyl ethanolamides AEA endogenous endocannabinoids CB1 CB2 receptors cellular uptake hydrolysis bonds enzymes fatty acids hydrolases FAAH N,N-dimethyl analogs human inhibits inhibition rat glial gap junction cell-cells comunications neurochemistry neuroscience inhibitors 6.545398579321
10007293 Arachidonoyl-N,N-dimethyl amide 45280-17-9 >98% 2006-01-11 6.736053670087 arachidonoyl-n-n-dimethyl-amide Arachidonic Acid-N,N-dimethyl amide anandamides arachidonoyl ethanolamides AEA endogenous endocannabinoids CB1 CB2 receptors cellular uptake hydrolysis bonds enzymes fatty acids hydrolases FAAH N,N-dimethyl analogs human inhibits inhibition rat glial gap junction cell-cells comunications neurochemistry neuroscience cannabinoids cbs synthetic 6.736053670087
10168 Arachidonoyl p-Nitroaniline 119520-58-0 >98% 2004-12-01 7.193835832675 arachidonoyl-p-nitroaniline ApNA FAAH substrates anandamides hydrolases colorimetric cannabinoids fatty acids para-nitroaniline aea nitroanilines arachidonoyl ethanolamides neurochemistry neuroscience 7.193835832675
62170 Arachidonoyl Serinol 183718-70-9 >98% 37.453093922652 arachidonoyl-serinol endocannabinoids anandamides 2AG CB1 receptors neurochemistry neuroscience cannabinoids cbs synthetic 37.453093922652
70665 Arachidonoyl Serotonin 187947-37-1 >98% 8.690570065294 arachidonoyl-serotonin AA-5HT inhibitors fatty acids amides hydrolase FAAH inactivation cannabinoids AA-5HT neurochemistry neuroscience 8.690570065294
62120 Arachidonyl Trifluoromethyl Ketone 149301-79-1 >98% 27.837851442603 arachidonyl-trifluoromethyl-ketone ATK; AATFMK ATK AACOCF3 inhibitors PLA2 analogs fatty acids lipoxygenases inhibition inhibits LOs neurochemistry neuroscience 27.837851442603
10005765 Arachidoyl Ethanolamide Exclusive 94421-69-9 >98% ✓ 2005-06-22 13.890865561694 arachidoyl-ethanolamide N-Arachidoylethanolamine arachidoyls ethanolamides N-acyls saturated anandamides analogs enocannabinoids CB1 CB2 memory weight loss appetite neurodegeneration tumors arachidoylethanolamide surveillance analgesia inflammations fatty hydrolytic enzymes FAAH acid amides hydrolases AEA neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic 13.890865561694
9000325 Arachidoyl glycine 617703-96-5 ≥98% 2008-12-02 0.579248618784 arachidoyl-glycine arachidic acid glycine fatty acids PUFAs polyunsaturated fatty acids 0.579248618784
13662 Arecoline (hydrobromide) 300-08-3 ≥95% 2010-08-19 0.530478821362 arecoline-hydrobromide 63-75-2 alkaloids betel nuts Areca agonists muscarinic acetylcholine receptors M1 M2 M3 M4 M5 smooth muscles contractions learning memory dementia Alzheimer’s diseases Methylarecaidin Arecholine Arecoline Arecholin Arecaline Arecolin 0.530478821362
90052 Arvanil 128007-31-8 >98% 13.559889502762 arvanil N-Vanillylarachidonamide capsaicin capsicum vanilloids receptors agonists cannabinoids analgesia anandamides analgesic vanillylamines amides neurochemistry neuroscience 13.559889502762
13644 Aspalatone Exclusive 147249-33-0 ≥98% ✓ 2010-02-19 1.521262825572 aspalatone Acetylsalicylic Acid Matol ester antioxidants platelet aggregation thrombosis epilepsy kainic acid thromboembolism anti-platelets antiplateles 2-(Acetyloxy)benzoic Acid Acid, Acetylsalicylic Acetylsalicylic Acid Aloxiprimum Polopiryna Polopirin Micristin Endosprin Acylpyrin Solupsan Magnecyl Colfarit Acetysal Zorprin Solprin Ecotrin Easprin Dispril Aspirin 1.521262825572
13160 AT-56 Exclusive 162640-98-4 ≥95% ✓ 2010-06-22 6.983799877225 at-56 Prostaglandins D synthases L-PGDS PGD2 lipocalin-type inflammation inhibition inhibitors inhibits PGs eosinophils LPGDs bronchoalveolar lavage fluid Lysosomal Proton Translocating ATPases Vacuolar Proton-Translocating ATPases Vacuolar Membrane H(+)-ATPase Proteins Membrane-Associated Membrane-Associated Proteins Membrane Associated Proteins Tacrolimus Binding Proteins Proteins Rapamycin-Binding Proteins Integral Membrane Membrane Proteins Integral Binding Proteins Rapamycin Rapamycin-Binding Proteins Rapamycin Binding Proteins Protein Integral Membrane Integral Membrane Proteins Vacuolar F(1)F(0) ATPasesLysosomal F(1)F(0) ATPase Integral Membrane Protein Vacuolar F(1)F(0) ATPase Proteins Cell Membrane Protein FK-506-Binding Proteins Cell Surface Protein FK506-Binding FK-506-Binding ProteinFK506 Binding Proteins FK 506 Binding Protein Cell Membrane Proteins FK506-Binding ProteinFK506 Binding Protein Cell Surface Proteins H+-ATPase, Vacuolar Vacuolar H+-ATPase Vacuolar H+ ATPase Proteins Membrane Proteins Vacuolar ATPase Rotamase FKBP V Type ATPase FKBP Rotamase Membrane FKBP 6.983799877225
10009410 ATF2 (Phospho-Ser490,498) Polyclonal Antibody - 2006-11-28 1.522790055248 atf2-phospho-ser490-498-polyclonal-antibody Activating Transcription Factor 2 wb western blotting blots ihc immunohistochemistry antibodies activating transcriptional factors CRE-BP1 AP-1 DNA response elements ATF/CREB leucine zipper proteins regulating regulation genes cytokines cells cycles controls apoptosis death cellular stress inflammatory UV irradiation activity phosphorylation serines brains substrates neuronal neurons growth differentiation human depression phospho-specific immunoblotting 1.522790055248
10009021 AVE-1625 Exclusive 358970-97-5 ≥98% ✓ 2008-04-03 5.985497237569 ave-1625 cannabinoids CB1 receptors schizophrenia parkinsons disease alzheimers disease metabolism obesity SR-141716 lipolysis glycogenolysis antagonist endocrinology neurochemistry 5.985497237569
13823 AX 048 Exclusive 873079-69-7 ≥98% ✓ 2010-09-15 7.192651933702 ax-048 Inflammation antihyperalgesia cPLA2 phospholipases inhibitors inhibition inhibits AX048 AX-048 signaling signalling group IVA PLA2 cannabinoids cbs synthetic Acids Octanoic Octanoic Acids 7.192651933702
10227 BACE (human recombinant) - ≥95% 2009-03-09 7.820828729281 bace-human-recombinant β-Secretase; Memapsin-2; Membrane-bound Aspartic Protease; BACE-1; ASP-2 proteins amyloids peptides C-terminus terminal alzheimers neurochemistry active 7.820828729281
600070 BACE Inhibitor Screening Assay Kit - 2009-03-26 16.731740331491 bace-inhibitor-screening-assay-kit β-Secretase Inhibitor Screening Assay Kit inhibitors inhibition inhibits assays kits β-sites .beta.-sites b-sites APP cleaving enzymes β-amyloids .beta.-amyloids b-amyloids peptides Ab A.beta. brain neurodegeneration Alzheimer's Diseases AD proteolytic cleavages precursors β-secretases b-secretases γ-secretases .gamma.-secretases g-secretases membranes aspartic C-terminal C-terminus fragments proteolysis therapeutics therapy cascade pathogenesis mice mouse murine transgenics cholinergic dysfunctions HIV humans fluorescents fluorescences fluorometer assays 16.731740331491
10011135 BAY-60-7550 439083-90-6 ≥95% 2009-03-13 55.561077348066 bay-60-7550 inhibitors inhibits inhibition cyclic nucleotides cGMP cAMP cells signalling signaling PDE2 memory memories phosphodiesterase 55.561077348066
11571 Bexarotene New 153559-49-0 ≥98% 2012-04-06 47.635666052793 bexarotene LGD 1069; SR 11247; Ro 26-4455; LG 100069; Targretin retinoid X receptors ligands agonist RXR genes expression cancers alzheimers diseases apoptosis angiogenesis metastasis cells proliferations β-amyloid amyloids βamyloid LG 100069 1069 69 LG-100069 LG-1069 LG-69 LGD 1069 LGD-1069 LGD1069 LG100069 LG1069 LG69 RO 26-4455 RO26-4455 RO-26-4455 RO 264455 RO-264455 RO264455 SR 11247 SR-11247 SR11247 targret targretin targretyn targrexin 47.635666052793
11727 Bicuculline New 485-49-4 ≥98% 2012-05-18 104.148098219766 bicuculline NSC 32192 bicucullin bucuculline GABA GABAA receptors antagonists epilepsy chloride channels neurosciences retinal neurobiology receptive fields allosteric inhibits inhibitors inhibitions cortical neurons blocks brains slices 104.148098219766
10506 Bio-active Lipid I Screening Library (96-Well) - 2010-06-15 39.676215469613 bio-active-lipid-i-screening-library-96-well vasoconstriction bronchoconstriction prostaglandins endocrinology prostaglandins HTS high thoroughput screening cannabinoids cbs synthetic 39.676215469613
10005836 bis(7)-Tacrine 224445-12-9 >98% 2005-04-15 6.130883977900 bis-7-tacrine 1,7-N-heptylene-bis-9,9'-amino-1,2,3,4-tetrahydro-acridine dimeric congeners amino acridines inhibits inhibitors inhibition acetylcholinesterases Alzheimer's disease hydrogen peroxides apoptosis pheochromocytoma cells neurochemistry neuroscience 6.130883977900
11507 BRD1 bromodomain (human recombinant) New - ≥95% 2012-03-01 15.723401238237 brd1-bromodomain-human-recombinant Bromodomain containing 1; DKFZp686F0325; BR140-like protein; BRL; BRPF1; BRPF2; Bromodomain and PHD finger-containing protein 2 BRD1 genes expression histones chromatin acetylation bromodomains epigenetics schizophrenia bipolar disorders BRD-1 BRDs 15.723401238237
11548 BRDT bromodomain 1 (human recombinant) New - ≥95% 2012-03-01 15.723401238237 brdt-bromodomain-1-human-recombinant BRD6; CT9; RING3-like protein; Cancer/testis antigen 9; BRD-containing protein testis specific BRD-T genes expression histones chromatin acetylation bromodomains epigenetics BET domains Extra Terminal RING3 PEST Bromodomain testis specific BRDs BRD T 15.723401238237
11283 Buphedrone (hydrochloride) New 166593-10-8 ≥98% 2012-01-23 42.613832706781 buphedrone-hydrochloride MABP; α-methylamino-Butyrophenone forensics phenethylamines amphetamines cathinones designer drugs ethcathinones psychoactive hydrochloride HCl stimulants 408332-79-6 42.613832706781
10488 Bupropion (hydrochloride) 31677-93-7 ≥98% 2010-08-16 6.125262942501 bupropion-hydrochloride NSC 315851 34841-36-6 Zyban Wellbatrin inhibitors inhibits inhibition reuptake dopamine norepinephrine Voxra Aplenzin Amfebutamone antagonists neuronal acetylcholine nicotinic receptors nAChR antidepressant depression neurosciences Wellbutrin 1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone GlaxoSmithKline Brand 2 of Bupropion Hydrochloride GlaxoSmithKline Brand 1 of Bupropion Hydrochloride Glaxo Wellcome Brand 3 of Bupropion Hydrochloride Glaxo Wellcome Brand 2 of Bupropion Hydrochloride Glaxo Wellcome Brand 1 of Bupropion Hydrochloride Esteve Brand of Bupropion Hydrochloride Bupropion Hydrochloride Bupropion Hydrochloride Zyban (Anti-Smoking) Amfebutamone Wellbutrin Bupropion Bupropion Zyntabac Quomen Isomer 6.125262942501
70090 BW 723C86 160521-72-2 >98% 22.216353591159 bw-723c86 bw-723c86 bw723-c86 5-ht2b agonist anxiolytic serotonin 5-hydroxy-tryptamine 5-OH-tryptamine bw723c86 receptors selective endocrinology neurochemistry neuroscience 22.216353591159
10011437 CaMKII Monoclonal Antibody (Clone 6G9) - 2008-05-20 15.209944751382 camkii-monoclonal-antibody-clone-6g9 Calcium/Calmodulin-dependent Protein Kinase II calcium calmodulin signalling signaling WB IHC IP EIA IF western blots immunohistochemistry immunoprecipitation immunofluorescence antibodies antiserum kinases neurochemistry enzyme immunoassays immunoblotting PPI PKA blotting 15.209944751382
10011438 CaMKII (Phospho-Thr286/Thr287) Monoclonal Antibody (Clone 22B1) - 2008-05-20 15.209944751382 camkii-phospho-thr286-thr287-monoclonal-antibody-clone-22b1 Calcium/Calmodulin-dependent Protein Kinase II calcium calmodulin signalling signaling WB IHC IP EIA IF western blots immunohistochemistry immunoprecipitation immunofluorescence antibodies antiserum kinases neurochemistry immunoblotting enzyme immunoassays PPI PKa blotting 15.209944751382
10489 Candesartan cilexetil 145040-37-5 ≥98% 2011-04-08 57.833971761817 candesartan-cilexetil TCV-116 angiotensin II receptors antagonists hypertension diabetes AT1 type 1 stress diastolic blood pressure anti-hypertensive antihypertensive 57.833971761817
90080 Cannabidiol 13956-29-1 >99% 31.817340173638 cannabidiol CBD delta9-THC .DELTA.9-THC delta9THC .DELTA.9THC marijuana neuroprotective tetrahydrocannabidiol d9-THC d9THC neurochemistry neuroscience synthetic cbs cannabinoids 31.817340173638
13285 Cannabidiol dimethyl ether 1242-67-7 ≥98% 2009-05-19 8.183425414364 cannabidiol-dimethyl-ether Cannabidiol-2',6'-dimethyl ether; CBDD 15-lipoxygenases 15-LOs dioxygenase fatty acids inflammation thrombosis cancer LDL oxidation inhibitions inhibition inhibiting cannabinoids cbs synthetic 8.183425414364
90081 Cannabidiol (solution) 13956-29-1 ≥99% 2011-03-03 45.111998995479 cannabidiol-solution CBD delta9-THC .DELTA.9-THC delta9THC .DELTA.9THC marijuana neuroprotective tetrahydrocannabidiol d9-THC d9THC neurochemistry neuroscience synthetic cbs cannabinoids 45.111998995479
92350 Capsaicin 404-86-4 ≥95% 2004-04-01 11.165374901341 capsaicin Capsicum peppers VR1 vanilloid receptors pain heat hot extracts nociceptive burning neurochemistry neuroscience lipid-soluble extracts calcium ca+ ion channels pathways desensitization non-myelinatedpolymomdal c-type nerve fibers 11.165374901341
10010743 Capsaicin (technical grade) 404-86-4 >60% 2007-11-27 7.538052486187 capsaicin-technical-grade Capsicum peppers VR1 vanilloid receptors pain heat hot extracts nociceptive burning neurochemistry neuroscience lipid-soluble extracts calcium ca+ ion channels pathways desensitization non-myelinatedpolymomdal c-type nerve fibers 7.538052486187
10007518 Capsazepine 138977-28-3 ≥98% 2006-03-29 58.537209944750 capsazepine vanilloid receptors 1 VR1 transient potential TRP endogenous stimuli tissues injury inflammation pain antagonists capsaicin Ca2+ neonatal rats dorsal root ganglias Chinese hamsters ovary ovaries cells 58.537209944750
13702 Cav1.2 Calcium Channel Monoclonal Antibody (Clone S57-46) - 2009-11-05 1.281767955801 cav1-2-calcium-channel-monoclonal-antibody-clone-s57-46 antibodies western blotting blots immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC channels ions fusion proteins gated voltage-gated ligand-gated voltage ligand 1.281767955801
13703 Cav1.3 Calcium Channel Monoclonal Antibody (Clone S38-8) - 2009-11-05 1.281767955801 cav1-3-calcium-channel-monoclonal-antibody-clone-s38-8 antibodies channels ions fusion proteins CACNAID western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC gated voltage-gated ligand-gated voltage ligand 1.281767955801
13706 Cav1.3 Calcium Channel Monoclonal Antibody (Clone S48A-9) - 2009-11-12 1.281767955801 cav1-3-calcium-channel-monoclonal-antibody-clone-s48a-9 antibodies channels ions fusion proteins CACNAID western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC gated voltage-gated ligand-gated voltage ligand 1.281767955801
13704 Cav3.2 Calcium Channel Monoclonal Antibody (Clone S55-10) - 2009-11-12 6.408839779006 cav3-2-calcium-channel-monoclonal-antibody-clone-s55-10 antibodies CACNA1H genes epilepsy up-regulations up regulations upregulations prostate cancers androgen-independent androgen independent western blotting blots WB fusion protein immunohistochemistry IHC immunocytochemistry ICC 6.408839779006
13701 Cavβ4 Calcium Channel Monoclonal Antibody (Clone S10-7) - 2009-11-05 1.281767955801 cav-4-calcium-channel-monoclonal-antibody-clone-s10-7 western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels antibodies epilepsy IGE JME subunits gated voltage-gated ligand-gated ligand voltage 1.281767955801
71652 CAY10401 288862-89-5 >98% 2005-02-02 7.964372007366 cay10401 FAAH inhibitors analgesics fatty acids amides hydrolases inhibits inhibition hydrolysis hydrolyze CAY-10401 inactivation anandamides AEA arachidonoyl ethanolamides neuroscience neurochemistry cannabinoids cbs synthetic 7.964372007366
72620 CAY10412 Exclusive 390824-17-6 >98% ✓ 10.908446132596 cay10412 endocannabinoids neurotransmitters ligands lipids CB1 CB2 receptors AEA fatty acids neurochemistry neuroscience cannabinoids inhibitors 10.908446132596
10004259 CAY10429 22972-55-0 >98% 2005-02-09 32.021406328478 cay10429 Abnormal Cannabidiol; Abn-CBD endocannabinoids cannabidiols abnormal abn-cbd non-CB1 non-CB2 receptors agonists BV-2 microglials hypotensives GPCR neurochemistry neuroscience 32.021406328478
10009523 CAY10429-d3 - ≥99% deuterated forms (d1-d3) 2007-10-02 4.785082872929 cay10429-d3 Abnormal Cannabidiol-d3; Abn-CBD-d3 endocannabinoids cannabidiols abnormal abn-cbd non-CB1 non-CB2 receptors agonists BV-2 microglials hypotensives GPCR neurochemistry neurosciences cannabindoids CB1 CB2 deuterated deuterium mass spectrometry LC-MS GC-MS AbnCBD LC/MS GC/MS cannabinoids cbs synthetic 4.785082872929
10005102 CAY10435 288862-73-7 >98% 2004-07-06 9.224487415592 cay10435 fatty acid amide inhibitors FAAH hydrolases inhibition inhibits hydrolysis hydrolyze CAY-10435 1-(Oxazolo[4,5-b]pyridin-2-yl)-1-oxo-dodecane neurochemistry neuroscience 9.224487415592
10005186 CAY10441 Exclusive 221529-58-4 >98% ✓ 2004-09-16 95.979825046041 cay10441 RO1138452 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma cyclic AMP cAMP adenylate cyclase 4,5-dihydro-1H-imidazol-2-yl-4-4-isopropoxy benzyl phenylamine atherosclerosis 95.979825046041
10005633 CAY10448 - ≥98% 2004-10-01 17.571325966850 cay10448 capsaicin capsicum vanilloids receptors antagonists cannabinoids analgesia anandamides analgesic vanillylamines amides analogs transient potential VR1 pain TRPV1 neurochemistry neuroscience 17.571325966850
10005913 CAY10449 Exclusive - >98% ✓ 2004-10-26 64.277476979742 cay10449 receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma adenylate cyclase cyclic AMP cAMP iloprost athersclerosis CAY 10449 64.277476979742
10005072 CAY10455 290374-09-3 >98% 2004-11-09 8.140732044199 cay10455 SKM 4-45-1 anandamides AEAs neurons fatty acid amide hydrolase FAAH analogs arachidonyl ethanolamides transporters acyl fluorescent fluorescence substrates cellular trafficking neurochemistry neuroscience 8.140732044199
10007955 CAY10498 863202-33-9 ≥98% 2006-08-02 41.749779005525 cay10498 2-phenyl-amino-N6-endo-norbornyladenine adenosine receptor antagonist A1 A2A A2B A3 AR G-protein stroke inflammation glaucoma neurodegenerative disease reversine dedifferentiation neurochemistry ophthalmology 41.749779005525
10008669 CAY10508 878533-35-8 ≥98% 2006-08-04 35.284060773480 cay10508 1,3-bis(4-bromophenyl)-5-phenyl-Imidazolidine-2,4-dione central peripheral cannabinoids receptors inverse agonists antagonists therapeutic therapy obesity drug dependence CB1 CB2 CP-55,940 cannabinoids cbs synthetic 35.284060773480
10010740 CAY10550 34320-83-7 ≥98% 2008-07-14 4.120286602210 cay10550 3-(4-Nitrophenyl)-1-phenyl-2-pyrazolin-5-one prion PrPc PrPsc PrPres mad cow disease scrapie creutzfeldt-jakob disease spongigorm encephalopathy radical scavenger inhibitors inhibits inhibition 4.120286602210
10012565 CAY10568 22913-17-3 ≥98% 2008-05-28 13.160810313075 cay10568 Santinamide TRPV1 QX314 cationic lidocaine capsaicin pain ion channel anesthetics analgesia nociception CAY10568 13.160810313075
10010032 CAY10570 Exclusive 875014-22-5 >98% ✓ 2008-06-03 11.915980662983 cay10570 FAAH fatty acids amides AEA anandamides CB1 inhibitors inhibits inhibition endocannabinoids hydrolases cannabinoids 11.915980662983
13281 CAY10598 Exclusive 346673-06-1 ≥98% ✓ 2010-05-07 55.690121546961 cay10598 Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection 55.690121546961
13358 CAY10608 Exclusive 457897-92-6 ≥98% ✓ 2010-04-29 1.305248618784 cay10608 N-Methyl-D-aspartate NMDA receptors antagonists glutamate glycine propanolamine NR2B subunit AMPA kainate neuroprotection neurochemistry antagonizes potently selectively non-competitively 1.305248618784
10743 CAY10650 Exclusive 1233706-88-1 ≥98% ✓ 2011-06-14 12.111933701657 cay10650 cPLA2α cPLA2 inhibitors inflammation anti-inflammatory dermatitis metabolite phospholipase cytosolic prostaglandins PGs leukotrienes synthesis 10662 CAY-10650 CAY10641 CAY-10641 12.111933701657
10820 CAY10651 Exclusive - ≥98% ✓ 2011-06-15 0E-12 cay10651 Glutamate neurotransmitters receptors mGlu5 pain anxiety antagonists gastresophageal reflux diseases dyskinesia fragile X syndromes drug addictions cortical astrocytes functional binding assays mobilization calcium CNS 0E-12
10010398 CB-13 432047-72-8 ≥98% 2009-06-30 38.500490737732 cb-13 CRA-13 cannabinoids CB1 CB2 central peripheral receptors agonists pains hyperalgesia blocks blocking CB13 CB 13 CRA13 CRA 13 38.500490737732
10006590 CB1 Receptor (C-Term) Polyclonal Antibody - 2005-05-10 74.772228360957 cb1-receptor-c-term-polyclonal-antibody Cannabinoid Receptor 1 cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC western blots blotting antisera antiserum WB IHC immunohistochemistry neuroscience neurochemistry endocrinology immunoblotting cannabinoids cbs synthetic 74.772228360957
101500 CB1 Receptor Polyclonal Antibody - 37.924069981583 cb1-receptor-polyclonal-antibody Cannabinoid Receptor 1 Polyclonal Antibody cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC western blots blotting antisera antiserum WB neuroscience neurochemistry endocrinology immunoblotting 37.924069981583
10010116 CB-25 Exclusive 869376-63-6 >98% ✓ 2007-10-25 20.448853591160 cb-25 cannabinoids ligands receptors CB1 CB2 THC anandamides AEA inverse agonists cannabinoids cbs synthetic 20.448853591160
101550 CB2 Receptor Polyclonal Antibody - 54.599819186338 cb2-receptor-polyclonal-antibody Cannabinoid Receptor 2 cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC antisera antiserum western blots blotting WB neuroscience neurochemistry endocrinology immunoblotting IHC immunohistochemistry 54.599819186338
10010712 CB2 Receptor Polyclonal FITC Antibody - 2008-01-15 39.452872928177 cb2-receptor-polyclonal-fitc-antibody Cannabinoid Receptor 2 cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC antisera antiserum western blots blotting WB neuroscience neurochemistry GPCRs FC flow cytometry immunoblotting IF immunofluorescence 39.452872928177
10010117 CB-52 Exclusive 869376-90-9 ≥98% ✓ 2007-10-25 20.362948895028 cb-52 cannabinoids ligands receptors CB1 CB2 THCs anandamides AEAs partial agonists neutral antagonists cannabinoids cbs synthetic 20.362948895028
13289 CB-86 Exclusive 1150586-64-3 ≥98% ✓ 2010-05-03 23.170741910023 cb-86 cannabinoids receptors CB1 CB2 antinociception agonists resorcinol anandamides hybrids CB86 CB 86 partial agonist neural antagonist antinociceptive effects 2-beta-D-Ribofuranosyl-1,2,4-triazine-3,5(2H,4H)-dione 6-Azauridine 6 Azauridine Azauridine cannabinoids cbs synthetic 23.170741910023
589101 CGRP (human) EIA Kit - 196.930524861878 cgrp-human-eia-kit Calcitonin Gene-Related Peptide (human) EIA Kit; CGRP (human) ELISA Kit calcitonin peptides measures kits eias enzyme immunoassays ELISAs spi-bio neurochemistry neuroscience spibio A05481 endocrinology assays 196.930524861878
589001 CGRP (rat) EIA Kit - 292.358287292818 cgrp-rat-eia-kit Calcitonin Gene-Related Peptide (rat) EIA Kit; CGRP (rat) ELISA Kit calcitonin peptides measures kits eias enzyme immunoassays ELISAs spi-bio neurochemistry neuroscience spibio A05482 endocrinology assays 292.358287292818
700610 Chloride Colorimetric Assay Kit - 2011-11-18 113.277184530386 chloride-colorimetric-assay-kit chlorides Cl assays kits measures measurements plasma serums urine saliva cells cultures lysates Hg2+ Fe2+ mercury iron mercury-thiocyanate Hg-thiocyanate thiocyanates mercuric mineral humans anions hydration osmotic pressure cation-anion balance vascular intestinal fluids compartments hypochloremia hyperchloremia vomiting renal diseases metabolic acidosis burns dehydration diarrhea congestive heart failure hyperventilation kidneys Lightwood syndromes parathyroid glands pathological ions channels Cystic Fibrosis myotonia congenita Barter's Syndrome 2002 bestrophins proteins hbest1 retinal progressive vision loss vitelliform macular dystrophy Best 113.277184530386
10011126 Clobenpropit (hydrobromide) 145231-35-2 ≥98% 2008-12-04 0.882665745856 clobenpropit-hydrobromide Carbamimidothioic Acid; VUF-9153 histamines receptors antagonist GABA neurons brains seizures 0.882665745856
580110 Clusterin (human) EIA Kit - 2011-08-02 2.154696132597 clusterin-human-eia-kit CLI; SGP-2; KUB-1; AAG4; TRPM-2; pADHC-9; Apo-J; Apolipoprotein J apolipoproteins Up-regulated in Azheimer's diseases brains Ku70-binding proteins 1 sulfated glycoproteins 2 aging-associated genes 4 complement lysis inhibitors testosterone-repressed prostate messages secreted disulfide-linked heterodimeric amyloid lipids bacteria leptin immunoglobulins endocytic receptors LDLs low-density lipoprotein-related LPR2 LPR8 8 endocytosis tissues mammals mammalian cells plasma serums semen cultures media medium developmental remodeling apoptotic neurodegeneration injury stress inhibits inhibition apoptosis carcinogenesis genes CLU ELISAs EIAs enzymes immunoassays kits measures measurements human supernatants 2.154696132597
10910 (+)-CP 47,497 134308-14-8 ≥98% 2011-05-05 13.281073688435 -cp-47-497 cannabinoid analgesia analgesic CB1 hypothermia motor depressant anticonvulsant Δ9-THC CBs analogs cbs synthetic cannabinoids 13.281073688435
10913 (±)-CP 47,497 70434-82-1 ≥98% 2011-05-05 34.382032339974 -cp-47-497 receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic 16851 34.382032339974
10908 (±)-CP 47,497-C8-homolog Exclusive 70434-92-3 ≥98% ✓ 2011-05-06 33.614779595787 -cp-47-497-c8-homolog CAY10596; Cannabicyclohexanol cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic 33.614779595787
10686 (±)-CP 47,497-C8-homolog-d7 (solution) Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-03-14 25.726973152059 -cp-47-497-c8-homolog-d7-solution Cannabicyclohexanol-d7 cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS GC LC standards stds 10914 25.726973152059
13216 (±)-CP 47,497-C8-homolog (solution) Exclusive 70434-92-3 ≥98% ✓ 2009-04-23 43.928671821398 -cp-47-497-c8-homolog-solution CAY10596; Cannabicyclohexanol cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic 10908 43.928671821398
10687 (±)-CP 47,497-d11 (solution) Exclusive - ≥99% deuterated forms (d1-d11) ✓ 2011-02-16 34.319074410242 -cp-47-497-d11-solution receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS 10907 34.319074410242
13219 (+)-CP 47,497 (solution) 134308-14-8 ≥98% 2009-04-13 18.224339434425 -cp-47-497-solution cannabinoid analgesia analgesic CB1 hypothermia motor depressant anticonvulsant Δ9-THC CBs analogs cbs synthetic cannabinoids 10910 18.224339434425
16851 (±)-CP 47,497 (solution) 70434-82-1 ≥98% 2008-12-10 49.485946899938 -cp-47-497-solution receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic 10913 49.485946899938
90084 (−)-CP 55,940 83002-04-4 ≥98% 2007-01-15 42.173747156320 -cp-55-940 CP 55940 CP-55940 CP-55,940 agonists cannabinoids CB1 CB2 THC receptors endocrinology cp55940 cp55,940 neurochemistry cbs synthetic 42.173747156320
13241 (±)-CP 55,940 Exclusive 83003-12-7 ≥98% ✓ 2009-05-20 21.967687152834 -cp-55-940 cannabinoids analgetic pain THC thermal mechanical chemicals receptors CB1 cannabimimetic potent non-selective CP55940 CP-55940 cbs synthetic 21.967687152834
10011388 Cu/Zn SOD (human) Polyclonal Antibody - 23 kDa 2008-04-03 152.239337016574 cu-zn-sod-human-polyclonal-antibody SOD1; Cu/Zn Superoxide Dimutase SOD1 SOD2 SOD3 EC-SOD oxidative stress ROS superoxide antibodies antiserum WB western blots immunoblotting IP EIA IHC immunohistochemistry neurochemistry immunoprecipitation enzyme immunoassays neurochemistry blotting 152.239337016574
581001 Cyclic AMP EIA Kit - 872.474818837547 cyclic-amp-eia-kit Adenosine 3',5'-cyclic monophosphate EIA Kit; cAMP EIA Kit; Adenosine 3',5'-cyclic mononucleotide EIA Kit; Cyclic AMP ELISA Kit solid plates cAMP adenosine measures kits eias enzyme immunoassays ELISAs second messengers neurochemistry neuroscience endocrinology assays 872.474818837547
581002 Cyclic AMP EIA Kit (without Acetic Anhydride) - 697.637638121547 cyclic-amp-eia-kit-without-acetic-anhydride cAMP EIA Kit (without Acetic Anhydride); Adenosine 3',5'-cyclic monophosphate EIA Kit (without Acetic Anhydride); Adenosine 3',5'-cyclic mononucleotide EIA Kit (without Acetic Anhydride); Cyclic AMP ELISA Kit (without Acetic Anhydride) solid plates cAMP adenosine measures kits eias enzyme immunoassays ELISAs second messengers neurochemistry neuroscience endocrinology assays 697.637638121547
581021 Cyclic GMP EIA Kit - 919.311042817679 cyclic-gmp-eia-kit Guanosine 3',5'-cyclic mononucleotide EIA Kit; Cyclic GMP ELISA Kit; cGMP EIA Kit; Guanosine 3',5'-cyclic monophosphate EIA Kit solid plates cGMP guanosine measures kits eias enzyme immunoassays ELISAs second messengers neurochemistry neuroscience endocrinology assays 919.311042817679
581022 Cyclic GMP EIA Kit (without Acetic Anhydride) - 517.867610497237 cyclic-gmp-eia-kit-without-acetic-anhydride Cyclic GMP ELISA Kit (without Acetic Anhydride); Guanosine 3',5'-cyclic monophosphate EIA Kit (without Acetic Anhydride); Guanosine 3',5'-cyclic mononucleotide EIA Kit (without Acetic Anhydride); cGMP EIA Kit (without Acetic Anhydride) solid plates cAMP adenosine measures kits eias enzyme immunoassays ELISAs second messengers assays 517.867610497237
13197 DAPT 208255-80-5 ≥95% 2010-09-16 16.308718232044 dapt GSI-IX amyloids precursors proteins APP Notch beta amyloid Aβ Alzheimer’s disease inhibitors inhibits inhibition γ-secretase Aβ42 cells signaling signals differentiation GSIIX GSI IX Dipeptides 16.308718232044
10603 DARPP-32 (Phospho-Thr34) Polyclonal Antibody - 2009-10-22 0.193370165745 darpp-32-phospho-thr34-polyclonal-antibody gamma inhibits inhibitors neurotransmitters WB western blots blotting receptors dopamine cAMP inhibition immunoblotting DARPs DARP32 DARP 32 0.193370165745
90349 Decanoyl m-Nitroaniline Exclusive 72298-61-4 ≥98% ✓ 8.538184688240 decanoyl-m-nitroaniline DemNA FAAH substrates anandamides hydrolases colorimetric cannabinoids aea meta-nitroanilines fatty acids anandamide nitroanilines nitroanalines arachidonoyl ethanolamides ethanolamines neurochemistry neuroscience 8.538184688240
10007903 D-erythro-Sphingosine C-20 6918-49-6 ≥98% 2008-11-21 10.081802486187 d-erythro-sphingosine-c-20 sphingosines sphingolipids ceramides C-18 C18 C20 gangliosides brain development neurodegenerations 10.081802486187
10010575 Desmethyltrimebutine-d3 (hydrochloride) - ≥99% deuterated forms (d1-d3) 2008-04-14 2.513812154696 desmethyltrimebutine-d3-hydrochloride timebutine anesthetic SPI disorders spasmolytic gastrointestinal neurochemistry 2.513812154696
11481 Desoxypipradrol (hydrochloride) Exclusive New 5807-81-8 ≥98% ✓ 2012-03-08 21.994917050250 desoxypipradrol-hydrochloride 2-Diphenylmethylpiperidine; 2-DPMP 519-74-4 designer drugs dopamine norepinephrine neuroscience forensics monoamine transporters inhibitors inhibits inhibition piperazines DDMP 2DPMP 21.994917050250
10012582 Diallyl Disulfide New 2179-57-9 ≥90% 2012-03-12 25.438090853284 diallyl-disulfide Garlicin; DADS; NSC 29228 disulphide dipropenyl H2S hydrogen sulfide cardiovascular diseases neuroscience vascular tone vasorelaxation neuroprotection cardiology hypertension signal transduction NSC29228 NSC-29228 garlic plants allicin 25.438090853284
11333 Diethylcathinone (hydrochloride) New 134-80-5 ≥98% 2012-02-20 19.900331294119 diethylcathinone-hydrochloride Menutil; Moderatan; Tenuate dospan tenuate-dospan amfepramone magrex retard lineal-rivo lineal rivo tepanil ten-tab Nu-dispoz regenon EINECS 205-156-5 CHEBI:643703 LS-125146 AC-16025 D03801 90-84-6 4830-79-9 parabolin phepranon prefamone modulor fepranon frekentine keramik keramin hydrochloride HCl forensics phenethylamines cathinones amphetamines designer drugs appetite suppressants prodrugs ethcathinone norepinephrine 19.900331294119
90235 Dihomo-γ-Linolenoyl Ethanolamide 150314-34-4 >98% 6.899275268118 dihomo-linolenoyl-ethanolamide endocannabinoids neurotransmitters dihomo-gamma-linolenoyl dihomo-g-linolenoyl dihomo-.gamma.-linolenoyl cannabinergic fatty acids neurochemistry neuroscience ethanolamines ethanolamides cannabinoids cbs synthetic 6.899275268118
10010669 Dihydrobupropion-d9 - ≥99% deuterated forms (d1-d9) 2009-04-17 11.113259668508 dihydrobupropion-d9 aminoketone ketones antideppressant dopamine smoking cessation treatment deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry 11.113259668508
92355 Dihydrocapsaicin 19408-84-5 ≥98% 7.067521704814 dihydrocapsaicin capsicum peppers VR1 receptors non-myelinated polymodal C-type nociceptive nerve fibers calcium ion channels pain pathways CA2+ vanilloid heat-activated neurochemistry hot extracts burning neuroscience lipid-souble desensitization patyways 7.067521704814
9000556 Dimebolin Exclusive 3613-73-8 ≥98% ✓ 2010-01-12 0E-12 dimebolin Dimebon™ neurodegeneration Alzheimer's diseases Huntington's neuroprotection cognition inhibitors inhibition β-amyloid calcium channels NMDA glutamate receptors mitochondria dimebone dimeboline preparation 84 Dimebolin 12687-54-6 20684-30-4 inhibited Indoles 0E-12
10011349 Dimebolin (hydrochloride) 97657-92-6 ≥98% 2010-02-19 0E-12 dimebolin-hydrochloride neurodegeneration Alzheimer's diseases Huntington's neuroprotection cognition inhibitors inhibits inhibition calcium channles β-amyloid β amyloid NMDA glutamate receptors mitochondria dimeboline dimebon neurochemistry neuroscience Indoles 0E-12
90310 Docosahexaenoic Acid 6217-54-5 ≥98% 91.329337016574 docosahexaenoic-acid DHA; Cervonic Acid polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 neurochemistry c22:6 22:6 91.329337016574
10005057 Docosahexaenoic Acid-d5 - ≥99% deuterated forms (d1-d5) 2005-03-16 218.188360957642 docosahexaenoic-acid-d5 Cervonic Acid-d5; DHA-d5 standards deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 retinol neuronal membranes neonatal deprivation hypertension 218.188360957642
10006865 Docosahexaenoic Acid methyl ester 2566-90-7 ≥98% 2005-09-06 87.794162062614 docosahexaenoic-acid-methyl-ester Cervonic Acid methyl ester; DHA methyl ester polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 esters diets dietary supplements hypertension neonatal photoreceptor degeneration retinitis pigmentosa depiration neural tissues retina 87.794162062614
10006829 Docosahexaenoic Acid Quant-PAK - 2005-08-08 50.848740331491 docosahexaenoic-acid-quant-pak DHA Quant-PAK; Cervonic Acid Quant-PAK Quant-PAKs polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 standards deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated retinol neuronal membranes neonatal deprivation hypertension neurochemistry packs 50.848740331491
10007534 Docosahexaenoyl Ethanolamide Exclusive 162758-94-3 ≥98% ✓ 2006-02-17 20.422555781719 docosahexaenoyl-ethanolamide DHEA; DEA neurochemistry neuroscience endocannabinoids brain retina docosahexaenoic acids DHA fatty w-3 .omega.-3 neural tissues ethanolamines ethanolamides arachidonoyl AEA lipids extracts piglets diets rats CB1 receptors shaker-related voltage-gated potassium channels cannabinoids cbs synthetic DEA 20.422555781719
9001108 Docosahexaenoyl Ethanolamide-d4 Exclusive New 946524-43-2 ≥99% deuterated forms (d1-d4) ✓ 2012-02-21 19.810945429872 docosahexaenoyl-ethanolamide-d4 DHEA-d4; DEA-d4 neurochemistry neuroscience endocannabinoids brain retina docosahexaenoic acids DHA fatty w-3 .omega.-3 neural tissues ethanolamines ethanolamides arachidonoyl AEA lipids extracts piglets diets rats CB1 receptors shaker-related voltage-gated potassium channels cannabinoids cbs synthetic DEA deuterateds deuteriums LC-MS GC/MS GC-MS mass spectrometry LC/MS MS 19.810945429872
9000328 Docosahexaenoyl Glycine Exclusive 132850-40-9 ≥98% ✓ 2009-01-28 18.429848066298 docosahexaenoyl-glycine polunsaturated fatty acids PUFAs docosahexaenoic DHA glycines fish oils ALA brain retina neuron neuronal membrane ω-3 α-linolenic 18.429848066298
10005823 Docosanoyl Ethanolamide Exclusive 94109-05-4 ≥98% ✓ 2006-01-11 12.658242803140 docosanoyl-ethanolamide neurochemistry neuroscience N-acylethanolamides cannabinoids central CB1 peripheral CB2 non-CB receptor-mediated pharmacology memory weight loss appetite neurodegeneration tumor surveillance analgesia inflammation saturated ion channels ethanolamines cbs synthetic 12.658242803140
90385 Docosatetraenoyl Ethanolamide 150314-35-5 ≥98% 6.723041923952 docosatetraenoyl-ethanolamide DEA endocannabinoids neurotransmitters ethanolamides docosatetraenoic acid fatty acids neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic 6.723041923952
13245 Donepezil 120014-06-4 ≥95% 2010-03-08 5.069640883978 donepezil Aricept® acetylcholine neurotransmitters acetylcholinesterase inhibitors inhibits inhibition central nervous system Alzheimer's diseases cognition memory dementia Donezepil signaling signalling AchE CNS behavior (±)-E 2020 (+/-)-E 2020 E2020 5.069640883978
10009372 Dopamine Transporter (C-Term) Polyclonal Antibody - 2006-11-13 0E-12 dopamine-transporter-c-term-polyclonal-antibody DAT antibodies proteins diseases antibodies antisera antiserum IHC immunohistochemistry WB western blots blotting c-terminal keyhole limpet hemocyanin KLH accumulation catecholamine biosynthesis markers dopaminergic noradrenergic neurons depression schizophrenia parkinson's dieseases drug abuse chronic administration immunoblotting 0E-12
10009373 Dopamine Transporter (Extracellular Loop 2) Polyclonal Antibody - 2006-11-13 0E-12 dopamine-transporter-extracellular-loop-2-polyclonal-antibody DAT (Extracellular Loop 2) antibodies proteins diseases antibodies antisera antiserum IHC immunohistochemistry WB western blots blotting c-terminal keyhole limpet hemocyanin KLH accumulation catecholamine biosynthesis markers dopaminergic noradrenergic neurons depression schizophrenia parkinson's dieseases drug abuse chronic administration immunoblotting 0E-12
10009370 Dopamine β-hydroxylase (C-Term; human) Polyclonal Antibody - 2006-11-13 0E-12 dopamine-hydroxylase-c-term-human-polyclonal-antibody DBH antibodies proteins diseases antibodies antisera antiserum WB western blots blotting beta-hydroxylase neurons dopaminergic noradrenergic catecholamine biosynthesis markers depression schizophrenia parkinson's diseases drugs abuse immunoblotting 0E-12
10009371 Dopamine β-hydroxylase (N-Term; human) Polyclonal Antibody - 2006-11-13 0E-12 dopamine-hydroxylase-n-term-human-polyclonal-antibody DBH antibodies proteins diseases antibodies antisera antiserum WB western blots blotting beta-hydroxylase neurons dopaminergic noradrenergic catecholamine biosynthesis markers depression schizophrenia parkinson's diseases drugs abuse immunoblotting 0E-12
10005516 Doppel Blocking Peptide - 2004-10-01 1.897790055249 doppel-blocking-peptide antibodies western blotting blots signaling signalling IHC WB formalin immunohistochemistry controls peptides proteins diseases GPI glycosylphosphatidylinositol central nervous system male fertility sertoli CNS spermatozoa nonglycosylated oligosaccharides 1.897790055249
10005517 Doppel Polyclonal Antibody - 2004-09-24 5.494475138122 doppel-polyclonal-antibody proteins diseases antibodies antisera antiserum GPI glycosylphosphatidylinositol central nervous system male fertility sertoli CNS spermatozoa nonglycosylated oligosaccharides WB western blots blotting IHC immunohistochemistry immunoblotting 5.494475138122
10009785 Dynamin (Phospho-Ser774) Polyclonal Antibody - 2007-05-24 1.740331491713 dynamin-phospho-ser774-polyclonal-antibody phosphopeptide phospho-specific western blots WB antibodies proteins blotting dephosphins phosphorylation synaptic vesicle endocytosis protein kinase 5 immunoblotting 1009785 1.740331491713
10009786 Dynamin (Phospho-Ser778) Polyclonal Antibody - 2007-05-24 1.740331491713 dynamin-phospho-ser778-polyclonal-antibody phosphopeptide phospho-specific western blots WB antibodies proteins blotting dephosphins phosphorylation synaptic vesicle endocytosis protein kinase 5 immunoblotting 1.740331491713
10010571 Entacapone-d10 - ≥98% 2008-04-14 11.348867403315 entacapone-d10 Parkinsons dieseases inhibitors inhibits inhibition SPI nitrocatechols catechol-o-methyl blood-brain barrier neurochemistry 11.348867403315
101740 EP1 Receptor Polyclonal Antibody - 33.782160220994 ep1-receptor-polyclonal-antibody Prostaglandin E2 Receptor 1; PGE2 Receptor 1 PGE2 prostaglandins receptors antibodies antisera antiserum western blots blotting wb icc immunocytochemistry neurochemistry immunoblotting 33.782160220994
101760 EP3 Receptor Polyclonal Antibody - 31.885082872927 ep3-receptor-polyclonal-antibody Prostaglandin E2 Receptor 3; PGE2 Receptor 3 PGE2 prostaglandins receptors antibodies antisera antiserum western blots blotting wb C-terminus WB ICC immunocytochemistry neurochemistry immunoblotting 31.885082872927
10919 (±)-epi CP 47, 497 - ≥98% 2011-05-05 9.598423751790 -epi-cp-47-497 3-trans CP 47,497 (±)-trans-CP 47,497 cannabinoids analogs receptors CB1 standards (±)-CP47,497 analgesic potency epimer THC .delta.-THC (±)-iso Δ-tetrahydrocannabidiol CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 13801 9.598423751790
13801 (±)-epi CP 47,497 (solution) Exclusive - ≥98% ✓ 2010-08-04 9.334116612362 -epi-cp-47-497-solution 3-trans CP 47,497 (±)-trans-CP 47,497 cannabinoids analogs receptors CB1 standards (±)-CP47,497 analgesic potency epimer THC .delta.-THC (±)-iso Δ-tetrahydrocannabidiol CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 10919 9.334116612362
11578 Eprosartan (mesylate) New 144143-96-4 ≥98% 2012-05-16 90.719337016575 eprosartan-mesylate SKF 108566J cardiovascular diseases hypertension angiotensin II rennin blood pressure ARB receptors blockers antagonists AT1 mesylate nervous system nerves vessels 90.719337016575
11241 Ethcathinone (hydrochloride) New 51553-17-4 ≥98% 2012-01-18 33.764379276579 ethcathinone-hydrochloride RMI 8201A; N-Ethylcathinone 71276-46-5 forensics phenethylamines cathinones designer drugs psychoactive recreational hydrochloride HCl amphetamines rats capsules tablets research N-monoethylcathinone RMI8201A RMI-8201A 33.764379276579
10012088 Ethyl-L-NIO (hydrochloride) 150403-97-7 ≥95% 2008-08-14 10.224350828729 ethyl-l-nio-hydrochloride L-N5-(1-Iminobutyl)ornithine hydrochloride nitric oxide synthase NOS iNOs nNOS selective inhibitors inhibits inhibition 10.224350828729
10007433 FABP5 (mouse recombinant) - ≥95% 2005-07-29 3.242867905575 fabp5-mouse-recombinant Epidermal-FABP; Fatty Acid Binding Protein 5; E-FABP protein-only proteins cytosolic acids lipophilic ligands uptake metabolism cellular membranes intracellular trafficking modulation enzymes lipids metabolic pathways cells growth differentiation antiparallel B .beta. strands barrel prostates bladder carcinomas atherosclerosis endocrinology neurochemistry 3.242867905575
301600 Fatty Acid Amide Hydrolase Blocking Peptide - 19.501482504604 fatty-acid-amide-hydrolase-blocking-peptide Oleamide Hydrolase; FAAH; Anandamide Amidohydrolase hydrolases peptides hydrolysis controls acids amides WB western blots blotting IHC immunohistochemistry immunoblotting antibodies neurochemistry neuroscience 19.501482504604
10010183 Fatty Acid Amide Hydrolase (human recombinant) - Whole-cell lysate 2008-11-05 41.269936858721 fatty-acid-amide-hydrolase-human-recombinant FAAH (human recombinant) FAAHs endocannabinoid AEA cannabinoids 2-AG 2AG proteins FAAH-1 acids amides hydrolases active 41.269936858721
101600 Fatty Acid Amide Hydrolase Polyclonal Antibody - 25.642178374112 fatty-acid-amide-hydrolase-polyclonal-antibody Oleamide Hydrolase; FAAH; Anandamide Amidohydrolase WB western blots hydrolases antibodies antiserum antisera hydrolysis immunohistochemistry IHC immunoblotting neurochemistry neuroscience blotting 25.642178374112
10010182 Fatty Acid Amide Hydrolase Western Ready Control - 66 kDa (His-tagged), 63 kDa (native) 2007-07-06 6.701616022099 fatty-acid-amide-hydrolase-western-ready-control Oleamide Hydrolase; FAAH; Anandamide Aminohydrolase fatty acid amides sleep nociception cancers liver brain testes uterus small intestine ocular tissues western blots blotting WB inhibitors 6.701616022099
10004236 Fluprostenol serinol amide - ≥98% 2004-09-23 7.056596685083 fluprostenol-serinol-amide Flu-SA PGF2.alpha. PGF2alpha analogs agonists prostaglandins receptors amides cannabinoids CB1 CBs synthetic 7.056596685083
70250 (±)-Flurbiprofen 5104-49-4 ≥99% 52.414400450173 -flurbiprofen Ansaid cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases neurochemistry synthase-1 synthase-2 inhibits 51543-38-5 52.414400450173
10600 GABAA Receptor δ-subunit (N-Term) Polyclonal Antibody - 2009-10-22 9.396255371393 gabaa-receptor-subunit-n-term-polyclonal-antibody γ-Aminobutyric Acid A Receptor gamma inhibits inhibitors neurotransmitters WB western blots blotting IP IHC immunoprecipitation immunohistochemistry 9.396255371393
10008346 Gabapentin 60142-96-3 ≥98% 2006-04-20 3.915138121546 gabapentin Neurontin® antiepileptic drugs Gamma-aminobutyric acids GABA neurotransmitters receptors spinal cord analogs anticonvulsants analgeics neuropathics pain syndromes Complex Regional types CRPS1 multiple sclerosis dysesthesias cancers HIV infections CNS central nervous systems calcium channels .gamma.-aminobutyric g-aminobutyric neurochemistry 3.915138121546
10009400 Gap-43 (Phospho-Ser41) Polyclonal Antibody - 2006-12-18 1.740331491712 gap-43-phospho-ser41-polyclonal-antibody GAP43 development and plasticity neuronal growth cones axonal regeneration knockout animals amplify path finding signals mediate actin phosphorylation kinases C PKC modulates neurotransmitters LTP antibodies antisera antiserum WB western blots IHC immunohistochemistry frozen sections blotting proteins diseases phospho-specific immunoblotting 1.740331491712
10566 Garcinol 78824-30-3 ≥95% 2011-10-25 9.634610820401 garcinol Camboginol inhibits inhibitors inhibition histones acetyltransferases HATs p300 PCAF GCN5 neurogenesis stem cells apoptosis cancers antiinflammatory anti-inflammatory inflammation neuroscience genes expressions regulations epigenetics 9.634610820401
10007621 GFAP (human) EIA Kit - 2006-07-11 0E-12 gfap-human-eia-kit Glial Fibrillary Acidic Protein (human) EIA Kit SPI-Bio spibio kits enzyme immunoassays A05188 assays 0E-12
10006306 Ghrelin (human acylated) EIA Kit - 2004-11-10 149.120320779315 ghrelin-human-acylated-eia-kit Ghrelin (human acylated) ELISA Kit spi-bio acylated immunoassays obesity growth hormones homeostasis ligands secretagogue A05106 receptors stomach hypothalmic spi-bio spibio A05106 adipokines endocrinology neurochemistry assays ghrelin assay 149.120320779315
10006307 Ghrelin (rat acylated) EIA Kit - 2004-11-10 197.262492791110 ghrelin-rat-acylated-eia-kit Ghrelin (rat acylated) ELISA Kit spi-bio acylated immunoassays obesity growth hormones homeostasis ligands secretagogue receptors stomach hypothalmic spibio A05117 adipokines endocrinology neurochemistry assays ghrelin assay 197.262492791110
10602 GluR1 (Phospho-Ser831) Polyclonal Antibody - 2009-10-22 0.193370165745 glur1-phospho-ser831-polyclonal-antibody Glutamate Receptor Subunit 1 gamma inhibits inhibitors neurotransmitters WB western blots blotting receptors NMDAR AMPAR kinase immunoblotting 0.193370165745
10601 GluR1 (Phospho-Ser845) Polyclonal Antibody - 2009-10-22 0.193370165745 glur1-phospho-ser845-polyclonal-antibody Glutamate Receptor Subunit 1 gamma inhibits inhibitors neurotransmitters WB western blots immunoblotting receptors NMDA AMPA kinases IHC immunohistochemistry 0.193370165745
10011347 Glycerophospho-N-Arachidonoyl Ethanolamine Exclusive 201738-25-2 ≥97% ✓ 2009-03-13 18.765230202578 glycerophospho-n-arachidonoyl-ethanolamine Glycerophospho-Arachidonoyl Ethanolamide; Glycerophosphoanandamide; GP-NArE anandamides arachidonoyl ethanolamide AEA NAE GDE1 cannabinoids neurotransmitters CB1 CB2 glycerophosphodiesterase 1 NAPE N-Acyl Phosphatidylethanolamide cbs synthetic 18.765230202578
10011357 Glycerophospho-N-Oleoyl Ethanolamine Exclusive 201738-24-1 ≥98% ✓ 2009-02-20 24.612817679558 glycerophospho-n-oleoyl-ethanolamine cannabinoids neurotransmitter PPARs neurochemistry neuroscience fatty acids amides hydrolase oleoyl ethanolamides methabolism obesity nutrition diet NAPE N-Acyl Phosphatidylethanolamide cannabinoids cbs synthetic 24.612817679558
10009399 Glycine Receptor Polyclonal Antibody - 2006-12-18 2.080801104972 glycine-receptor-polyclonal-antibody GLY inhibits inhibitors inhibition inhibitory transmitter brainstem spinal cord ligand-gated ion channels family LGICs chemical neurotransmission chloride conductance membranes hyperpolarization synapses cytoplasmic proteins gephyrin alcohol synaptic clustering NMDAR subunit antibodies antisera antiserum WB western blots blotting proteins diseases immunoblotting IHC immunohistochemistry 2.080801104972
10224 GPR55 Polyclonal Antibody - 2010-01-19 42.302316495658 gpr55-polyclonal-antibody G Protein-Coupled Receptor 55 proteins receptors antibodies western blots WB ICC signals signaling nucleotides THC amino acids blotting immunoblotting immunocytochemistry signalling cannabinoids cbs synthetic 42.302316495658
10851 Guanabenz (hydrochloride) - ≥98% 2011-09-30 0E-12 guanabenz-hydrochloride Wytensin adrenergic receptors hypertension imidazoline adipose tissues neurosciences cardiovascular diseases agonists 5051-62-7 α2 alpha2 I2 hydrochloride HCl 0E-12
10010372 GW 842166X 666260-75-9 ≥98% 2008-05-23 34.145428176795 gw-842166x inflammatory pain arthritis neuropathic hyperalgesia CB2 cannabinoids agonists anandamide receptors neurochemistry cannabinoids cbs synthetic 34.145428176795
13205 Halopemide Exclusive 59831-65-1 ≥98% ✓ 2009-04-21 9.318287292817 halopemide R34301; NSC 354856 inhibitors phospholipases D PLD PLD1 PLD2 dopamine receptors inhibits inhibition potent cells DP nueraleptic 9.318287292817
10995 Harmaline 304-21-2 ≥98% 2011-10-11 1.286187845304 harmaline inhibitors monoamine oxidases MAOI receptor agonists inverse agonists NMDA herbal mixtures forensics bath salts spices plants N-methyl-D-aspartate inhibits inhibition adulterant CBs cannabinoids hallucinogenic tryptamines 1.286187845304
13705 HCN1 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S70-28) - 2009-12-01 0E-12 hcn1-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s70-28 antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-1 HCN 1 0E-12
13707 HCN2 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S71-37) - 2009-12-01 0E-12 hcn2-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s71-37 antibodies western blots blotting immunoblotting WB immunohistochemistry IHC ions channels HCN-2 HCN 2 ICC immunocytochemistry immunoprecipitation IP 0E-12
13708 HCN3 Cyclic Neuclotide-gated Channel Monoclonal Antibody (Clone S141-28) - 2009-12-01 0E-12 hcn3-cyclic-neuclotide-gated-channel-monoclonal-antibody-clone-s141-28 antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-3 HCN 3 0E-12
13709 HCN4 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S114-10) - 2009-12-02 0E-12 hcn4-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s114-10 antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-4 HCN 4 hyperpolarization-activated cation gene family hyperpolarization activated activity activates 0E-12
10011038 Hemopressin - 2009-08-13 29.761006314127 hemopressin peptides antagonist inhibitors inhibits inhibition hypertension binding asoactive vasoactive cannabinoids cbs synthetic 29.761006314127
90342 Heptadecanoyl Ethanolamide - ≥98% 7.549571823204 heptadecanoyl-ethanolamide pea cannabinoids palmitoyl ethanolamides anandamides neurochemistry neuroscience ethanolamines 7.549571823204
90082 HU-210 112830-95-2 >98% 45.112620856353 hu-210 agonists analogs d9-THC marijuana CB1 CB2 receptors cannabinoids HU210 .DELTA.9-THC delta9-THC neuroscience neurochemistry endocrinology cannabinoids cbs synthetic 45.112620856353
90083 HU-210 (solution) 112830-95-2 ≥98% 2011-03-03 30.987411207576 hu-210-solution agonists analogs d9-THC marijuana CB1 CB2 receptors cannabinoids HU210 .DELTA.9-THC delta9-THC neuroscience neurochemistry endocrinology cannabinoids cbs synthetic Tetrahydrocannabinol, Trans-(+-)-Isomer Tetrahydrocannabinol, (6a-trans)-Isomer Tetrahydrocannabinol (6aS-cis)-Isomer Tetrahydrocannabinol (6aR-cis)-Isomer Solvay Brand of Tetrahydrocannabinol Tetrahydrocannabinol Trans-Isomer Tetrahydrocannabinol Trans Isomer delta(9)-Tetrahydrocannabinol delta(1)-Tetrahydrocannabinol 9-ene-Tetrahydrocannabinol 9 ene Tetrahydrocannabinol Tetrahydrocannabinol delta(9)-THC delta(1)-THC Dronabinol Marinol THC 30.987411207576
10006350 HU-211 112924-45-5 ≥98% 2005-03-30 101.370524861878 hu-211 Dexanabinol HU211 endocannabinoids cannabis CB2 pain inflammation NF-kB NF-.kappa.B inhibition antioxidants neurochemistry terpene-based psychomotor DELTA9-THC .DELTA.9-THC D9-THC neuroprotective cannabidiols CB1 inflammatory pharmacology neuroscience neurochemistry 101.370524861878
90086 HU-308 256934-39-1 >98% 2005-03-16 36.678093031545 hu-308 endocannabinoids CB2 pain inflammation G-protein coupled receptors agonists hypotensives analgesics anti-inflammatory phenolic .DELTA.9-THC D9-THC CB1 FAAH fatty acid hydrolases substrates selective neuroscience neurochemistry GPCRs HU308 HU 308 cannabinoids 36.678093031545
10005673 HU-331 137252-25-6 ≥95% 2005-09-09 39.848813177818 hu-331 cannabidiols analogs antiproliferative activity endocannabinoids central CB1 peripheral CB2 non-CB receptor-mediated pharmacology receptors memory weight loss appetite neurodegeneration tumor surveillance analgesia inflammation hydroxylquinone antineoplastic human cancer cells lines inhibits inhibitors inhibition growth Raji Jurkat lymphomas in vitro HT-29 colon carcinomas neuroscience neurochemistry cannabinoids cbs sythetic 39.848813177818
70280 (±)-Ibuprofen 15687-27-1 ≥99% 25.678516286251 -ibuprofen Motrin PPAR cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits peroxisome proliferator-activated receptors neurochemistry 25.678516286251
10137 Icilin 36945-98-9 ≥98% 2004-04-27 13.087421731123 icilin AG 3-5 cooling agent cold receptors CMR1 neurons transient receptors potential VR1 vanilloid receptos TRPM8 neurochemistry neuroscience 13.087421731123
10215 IDFP 615250-02-7 ≥98% 2009-03-09 25.537969613259 idfp Isopropyl Dodecylfluorophosphonate CB1 agonist nerve agent serins organophophorus MAGL inhibitors inhibits inhibition FAAH 2-AG 2AG AEA arachidonic acids MGL inhibitors cannabinoids 25.537969613259
70275 IMMA - ≥98% 12.406973603437 imma Indomethacin Morpholinylamide; BML-190 cannabinoids receptors CB2 neuroscience neurochemistry endocrinology 12.406973603437
70270 Indomethacin 53-86-1 ≥99% 29.233316340602 indomethacin Indocin cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin synthases synthase-1 synthase-2 PPARs peroxisome proliferator-activated receptors inhibits neurochemistry 29.233316340602
10005518 IP Receptor (human) Polyclonal Antibody - 2004-10-21 25.489591774094 ip-receptor-human-polyclonal-antibody Prostaglandin I2 Receptor; Prostacyclin Receptor; PGI2 Receptor antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors immunoblotting atherosclerosis 25.489591774094
160070 IP Receptor (mouse) Polyclonal Antibody - 2004-05-25 19.648040515653 ip-receptor-mouse-polyclonal-antibody PGI2 Receptor; Prostacyclin Receptor; Prostaglandin I2 Receptor antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors atherosclerosis neurochemistry immunoblotting 19.648040515653
13325 Iso-Olomoucine 101622-50-8 ≥98% 2011-07-27 0.331546961326 iso-olomoucine cyclin dependent kinases Cdks cells cycles dopamine inhibitors inhibits inhibition inactive controls regulators iso olomoucine transporter diseases neurodegenerative signaling rats dorsal striatal synaptosomes cancers neuroscience 0.331546961326
10008661 JP104 Exclusive - ≥98% ✓ 2006-09-05 7.391034655951 jp104 click chemistry probes FAAH fatty acids amides hydrolases inhibits inhibitors inhibition URB598 acyl anandamide AEA esters unsaturated carbamates neurochemistry 7.391034655951
10008660 JP83 887264-44-0 ≥98% 2006-08-30 6.974116022099 jp83 FAAH fatty acids amides hydrolases inhibits inhibitors inhibition URB597 acyl anandamide AEA esters unsaturated carbamates arachidonoyl ethanolamides neurochemistry 6.974116022099
10266 JWH 007 Exclusive 155471-10-6 ≥98% ✓ 2011-02-23 32.475658424607 jwh-007 agonists cannabinoids receptors CB1 CB2 Δ9-THC pain antinociception hypothermia catalepsy JWHs CBs JWH-007 JWH007 JWH-7 JWH 7 JWH7 32.475658424607
10486 JWH 007-d9 - ≥99% deuterated forms (d1-d9) 2010-10-11 38.180851749539 jwh-007-d9 agonists cannabinoids receptors CB1 CB2 Δ9-THC pain antinociception hypothermia catalepsy deuterateds deuteriums mass spectrometry MS standards JWHs JWH007-d9 JWH-007-d9 cannabinoids cbs synthetic JWH7-d9 JWH 7-d9 JWH-7-d9 38.180851749539
9001058 JWH 011 Exclusive 155471-13-9 ≥98% ✓ 2011-09-06 22.113556607671 jwh-011 JWH 004 1-methylhexyl analog JWH011 JWH-011 JWH11 JWH-11 JWH015 JWH-015 JWH15 JWH-15 JWHs analogs forensics sciences cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices synthetics central peripheral 22.113556607671
10009018 JWH 015 155471-08-2 ≥98% 2006-10-05 63.861233412638 jwh-015 agonists CB1 CB2 cannabinoids aminoalkylindole receptors MS multiple sclerosis WIN 55212-2 ACEA CD4+ T cells IFN-g IFN-.gamma. CD40 JAK STAT1 endocrinology neurochemistry JWH015 JWH-015 cannabinoids cbs synthetic JWH15 JWH-15 JWH 15 63.861233412638
10660 JWH 015-d7 Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-02-21 44.219281767956 jwh-015-d7 agonists CB1 CB2 cannabinoids aminoalkylindole receptors MS multiple sclerosis WIN 55212-2 ACEA CD4+ T cells IFN-γ IFN-gamma CD40 JAK STAT1 endocrinology neurochemistry JWH015 JWH-015 cannabinoids cbs synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry deuteriums deuterateds standards JWH15-d7 JWH 15-d7 JWH-15-d7 44.219281767956
10900 JWH 018 209414-07-3 ≥98% 2011-05-05 28.369097520404 jwh-018 cannabinoids CB1 CB2 agonists selective receptors WIN 55212-2 JWH-018 JWH018 cbs synthetic JWH 18 JWH-018 JWH18 JWH-18 13169 28.369097520404
9000844 JWH 018 2-hydroxyindole metabolite Exclusive - ≥98% ✓ 2010-10-26 19.190639893467 jwh-018-2-hydroxyindole-metabolite cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs monohydroxylated cbs synthetic JWH-018 JWH018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 19.190639893467
10711 JWH 018 2-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated forms (d1-d9) ✓ 2011-02-25 12.710481456396 jwh-018-2-hydroxyindole-metabolite-d9 cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs monohydroxylated standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 12.710481456396
9001007 JWH 018 2'-naphthyl-N-(1,1-dimethylpropyl) isomer Exclusive New - ≥98% ✓ 2012-01-13 27.454796925647 jwh-018-2-naphthyl-n-1-1-dimethylpropyl-isomer cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic isomers JWH018 JWH-018 JWH 18 JWH-18 JWH18 JWHs pejntyl chains indoles naphthyl moiety herbal blends central peripheral 27.454796925647
11586 JWH 018 2’-naphthyl-N-(1-ethylpropyl) isomer Exclusive New - ≥98% ✓ 2012-04-03 60.270715257992 jwh-018-2-naphthyl-n-1-ethylpropyl-isomer neuroscience synthetic cannabinoids CBs herbals blends isomers forensics cannabimimetics CB1 CB2 receptors agonists central peripheral spices 60.270715257992
9000851 JWH 018 4-hydroxyindole metabolite Exclusive - ≥98% ✓ 2010-09-01 29.965426746809 jwh-018-4-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics JWH-018 JWH018 209414-07-3 JWH018-metabolite JWH 018-metabolite one CBs M-1 M1 smoking mixtures spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 29.965426746809
10712 JWH 018 4-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated forms (d1-d9) ✓ 2011-02-25 15.974211548210 jwh-018-4-hydroxyindole-metabolite-d9 cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 15.974211548210
9000852 JWH 018 5-hydroxyindole metabolite Exclusive - ≥98% ✓ 2010-09-01 31.649293691525 jwh-018-5-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite two 2 smoking mixtures spices CBS M-2 M2 synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 31.649293691525
10713 JWH 018 5-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated forms (d1-d9) ✓ 2011-03-11 16.057740414512 jwh-018-5-hydroxyindole-metabolite-d9 cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards M-2 M2 JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 16.057740414512
9000853 JWH 018 6-hydroxyindole metabolite Exclusive - ≥98% ✓ 2010-09-01 30.292668565763 jwh-018-6-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 CBs smoking mixture spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 30.292668565763
10714 JWH 018 6-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated forms (d1-d9) ✓ 2011-03-25 29.737593084863 jwh-018-6-hydroxyindole-metabolite-d9 cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 CBs smoking mixture spices cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 29.737593084863
10697 JWH 018 6-methoxyindole analog Exclusive - ≥98% ✓ 2011-02-15 19.075558118861 jwh-018-6-methoxyindole-analog analogs metabolites cannabinoids receptors agonists CBs JWH-018 JWH018 JWH18 JWH-18 JWH 18 19.075558118861
9000854 JWH 018 7-hydroxyindole metabolite Exclusive - ≥98% ✓ 2010-09-01 26.744422027828 jwh-018-7-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite four 4 M4 M-4 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 26.744422027828
10715 JWH 018 7-hydroxyindole metabolite-d9 Exclusive - ≥99% deuterated forms (d1-d9) ✓ 2011-07-26 8.456755434286 jwh-018-7-hydroxyindole-metabolite-d9 WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 smoking mixture spices synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 CBs cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic sciences pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 4 M4 M-4 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 8.456755434286
9000799 JWH 018 adamantyl analog Exclusive - ≥97% ✓ 2011-07-18 42.958777573540 jwh-018-adamantyl-analog AB-001 JWH 018 JWH-018 JWHs analogs forensics sciences cannabinoids CBs receptors WIN 55,212-2 CB1 CB2 cannabimimetics 42.958777573540
9001193 JWH 018 adamantyl carboxamide Exclusive New 1345973-50-3 ≥98% ✓ 2012-03-08 139.322541233127 jwh-018-adamantyl-carboxamide 2NE1; APICA JWHs JWH018 JWH-018 JWH18 JWH 18 JWH-18 cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics science neuroscience synthetic central peripheral herbal blends analogs 139.322541233127
13824 JWH 018-d9 (solution) - ≥99% deuterated forms (d1-d9) 2010-06-21 48.264956879881 jwh-018-d9-solution cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cbs synthetic JWH018-d9 JWH-018-d9 JWH-18-d9 JWH 18-d9 JWH18-d9 JWH18d9 10901 48.264956879881
11585 JWH 018 N-(1-ethylpropyl) isomer Exclusive New - ≥98% ✓ 2012-04-03 81.793275619358 jwh-018-n-1-ethylpropyl-isomer neuroscience synthetic cannabinoids CBs herbals blends isomers forensics cannabimimetics CB1 CB2 receptors agonists central peripheral spices 81.793275619358
10690 JWH 018 N-(2-methylbutyl) isomer Exclusive - ≥97% ✓ 2011-03-16 18.135527365523 jwh-018-n-2-methylbutyl-isomer JWH 073 2-methylbutyl homolog cannabinoids CBs receptors WIN 55,212-2 CB1 cannabimimetics analogs forensics standards JWH-073 JWH 73 JWH73 JWH-73 18.135527365523
10691 JWH 018 N-(3-methylbutyl) isomer - ≥97% 2011-02-07 18.534992637709 jwh-018-n-3-methylbutyl-isomer JWH 073 3-methylbutyl homolog cannabinoids agonist selective receptors WIN55212-2 WIN552122 WIN 55212-2 WIN 55,212-2 CB1 cannabimimetics analog forensics CBs JWH-073 JWH-73 JWH 73 JWH73 18.534992637709
11075 JWH 018 N-(4,5-epoxypentyl) analog - ≥98% 2011-10-21 22.906958377970 jwh-018-n-4-5-epoxypentyl-analog JWH 018 epoxide cannabinoids CBs cannabimimetic CB1 CB2 receptor agonists spices forensics synthetic herbal central peripheral alkyl chains 22.906958377970
10796 (±)-JWH 018 N-(4-hydroxypentyl) metabolite Exclusive - ≥97% ✓ 2011-05-31 30.827097139518 -jwh-018-n-4-hydroxypentyl-metabolite JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabinoids WIN 55,212-2 urinary metabolites forensics CBs WIN 55212-2 WIN55,212-2 WIN55212-2 monohydroxylation metabolism N-alkyl chains agonists peripheral central receptors smoking mixtures 30.827097139518
10926 (±)-JWH 018 N-(4-hydroxypentyl) metabolite-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2011-06-28 48.189223825681 -jwh-018-n-4-hydroxypentyl-metabolite-d5 JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabinoids WIN 55,212-2 urinary metabolites forensics CBs WIN 55212-2 WIN55,212-2 WIN55212-2 monohydroxylation metabolism N-alkyl chains agonists peripheral central receptors smoking mixtures GC/MS deuteriums standards deuterateds LC/MS GC-MS LC-MS mass spectrometry 48.189223825681
11047 JWH 018 N-(5-bromopentyl) analog New - ≥98% 2012-01-19 32.302845590090 jwh-018-n-5-bromopentyl-analog cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic central peripheral analogs JWH-018 JWH018 JWH 18 JWH18 JWH-18 JWHs herbal blends bromine pentyl chains 32.302845590090
10521 JWH 018 N-(5-chloropentyl) analog New - ≥95% 2012-01-17 45.193105703607 jwh-018-n-5-chloropentyl-analog cannabinoids CBs cannabimimetics CB1 CB2, receptors agonists spices forensics synthetic JWH018 JWH-018 JWH 18 JWH18 JWH-18 JWHs herbal blends analogs chlorine pentyl chains 45.193105703607
9000855 JWH 018 N-(5-hydroxypentyl) metabolite Exclusive - ≥98% ✓ 2010-09-01 112.481585773088 jwh-018-n-5-hydroxypentyl-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite five 5 CBs M-5 M5 smoking mixtures spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 112.481585773088
10933 JWH 018 N-(5-hydroxypentyl) metabolite-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2011-06-22 65.383411098240 jwh-018-n-5-hydroxypentyl-metabolite-d5 cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite two 2 smoking mixtures spices CBs M-5 M5 synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 bath salts LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums agonists selective M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 65.383411098240
9000856 JWH 018 N-pentanoic acid metabolite Exclusive - ≥95% ✓ 2010-09-01 83.447861697431 jwh-018-n-pentanoic-acid-metabolite cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 6 six CBs M6 M-6 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 83.447861697431
9000867 JWH 018 N-pentanoic acid metabolite-d4 Exclusive - ≥99% deuterated forms (d1-d4) ✓ 2010-09-15 231.759091679792 jwh-018-n-pentanoic-acid-metabolite-d4 JWH-018 JWH018 deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 6 six CBs M6 M-6 smoking mixtures spices synthetic M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M 231.759091679792
13169 JWH 018 (solution) 209414-07-3 ≥98% 2009-03-12 47.491561336422 jwh-018-solution cannabinoids CB1 CB2 agonists selective receptors WIN 55212-2 JWH-018 JWH018 cbs synthetic JWH 18 JWH-018 JWH18 JWH-18 10900 47.491561336422
13633 JWH 019 209414-08-4 ≥98% 2010-01-14 51.392604445863 jwh-019 cannabinoids CB1 CB2 receptors THC JWH-019 JWH019 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinol cannabinmimetic indoles cannabinoids cbs synthetic JWH019 JWH-019 JWH19 JWH 19 JWH-19 51.392604445863
9000764 JWH 019 5-hydroxyindole metabolite Exclusive - ≥98% ✓ 2011-07-06 17.245524861878 jwh-019-5-hydroxyindole-metabolite JWH 019-M2 JWH019 JWH-019 JWH-19 JWH 19 JWH19 cannabinoids cannabimimetic metabolites CB1 CB2 receptors agonists spice forensics synthetic smoking urinary urine serum neuroscience CBs 17.245524861878
9000765 JWH 019 N-(6-hydroxyhexyl) metabolite Exclusive - ≥98% ✓ 2011-10-13 23.631270718231 jwh-019-n-6-hydroxyhexyl-metabolite JWH019 JWH-019 JWH-19 JWH 19 JWH19 JWHs cannabinoids cannabimimetic metabolites CB1 CB2 CBs receptors agonists spices forensics synthetic smoking urinary urine serum herbal blends metabolized livers 23.631270718231
10850 JWH 020 Exclusive 209414-09-5 ≥98% ✓ 2011-06-02 42.261104716287 jwh-020 cannabinoids CBs cannabimimetic CB1 receptors agonists CB2 forensics bath salts JWH020 JWH-020 WIN55212-1 WIN55212-2 WIN-55212-1 WIN-55212-2 WIN552121 WIN552122 in vivo JWH 020 42.261104716287
9001056 JWH 022 Exclusive 209414-16-4 ≥98% ✓ 2011-08-09 81.900196852686 jwh-022 AM2201 N-(4-pentenyl) analog JWH022 JWH-022 JWH22 JWH-22 JWHs cannabinoids CBs synthetic standards forensics sciences 81.900196852686
10831 JWH 030 Exclusive 162934-73-8 ≥98% ✓ 2011-10-11 25.915750473185 jwh-030 JWH-030 JWH030 JWH30 JWH-30 JWH30 cannabimimetic cannabinoids synthetics CB1 CB2 CBs receptors forensics neuroscience naphtholyl pyrrole mouse mice inhibits inhibition inhibitors electrically induced vas deferens 25.915750473185
10824 JWH 031 New 162934-74-9 ≥98% 2012-02-17 35.576244985832 jwh-031 JWH-031 JWH031 JWH31 JWH-31 JWH31 JWHs cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic central peripheral mice 35.576244985832
9001201 JWH 072 New 209414-06-2 ≥98% 2012-03-02 43.335915114003 jwh-072 cannabinoids CBs forensics neuroscience cannabimimetic CB1 CB2 receptors spice herbal central peripheral synthetic JWHs JWH072 JWH-072 JWH 72 JWH-72 JWH72 43.335915114003
10904 JWH 073 208987-48-8 ≥97% 2011-05-06 35.953065587533 jwh-073 cannabinoid CB1 CB2 agonist selective receptors WN55212-2 WIN552122 WIN 552122 WIN 55212-2 jwh073 cannabinoids cbs synthetic JWH-073-d7 JWH073-d7 JWH73d7 10904 35.953065587533
10633 JWH 073 2-hydroxyindole metabolite - ≥98% 2011-01-11 31.011945190575 jwh-073-2-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs JWH073 JWH-073 cannabinoids cbs synthetic JWH 73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 31.011945190575
10716 JWH 073 2-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-03-10 13.307377506650 jwh-073-2-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites monohydroxylated forensics JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 glucuroconjugate JWH-073 JWH073 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 13.307377506650
10848 JWH 073 2-methylnaphthyl analog Exclusive - ≥98% ✓ 2011-10-11 29.764054293704 jwh-073-2-methylnaphthyl-analog JWHs cannabinoids cannabimimetic CB1 CB2 CBs receptors agonists spices forensics synthetics herbal blends JWH-073 073 JWH73 JWH-73 JWHs 73 29.764054293704
9001017 JWH 073 2'-naphthyl-N-(1,1-dimethylethyl) isomer Exclusive New - ≥98% ✓ 2012-01-12 21.552955906945 jwh-073-2-naphthyl-n-1-1-dimethylethyl-isomer cannabinoids cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic CBs herbal blends research applications isomers JWH073 JWH-073 JHW 73 JWH73 JWH-73 JWHs naphthyl groups butyl chains central peripheral 21.552955906945
9000861 JWH 073 4-hydroxyindole metabolite - ≥98% 2010-09-01 31.007088490801 jwh-073-4-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 1 JWH-073 JWH073 M-1 CBs smoking mixtures spices synthetic standards CBs JWH073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 31.007088490801
10717 JWH 073 4-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-02-21 6.044669013027 jwh-073-4-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 1 JWH-073 JWH073 M-1 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 6.044669013027
9001076 JWH 073 4-methylnaphthyl analog - ≥98% 2011-09-06 34.341054498329 jwh-073-4-methylnaphthyl-analog JWH 122 N-butyl analog; 1-butyl-3-(1-(4-methyl)naphthoyl) indole JWH073 JWH-073 JWH73 JWH-73 analogs hybrids forensics sciences cannabinoids CBs JWHs indoles cannabimimetics JWH 018 122 smoking incense spices forensics pains neuroscience 34.341054498329
9000862 JWH 073 5-hydroxyindole metabolite Exclusive - ≥98% ✓ 2010-09-01 26.670627826984 jwh-073-5-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 2 JWH-073 JWH073 CBs M-2 agonists smoking mixtures spices cbs synthetic JWH073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 26.670627826984
10718 JWH 073 5-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-03-11 10.114667254961 jwh-073-5-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics Metabolite 2 JWH-073 JWH073 M-2 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 10.114667254961
9000863 JWH 073 6-hydroxyindole metabolite Exclusive - ≥95% ✓ 2010-09-01 24.845264190709 jwh-073-6-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 3 JWH-073 JWH073 M-3 CBs smoking mixtures spices synthetic JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 24.845264190709
10719 JWH 073 6-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-03-11 5.957007871222 jwh-073-6-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 3 JWH-073 JWH073 M-3 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 5.957007871222
9000864 JWH 073 7-hydroxyindole metabolite Exclusive - 98% ✓ 2010-09-01 20.294200571000 jwh-073-7-hydroxyindole-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 4 JWH-073 CBs JWH073 M-4 mixtures smoking spices synthetic JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 20.294200571000
10720 JWH 073 7-hydroxyindole metabolite-d7 Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2011-07-25 2.962005138349 jwh-073-7-hydroxyindole-metabolite-d7 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics CBs deuterateds deuterium mass spectrometry MS LC/MS LC-MS GC-MS GC/MS WIN55212-2 WIN552122 pain neuroscience JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 2.962005138349
9000868 JWH 073-d7 (solution) Exclusive - ≥99% deuterated forms (d1-d7) ✓ 2010-08-10 34.439604184391 jwh-073-d7-solution deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-073 JWHs JWH073 JWH73 JWH-73 JWH 73 cannabinoids CB1 receptors CB2 peripheral central cbs synthetic JWH073d7 JWH-073-d7 JWH073-d7 JWH73-d7 JWH-73-d7 JWH73-d7 JWH73d7 10905 34.439604184391
9001013 JWH 073 N-(1,1-dimethylethyl) isomer Exclusive New - ≥98% ✓ 2012-01-12 21.552955906945 jwh-073-n-1-1-dimethylethyl-isomer cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWHs JWH073 JWH-073 central peripheral herbal blends butyl chains isomers 21.552955906945
10795 (±)-JWH 073 N-(3-hydroxybutyl) metabolite Exclusive - ≥98% ✓ 2011-05-31 38.503368091955 -jwh-073-n-3-hydroxybutyl-metabolite JWH-073 JWH073 JWH73 JWH-73 JWH73 cannabinoids metabolites cannabimimetic aminoalkyl chains adulterant CBs metabolism in vitro smoking mixtures 38.503368091955
10927 (±)-JWH 073 N-(3-hydroxybutyl) metabolite-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2011-07-25 34.000722142645 -jwh-073-n-3-hydroxybutyl-metabolite-d5 deuterateds deuterium GC-MS GC/MS LC-MS LC/MS mass spectrometry MS JWH073 JWH73 JWH-073 JWH-73 cannabinoids metabolites cannabimimetic aminoalkyl chains adulterant CBs metabolism in vitro smoking mixtures pain neuroscience 34.000722142645
9000865 JWH 073 N-(4-hydroxybutyl) metabolite Exclusive - ≥98% ✓ 2010-09-01 94.571567053504 jwh-073-n-4-hydroxybutyl-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 5 JWH-073 smoking JWH073 CBs mixtures spices M-5 synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 94.571567053504
10934 JWH 073 N-(4-hydroxybutyl) metabolite-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2011-10-14 60.928260173248 jwh-073-n-4-hydroxybutyl-metabolite-d5 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M deuterated deuterium metabolites cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 5 JWH-073 smoking JWH073 CBs mixtures spices 60.928260173248
9000866 JWH 073 N-butanoic acid metabolite Exclusive - ≥98% ✓ 2010-09-01 84.149065798149 jwh-073-n-butanoic-acid-metabolite cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH 073 Metabolite 6 JWH-073 CBs JWH073 M-6 smoking mixtures spices cbs synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 84.149065798149
9000870 JWH 073 N-butanoic acid metabolite-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2010-09-20 81.275709907057 jwh-073-n-butanoic-acid-metabolite-d5 JWH 073 Metabolite 6-d5 JWH-073 JWH073 cannabinoids CBs receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 deuterateds deuteriums mass spec GC-MS LC-MS GC/MS LC/MS M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M 81.275709907057
13170 JWH 073 (solution) 208987-48-8 ≥97% 2009-03-02 42.977244992795 jwh-073-solution cannabinoid CB1 CB2 agonist selective receptors WN55212-2 WIN552122 WIN 552122 WIN 55212-2 jwh073 cannabinoids cbs synthetic JWH-073-d7 JWH073-d7 JWH73d7 10904 42.977244992795
10579 JWH 081 210179-46-7 ≥98% 2010-10-22 63.246342720480 jwh-081 cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine forensics endocannabinoids indoles central peripheral receptors cannabinoids cbs synthetic JWH-081 JWH 81 JWH-81 JWH81 63.246342720480
9001045 JWH 081 3-methoxynaphthyl isomer Exclusive New - ≥98% ✓ 2012-01-25 28.522489911432 jwh-081-3-methoxynaphthyl-isomer cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWH-081 JWH081 JWH81 JWH-81 JWH 81 central peripheral 28.522489911432
9001047 JWH 081 6-methoxynaphthyl isomer Exclusive New 824961-41-3 ≥98% ✓ 2012-01-19 27.884690218810 jwh-081-6-methoxynaphthyl-isomer JWH 166 cannabinoids CBs cannabimimetics central CB1 CB2 peripheral receptors agonists spices forensics synthetic isomers methoxy groups naphthyl rings research JWH081 JWH-081 JWH 81 JWH-81 JWH81 JWH166 JWH-166 JWHs 27.884690218810
9001049 JWH 081 8-methoxynaphthyl isomer Exclusive New - ≥98% ✓ 2012-01-11 22.567714115868 jwh-081-8-methoxynaphthyl-isomer cannabinoids cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic CBs ten-fold ten fold reduced reduces affinity isomers methoxy groups naphthyl rings central peripheral 22.567714115868
10511 JWH 081-d9 - ≥99% deuterated forms (d1-d9) 2011-09-08 34.895498379446 jwh-081-d9 cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine forensics endocannabinoids indoles central peripheral receptors cannabinoids CBs synthetic JWH-081 JWH 81 JWH-81 JWH81 standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS 34.895498379446
9000768 JWH 081 N-(5-hydroxypentyl) metabolite Exclusive - ≥95% ✓ 2011-08-05 33.587906619445 jwh-081-n-5-hydroxypentyl-metabolite JWH-081 JWH081 JWH-81 JWH81 JWH 81 JWHs CBs cannabinoids forensics sciences metabolites cannabimimetics metabolites CB1 CB2 receptors agonists spices synthetics smoking urinary urine serum 33.587906619445
10680 JWH 098 Exclusive 316189-74-9 ≥98% ✓ 2011-04-20 38.943367530193 jwh-098 JWH-098 JWH98 JWH-98 JWH 98 cannabinoids cannabimimetics CBs CB1 receptors agonists CB2 pain spice forensics synthetic naphthalen-1-yl-(1-pentylindol-3-yl)methanone 1-propyl-2-methyl-3-(1-naphthoyl)indole 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC 1-pentyl-3-(1-naphthoyl)indole naphthalenes JWH 133 JWH133 JWH-133 JWH-018 JWH018 JWH 018 JWH18 JWH015 JWH15 JWH 015 JWH-015 indoles 38.943367530193
10512 JWH 122-d9 - ≥99% deuterated forms (d1-d9) 2011-09-08 82.701417264663 jwh-122-d9 JWHs JWH-122 JWH122 cannabinoids CB1 CB2 CBs CB-1 CB-2 receptors potent synthetic forensics pain central peripheral cannabinoids CBs synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS 82.701417264663
11784 JWH 122 N-(4-hydroxypentyl) metabolite Exclusive New - ≥98% ✓ 2012-05-21 177.343209960627 jwh-122-n-4-hydroxypentyl-metabolite cannabinoids forensics CB1 CB2 metabolites metabolism designer drugs neuroscience CBs JWH-210 JWH210 JWH122 JWH-122 serum urine 177.343209960627
11611 JWH 122 N-(4-pentenyl) analog Exclusive New - ≥98% ✓ 2012-04-20 169.727469987228 jwh-122-n-4-pentenyl-analog MAM2201 N-(4-pentenyl) analog; JWH 022 4-methylnaphthyl analog cannabinoids CBs forensics CB1 CB2 analogs designer drugs JWH122 neuroscience JWH-122 synthetics central peripheral MAM2201 JWH 022 JWH022 JWH-022 169.727469987228
10925 JWH 122 N-(5-hydroxypentyl) metabolite Exclusive - ≥98% ✓ 2011-06-17 62.067860111477 jwh-122-n-5-hydroxypentyl-metabolite MAM2201 N-(5-hydroxypentyl) metabolite cannabinoids CBs receptors CB1 CB2 cannabimimetics analogs forensics JWH122 JWH-122 monohydroxylation N-alkyl chains naphthoylindole JWH 018 JWH018 JWH-018 JWH18 JWH-18 JWH 18 JWH073 JWH-073 JWH 073 JWH73 JWH-73 JWH 73 62.067860111477
11475 JWH 122 N-(5-hydroxypentyl) metabolite-d5 Exclusive New - ≥99% deuterated forms (d1-d5) ✓ 2012-04-27 177.815253720284 jwh-122-n-5-hydroxypentyl-metabolite-d5 MAM2201 N-(5-hydroxypentyl) metabolite-d5 LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cannabinoids cbs synthetic receptors CB1 CB2 cannabimimetics analogs forensics JWH122 JWH-122 monohydroxylation N-alkyl chains naphthoylindole JWH 018 JWH018 JWH-018 JWH18 JWH-18 JWH 18 JWH073 JWH-073 JWH 073 JWH73 JWH-73 JWH 73 177.815253720284
10825 JWH 145 Exclusive 914458-19-8 ≥95% ✓ 2011-11-10 24.008926127631 jwh-145 JWH-145 JWH145 JWHs cannabinoids CBs CB1 CB2 herbals smoking forensics receptors agonists cannabimimetic aminoalkylindole JWH018 JWH-018 JWH 018 blends 73 18 JWH073 JWH-073 JWH 073 JWH73 JWH 73 JWH-73 JWH18 JWH-18 24.008926127631
10826 JWH 147 New 914458-20-1 ≥95% 2012-03-06 38.607296567102 jwh-147 JWH147 JWH-147 JWHs CBs smoking receptors agaonists aminoalkylindoles cannabinoids central peripheral cannabimimetic CB1 CB2 spices forensics neuroscience pain herbal 38.607296567102
11201 JWH 175 Exclusive New 619294-35-8 ≥98% ✓ 2012-02-09 33.281770722897 jwh-175 CBs JWH-175 JWH175 JWHs CB1 CB2 cannabinoids JWH018 JWH-018 JWH 018 receptors agonist spices synthetic 33.281770722897
9001205 JWH 180 New 824959-87-7 ≥98% 2012-03-26 67.051033200285 jwh-180 JWH-180 JWH180 cannabinoids CBs designer drugs cannabimimetics CB1 CB2 receptors agonists herbals blends synthetics central peripheral forensics 67.051033200285
10643 JWH 182 Exclusive 824960-02-3 ≥97% ✓ 2011-10-11 37.014994360320 jwh-182 JWH-182 JWHs CB1 CB2 CBs receptors agonists pains spices forensics synthetics cannabinoids cells animals 37.014994360320
10902 JWH 200 103610-04-4 ≥98% 2011-05-05 23.047589726815 jwh-200 cannabinoids receptors agonists CB1 pain antinociception cannabinoids cbs synthetic JWH200 JWH-200 10902 23.047589726815
10744 JWH 200 4-hydroxyindole metabolite Exclusive - ≥98% ✓ 2011-04-15 29.918738489871 jwh-200-4-hydroxyindole-metabolite JWH-200 JWH200 cannabinoids receptors agonists pain antinociception CBs cannabimimetic metabolites CB1 CB2 spices forensics synthetic smoking urinary urine 29.918738489871
10745 JWH 200 5-hydroxyindole metabolite Exclusive - ≥98% ✓ 2011-07-06 19.416322020521 jwh-200-5-hydroxyindole-metabolite JWH-200 JWH200 cannabinoids receptors agonists pain antinociception CBs cannabimimetic metabolites CB1 CB2 spices forensics synthetic smoking urinary urine neuroscience 19.416322020521
10903 JWH 200-d5 - ≥99% deuterated forms (d1-d5) 2011-05-06 7.401256906077 jwh-200-d5 cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-200-d5 JWH200-d5 10903 7.401256906077
10682 JWH 200-d5 (solution) - ≥99% deuterated forms (d1-d5) 2011-01-07 35.027270718231 jwh-200-d5-solution cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-200-d5 JWH200-d5 10903 35.027270718231
13171 JWH 200 (solution) 103610-04-4 ≥98% 2009-03-25 42.655236723869 jwh-200-solution cannabinoids receptors agonists CB1 pain antinociception cannabinoids cbs synthetic JWH200 JWH-200 10902 42.655236723869
10721 JWH 201 Exclusive 864445-47-6 ≥98% ✓ 2011-02-24 52.971855179095 jwh-201 cannabinoids CB1 CB2 receptors CBs JWH201 JWH-201 JWH250 JWH-250 JWH 250 52.971855179095
9000736 JWH 203 864445-54-5 ≥98% 2011-02-21 60.724386917343 jwh-203 cannabinoids receptors JWH 250 JWH203 JWH-203 CB1 CB2 cannabimimetics forensics pain CBs binding analgesic 60.724386917343
10868 JWH 203 3-chlorophenyl isomer Exclusive 864445-56-7 ≥98% ✓ 2011-06-03 27.553149171271 jwh-203-3-chlorophenyl-isomer JWH 237; JWH 203 3-chloro isomer cannabinoids receptors JWH 250 JWH203 JWH-203 CB1 CB2 CBs cannabimimetics forensics pain bath salts phenylacetylindole analog 27.553149171271
10867 JWH 203 4-chlorophenyl isomer Exclusive 864445-58-9 ≥98% ✓ 2011-06-02 35.659226519337 jwh-203-4-chlorophenyl-isomer JWH 206; JWH 203 4-chloro isomer cannabinoids CB1 CB2 receptors synthetic forensics pain bath salts CBs JWH203 JWH-203 JWH206 JWH-206 35.659226519337
10644 JWH 210 824959-81-1 ≥98% 2011-02-01 91.721299146051 jwh-210 cannabimimetic cannabinoids alklyindoles CB1 CB2 receptors agonists CBs JWH-210 JWH210 91.721299146051
9001039 JWH 210 3-ethylnaphthyl isomer Exclusive New - ≥98% ✓ 2011-11-30 15.530770432025 jwh-210-3-ethylnaphthyl-isomer cannabinoids CBs cannabimimetic metabolites receptors agonists spices forensics synthetic smoking urinary urine serum JWHs JWH210 JWH-210 alkylindole herbal blends isomers ethyl chains naphthyl groups 15.530770432025
9000771 JWH 210 5-hydroxyindole metabolite Exclusive - ≥98% ✓ 2011-08-10 14.867951564468 jwh-210-5-hydroxyindole-metabolite JWH-210 JWH210 cannabinoids CBs cannabimimetic metabolites CB1 CB2 receptors agonists spices forensics synthetic smoking urinary urine serum 14.867951564468
9001041 JWH 210 6-ethylnaphthyl isomer Exclusive New - ≥98% ✓ 2012-01-31 27.473526939369 jwh-210-6-ethylnaphthyl-isomer cannabinoids CBs cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic smoking JWH210 JWH-210 JWHs isomers alkylindoles extracts herbal blends 27.473526939369
10510 JWH 210-d9 - ≥99% deuterated forms (d1-d9) 2011-09-08 28.281393228426 jwh-210-d9 cannabimimetic cannabinoids alklyindoles CB1 CB2 receptors agonists CBs JWH-210 JWH210 JWHs standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS pain 28.281393228426
10940 JWH 210 N-(4-hydroxypentyl) metabolite New - ≥95% 2012-01-19 31.847586683177 jwh-210-n-4-hydroxypentyl-metabolite cannabinoids CBs cannabimimetics metabolites receptors agonists spices forensics synthetic smoking urinary urine serum JWH210 JWH-210 JWHs alkylindoles liver 31.847586683177
11153 JWH 249 New 864445-60-3 ≥98% 2012-02-10 28.643596557285 jwh-249 cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWH249 JWH-249 JWHs central peripheral 28.643596557285
13634 JWH 250 864445-43-2 ≥98% 2010-01-14 81.333491122734 jwh-250 cannabinoids CB1 CB2 receptors THC JWH-250 JWH250 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinols indoles cbs synthetic 81.333491122734
9000766 JWH 250 5-hydroxyindole metabolite Exclusive - ≥98% ✓ 2011-07-20 46.724391608983 jwh-250-5-hydroxyindole-metabolite JWH250 JWH-250 cannabinoids CBs cannabimimetics metabolite CB1 CB2 receptors agonists spices forensics synthetic smoking urinary urine serum 46.724391608983
10661 JWH 250-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2011-02-14 37.389532481263 jwh-250-d5 cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-250-d5 JWH250-d5 37.389532481263
10939 JWH 250 N-(4-hydroxypentyl) metabolite Exclusive - ≥98% ✓ 2011-10-24 54.240961699935 jwh-250-n-4-hydroxypentyl-metabolite JWHs JWH-250 JWH250 metabolites cannabinoids CB1 CB2 CBs herbal smoke smoking forensics receptors agonist cannabimimetic metabolite metabolism 54.240961699935
10938 JWH 250 N-(5-carboxypentyl) metabolite Exclusive - ≥98% ✓ 2011-07-19 69.224958016694 jwh-250-n-5-carboxypentyl-metabolite JWHs JWH-250 JWH250 metabolites forensics sciences urinary urine synthetics cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices synthetics smoking urinary urine serum 69.224958016694
9000767 JWH 250 N-(5-hydroxypentyl) metabolite Exclusive - ≥98% ✓ 2011-08-05 56.847280509968 jwh-250-n-5-hydroxypentyl-metabolite JWH250 JWH-250 forensic sciences CBs cannabinoids JWHs cannabimimetics metabolites CB1 CB2 receptors agonists spices forensics synthetics smoking urinary urine serum 56.847280509968
11474 JWH 250 N-(5-hydroxypentyl) metabolite-d5 Exclusive New - ≥99% deuterated forms (d1-d5) ✓ 2012-04-27 122.875777105692 jwh-250-n-5-hydroxypentyl-metabolite-d5 deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS synthetic JWH250 JWH-250 forensic sciences CBs cannabinoids JWHs cannabimimetics metabolites CB1 CB2 receptors agonists spices forensics synthetics smoking urinary urine serum JWH-18 JWH 18 JWH18 JWH018 JWH-018 JWH 018 JWH 15 JWH-15 JWH15 JWH015 JWH-015 JWH 015 122.875777105692
10578 JWH 251 864445-39-6 ≥98% 2010-08-20 44.132323069158 jwh-251 cannabinoids receptors JWHs JWH-251 JWH251 WIN55212-2 WIN 55212-2 CB1 CB2 cannabimimetics urine forensics cannabinoids cbs synthetic 44.132323069158
10722 JWH 302 Exclusive 864445-45-4 ≥95% ✓ 2011-03-04 58.664660429136 jwh-302 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine forensics CBs JWH302 JWH-302 indoles central peripheral GTPγS binding 58.664660429136
10797 JWH 307 New 914458-26-7 ≥96% 2011-12-15 54.650958008575 jwh-307 JWH307 JWH-307 cannabinoids CBs CB1 CB2 herbal smoking forensics receptors agonists JWHs cannabimimetic psychological neurological nuerology toxicological toxicology 54.650958008575
10830 JWH 309 Exclusive New 914458-42-7 ≥98% ✓ 2012-02-28 31.150459420982 jwh-309 JWH309 JWH-309 cannabinoids forensic science neuroscience cannabimimetic CB1 CB2 receptors spices herbal central peripheral 31.150459420982
10829 JWH 368 New 914458-31-4 ≥98% 2011-12-14 35.244410394511 jwh-368 JWH368 JWH-368 cannabinoids CBs CB1 CB2 herbal smoking forensics sciences receptors agonists cannabimimetic JWHs 35.244410394511
10828 JWH 369 New 914458-27-8 ≥95% 2012-01-25 28.568664451965 jwh-369 JWH369 JWH-369 cannabinoids cannabimimetics CB1 CB2 CBs receptors agonists spices forensics synthetic central peripheral mouse research 28.568664451965
10827 JWH 370 914458-22-3 ≥95% 2011-11-10 23.615292190691 jwh-370 JWH370 JWH-370 JWHs cannabinoids CB1 CB2 herbal smoking forensics receptors agonists cannabimimetic aminoalkylindole JWH 018 JWH 18 JWH-018 JWH018 JWH073 JWH 73 JWH 073 JWH-073 analogs blends JWH-73 JWH73 JWH-18 JWH18 23.615292190691
13636 JWH 398 Exclusive - ≥95% ✓ 2010-10-22 75.850922185528 jwh-398 jwh398 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine forensics CBs JWH-398 cbs synthetic 75.850922185528
9001024 JWH 398 3-chloronaphthyl isomer Exclusive New - ≥98% ✓ 2012-01-11 20.466262453979 jwh-398-3-chloronaphthyl-isomer cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWH398 JWH-398 JWHs isomers herbal mixtures chlorine naphthyl rings central peripheral 20.466262453979
9001028 JWH 398 8-chloronaphthyl isomer Exclusive New - ≥98% ✓ 2012-01-13 23.049348494365 jwh-398-8-chloronaphthyl-isomer cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic isomers herbal mixtures JWHs JWH-398 JWH398 central peripheral 23.049348494365
9001203 JWH 424 New - ≥98% 2012-02-27 32.938874205072 jwh-424 cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWHs JWH424 JWH-424 JWH018 JWH-018 JWH 18 JWH-18 JWH18 herbal blends 32.938874205072
13158 JZL 184 1101854-58-3 ≥97% 2009-01-26 215.123167587476 jzl-184 2-AG 2AG MAGL inhibitors inhibits inhibition endocannabinoids pains analgesia MGL inhibitor JZL184 JZL-184 cannabinoids 215.123167587476
13668 JZL 195 121004-12-8 ≥98% 2010-02-10 222.909116022099 jzl-195 fatty acid amide hydrolase FAAH monoacylglycerol lipase MAGL endocannabinoids arachidonoyl ethanolamide AEA 2-arachidonoylglycerol 2-AG inibitors inhibition inhibits PF-3845 PF 3845 PF3845 JZL195 JZL-195 JZL184 antinociception pain catalepsy hypomotility CB1 2AG cannabinoids inhibitors cbs sythetic Methylenedioxybenzenes 1,3-Dioxaindans 1,3 Dioxaindans 1,3-Dioxindans 1,3 Dioxindans Benzodioxoles 222.909116022099
13711 KCNQ1 Potassium Channel Monoclonal Antibody (Clone S37A-10) - 2009-12-02 0E-12 kcnq1-potassium-channel-monoclonal-antibody-clone-s37a-10 antibodies western blots WB immunoblotting blotting immunoprecipitation IP immunohistochemistry IHC KCNQ-1 IKs inner ears cardiac muscles channels Kv7.1 hyperpolarization-activated cation hyperpolarization activated activity activate 0E-12
13712 KCNQ2 Potassium Channel Monoclonal Antibody (Clone S26A-23) - 2009-12-02 0E-12 kcnq2-potassium-channel-monoclonal-antibody-clone-s26a-23 antibodies western blots WB immunoblotting blotting immunoprecipitation IP immunohistochemistry IHC KCNQ-2 IKs inner ears cardiac muscles channels Kv7.1 familial neonatal convulsions benign hyperpolarization activated 0E-12
13713 KCNQ4 Potassium Channel Monoclonal Antibody (Clone S43-6) - 2009-12-02 0E-12 kcnq4-potassium-channel-monoclonal-antibody-clone-s43-6 antibodies western blots blotting immunoblotting immunoprecipitation immunocytochemistry ICC IP KCNQ-4 proteins retigabine hyperpolarization-activated hyperpolarization activated activity activate cation antioconvuslants anti-convulsantd 0E-12
10640 KM 233 Exclusive 628263-22-9 ≥98% ✓ 2011-07-07 30.745445845929 km-233 KM233 KM-233 CBs cannabinoids CB2 agonists recptors CB1 gliomas anti tumors cancers 30.745445845929
11305 Kynurenine New 2922-83-0 ≥98% 2012-02-27 3.048518081679 kynurenine 3-anthraniloyl-Alanine typtophan pathways catabolism glioma typtophan-2,3-dioxygenase tumors AhR aryl hydrocarbons receptors quinolinic acid neurodegenerative diseases L-Kynurenine 3-anthraniloyl-alanine kynurenin 3.048518081679
10009280 L-759,633 174627-50-0 >98% 2007-09-13 33.291215469613 l-759-633 L759633 cannabinoids receptors agonists CB1 CB2 endocrinology neurochemistry cannabinoids cbs synthetic 33.291215469613
10008618 Lauric Acid Leelamide - >98% 2006-09-05 0.377171270718 lauric-acid-leelamide saturated fatty acids synthesized synthesis plants animals acetyl coenzymes CoA energy storage 12-carbons coconut nut oils COX-2 cyclooxygenase-2 cyclooxygenases expressions C:8-18 inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine leelamine cannabinoids cbs synthetic 0.377171270718
13248 L-DOPA 59-92-7 ≥95% 2010-02-03 6.129834254143 l-dopa 3,4-Dihydroxyphenylalanine; Pardopa; Syndopa; Levodopa dopamine neurotransmitter locomotion Parkinson's disease stroke dopaflex (-)-dopa 3,4-dihydroxyphenylalanine parda larodopa laradopa levopa veldopa weldopa dopalina dopastral doparkine dopasol 3-(3,4-dihydroxyphenyl)-alanine ledopa DOPA phenylalanines alanines 1-(-)-dopa L-3,4-Dihydroxyphenylalanine L 3,4 Dihydroxyphenylalanine Medphano Brand of Levodopa Roberts Brand of Levodopa Roche Brand of Levodopa 3-Hydroxy-L-tyrosine 3 Hydroxy L tyrosine Levodopa Larodopa Dopaflex Levopa L-Dopa L Dopa Dopar 6.129834254143
10006148 Leelamine 1446-61-3 >98% 2006-05-10 0.274861878453 leelamine Dehydroabietylamine inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine cannabinoids cbs synthetic 0.274861878453
10008614 Leelamine (hydrochloride) - ≥98% 2006-05-10 0.154696132596 leelamine-hydrochloride Dehydroabietylamine inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine cannabinoids cbs synthetic 0.154696132596
10010572 Lercanidipine-d3 (hydrochloride) - >99% deuterated product 2008-04-14 0E-12 lercanidipine-d3-hydrochloride SPI blocker calcium dihydropyrine neurochemistry 0E-12
13353 Lignoceric Acid 557-59-5 ≥98% 2009-08-04 3.057867471523 lignoceric-acid FL 88 fatty acids brains development cerebrosides sphingomyelin myelin galactoplipids peroxisome Zellweger cerebro-hepato-renal cerebrohepatorenal syndromes X chromosomes X-chromosomes chromosome-linked linked adrenoleukodystrophy lignin FL88 L 88 FL-88 L-88 3.057867471523
90155 Linoleoyl Ethanolamide 68171-52-8 >98% 4.542530386740 linoleoyl-ethanolamide cannabinoids neurotransmitter ethanolamides fatty acids neurochemistry neuroscience ethanolamines linoleyl cbs synthetic 4.542530386740
9000553 Linoleoyl Ethanolamide-d4 Exclusive - ≥99% deuterated forms (d1-d4) ✓ 2010-01-13 2.351657458564 linoleoyl-ethanolamide-d4 cannabinoids neurotransmitter ethanolamides fatty acids neurochemistry neuroscience ethanolamines linoleyl deuterateds deuteriums LC-MS GC/MS GC-MS mass spectrometry standards LC/MS MS cbs synthetic 2.351657458564
9000326 Linoleoyl Glycine 2764-03-6 ≥98% 2008-10-29 3.413839779005 linoleoyl-glycine N-Linoleoyl Glycine; LinGly; Glycine Linoleamide arachidonyl glycine fatty acids AEA FAAH inhibits inhibitor inhibition anandamide homologs 3.413839779005
700570 L-Theanine Fluorometric Assay Kit Exclusive - ✓ 2011-05-31 249.451887176504 l-theanine-fluorometric-assay-kit 5-N-ethyl-Glutamine; Glutamic Acid γ-ethyl amide; γ-ethylamino-L-Glutamic Acid; γ-Glutamylethylamide kits assays measures measurements glutamines amino acids aa Camellia sinensis C. sinensis green teas japonica sasanqua mushrooms Xerocomus badius X. badius water-solubles non-proteins plants leaves umami humans immune systems .gamma..delta. gammadelta γδ T cells T-cells infection-fighting infections antigens ethylamine renal metabolites brains .alpha.-waves alpha-waves α-waves alertness schizophrenia neuroprotective effects glutamates receptors N-methyl-D-aspartate NMDA calcium Ca Ca2+ intracellular animals anthracyclines hypertensives rats antihypertensives blood pressures dopamines norepinephrines serotonins 249.451887176504
9001219 MAM2201 Exclusive New 1354631-24-5 ≥98% ✓ 2012-03-28 330.627994973750 mam2201 AM2201 4-methylnaphthyl analog; JWH 122 N-(5-fluoropentyl) analog cannabinoids CBs CB1 CB2 cannabimimetics receptors herbals spices designer drugs AM-2201 AM 2201 MAM-2201 MAM 2201 analogs synthetics central peripheral forensics JWH122 JWH 122 JWH-122 330.627994973750
10563 MDA 19 1048973-47-2 ≥95% 2010-09-17 47.691606156274 mda-19 agonists cannabinoids CB2 CB1 pains 1104302-26-2 tactile allodynia paclitaxel spinal nerves ligation MDA-19 MDA19 CBs peripheral central MDAs central cannabinoids cbs synthetic cannabinoids Epidermal Growth Factor Receptor Protein-Tyrosine Kinase Receptors, Epidermal Growth Factor-Urogastrone Receptor Transforming Growth Factor alpha Transforming Growth Factor alpha Receptor Epidermal Growth Factor Receptor Kinase Receptor Epidermal Growth Factor Receptor erbB 1 Proto Oncogene Protein Receptor Urogastrone Urogastrone Receptor Receptor TGF alpha TGF-alpha Receptor c-erbB-1 Protein Proto-Oncogene Receptor EGF EGF Receptor 47.691606156274
9001102 MDAI (hydrochloride) 155344-90-4 ≥95% 2011-11-04 33.742762430940 mdai-hydrochloride 5,6-Methylenedioxy-2-aminoindane designer drugs forensics MDA MDMA neuroscience neurotoxicity analogs amphetamine serotonin neurotoxin methamphetamine 12440-03-9 13274-81-2 33.742762430940
10979 MDMA methylene homolog (hydrochloride) Exclusive - ≥98% ✓ 2011-06-22 31.106511302061 mdma-methylene-homolog-hydrochloride 3,4-Methylenedioxymethamphetamine methyl homolog forensic sciences cannabinoids CBs pyrovalerones pentylones designer drugs forensics neuroscience psychoactive ecstasy HCl 31.106511302061
13775 MeCP2 Polyclonal Antibody - 2010-04-27 0E-12 mecp2-polyclonal-antibody Methyl-CpG-Binding Protein 2 antibodies domains cytosines dinucleotides methylations DNA proteins mammalian MED1 MeCP2 PCM1 MBDs MBDs MBD-1 MBD-2 MBD-3 MBD-4 MBD2 MBD3 MBD4 MBD 2/3 MBD-2/3 MBD 1 MBD 2 MBD 3 MBD 4 MBD2-3 MBD 2-3 0E-12
10009518 MEK1 (Phospho-Thr292) Polyclonal Antibody - 2007-01-12 0E-12 mek1-phospho-thr292-polyclonal-antibody MAP Kinase Kinase 1; MAPKK1 antibodies WB western blot MEK 1 phosphorylation MAP kinase cell growth differentiation threonine tyrosine phospho-specific blotting immunoblotting 0E-12
10009517 MEK1 (Phospho-Thr386) Polyclonal Antibody - 2007-01-11 0E-12 mek1-phospho-thr386-polyclonal-antibody MAPK1; MAP Kinase Kinase 1 antibodies WB western blot MEK 1 phosphorylation MAP kinase cell growth differentiation threonine tyrosine phospho-specific blotting immunoblotting 0E-12
600180 Melanocortin-3 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-01-05 16.893913207725 melanocortin-3-receptor-step-reporter-assay-kit-luminescence MC3R MC-3R melanocortins petides hormones proopiomelanocortins pituitary CNS central nervous systems skin placenta tissues MCR receptors G protein-coupled GPCRs cAMP Adenosine 3',5' cyclic mononucleotides messenger signal transduction pathways melanocortin-3 hypothalmus homeostasis fat lean mass hyperphagia MC4R melanocortin-4 adiposity MC3R-knockout mice mouse murine fatty acids oxidations blood pressure hypertension obesity glucose metabolisms insulin insensitivity agonists ligands Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated endocytosis solution-phase co-transfection plasmids secretory alkalines phosphatases substrates SEAP proteins lipids signal transduction luminescence-based cell-based assays kits CBAs high-throughput screening a-MSH alpha-MSH α-MSH 16.893913207725
10006355 Melanocortin-4 Receptor Polyclonal Antibody - 2005-08-03 12.923232044199 melanocortin-4-receptor-polyclonal-antibody MC4R antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry melanocortins melanogenesis steroidogenesis sexual functions inflammations appetite regulations energy homeostasis G-proteins coupled receptors GPCRs MC1R MC2R MC3R MC5R transcripts brain genetic studies heteozygous mutations human obesity mammalian unglycosylated SDS-PAGE endocrinology immunoblotting 12.923232044199
600190 Melanocortin-4 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-01-05 18.301739308369 melanocortin-4-receptor-step-reporter-assay-kit-luminescence MC4R MC-4R melanocortins petides hormones proopiomelanocortins pituitary CNS central nervous systems skin placenta tissues MCR receptors G protein-coupled GPCRs cAMP Adenosine 3',5' cyclic mononucleotides messenger signal transduction pathways melanocortin-3 hypothalmus homeostasis fat lean mass hyperphagia MC4R melanocortin-4 adiposity MC3R-knockout mice mouse murine fatty acids oxidations blood pressure hypertension obesity glucose metabolisms insulin insensitivity agonists ligands sexual function antagonists fever suppression inflammatory mediators in vivo Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated endocytosis solution-phase co-transfection plasmids secretory alkalines phosphatases substrates SEAP proteins lipids signal transduction luminescence-based cell-based assays kits CBAs high-throughput screening a-MSH alpha-MSH α-MSH 18.301739308369
10529 Methedrone (hydrochloride) 879665-92-6 ≥98% 2011-10-11 38.735937118424 methedrone-hydrochloride 4-Methedrone; Methoxyphedrine; PMMC; para-Methoxymethcathinone cathinone analogs MAO inhibitors PMMC mephedrone PMMA 530-54-1 inhibits inhibition phenethylamines amphetamines cathinones derivatives psychoactive MDMA hydrochloride HCl 38.735937118424
70660 Methyl Arachidonyl Fluorophosphonate 188404-10-6 ≥98% 84.365923879680 methyl-arachidonyl-fluorophosphonate MAFP phospholipases inhibitors cPLA2 iPLA2 MAFP fatty acids neuroscience neurochemistry 84.365923879680
10624 Methylenedioxy Pyrovalerone Exclusive 687603-66-3 ≥98% ✓ 2011-01-07 31.370797503581 methylenedioxy-pyrovalerone MDPV 3,4-methylenedioxypyrovalerone inhibitors neurotransmitters dopamine norepinephrine MDMA ecstasy forensics designer drugs Hemihydrate Apomorphine Hydrochloride Anhydrous Apomorphine Hydrochloride Chloride Apomorphine Apomorphin Teclapharm Apomorphine Chloride Berberine Alkaloids Camptothecine Camptothecin Umbellatine Apomorphine Britaject Berberine Alkaloids Berbines Apokinon 31.370797503581
10679 Methylenedioxy Pyrovalerone-d8 (hydrochloride) 1246820-09-6 ≥99% deuterated product 2011-02-15 24.109879362481 methylenedioxy-pyrovalerone-d8-hydrochloride MDPV-d8 3,4-methylenedioxypyrovalerone inhibitors neurotransmitters dopamine norepinephrine MDMA ecstasy neuroscience forensics designer drugs deuterateds deuteriums GC/MS GC-MS LC/MS LC-MS mass spectrometry MS standards 24.109879362481
10684 Methylenedioxy Pyrovalerone (hydrochloride) 24622-62-6 ≥98% 2011-01-07 42.836000070156 methylenedioxy-pyrovalerone-hydrochloride MDPV 3,4-methylenedioxypyrovalerone inhibitors neurotransmitters dopamine norepinephrine MDMA ecstasy neuroscience forensics designer drugs 42.836000070156
70662 Methyl α-Linolenyl Fluorophosphonate - ≥98% 20.089707971586 methyl-linolenyl-fluorophosphonate MLnFP PLA2s phospholipases A2 FAAH fatty acids amides hydrolase inhibitors cannabinoids CB receptors antagonists analogs MAFP MaLnFP M.alpha.LnFP MalphaLnFP alpha-linolenyl .alpha.-linolenyl neurochemistry neuroscience 20.089707971586
70664 Methyl γ-Linolenyl Fluorophosphonate - ≥98% 21.169318600368 methyl-linolenyl-fluorophosphonate MγLnFP PLA2s phospholipases A2 FAAH fatty acids amides hydrolases inhibitors cannabinoids CB receptor antagonists M.gamma.LnFP MgammaLnFP analogs MAFP neurochemistry neuroscience 21.169318600368
11151 Mitragynine New 4098-40-2 ≥95% 2011-12-01 38.039228629241 mitragynine Kratom; 9-methoxy Corynantheidine alkaloids forensics Mitragyna pain neuroscience opioids receptors agonists incense indoles plants noradreneric serotonergic metabolites 11047-39-5 36455-45-5 1383-32-0 6202-22-8 38.039228629241
10212 Monoacylglycerol Lipase (FL) Polyclonal Antibody - 2010-03-23 37.858350434096 monoacylglycerol-lipase-fl-polyclonal-antibody MAGL; MGL WB western blots hydrolases antibodies antiserum antisera hydrolysis immunohistochemistry IHC immunoblotting MGL monoacylglycerol neuroscience neurochemistry MAGL monoglycerol blotting 37.858350434096
10007812 Monoacylglycerol Lipase (human recombinant) - >95% 2008-04-01 58.963167587477 monoacylglycerol-lipase-human-recombinant MAGL; MGL neuroscience neurochemistry 2-AG endocannabinoids hydrolases proteins MAGLs MGLs recombinant active 58.963167587477
705192 Monoacylglycerol Lipase Inhibitor Screening Assay Kit - 2009-10-22 102.257324388319 monoacylglycerol-lipase-inhibitor-screening-assay-kit MAGL; MGL neuroscience neurochemistry inhibitors inhibiting inhibition inhibits endocannabinoids serines hydrolases pain obesity monoglycerol 102.257324388319
100035 Monoacylglycerol Lipase Polyclonal Antibody - 35.387975891512 monoacylglycerol-lipase-polyclonal-antibody MAGL; MGL WB western blots hydrolases antibodies antiserum antisera hydrolysis immunohistochemistry IHC immunoblotting MGL monoacylglycerol neuroscience neurochemistry MAGL monoglycerol blotting 35.387975891512
10009566 Monoacylglycerol Lipase Western Ready Control - Whole cell lysate 2007-01-31 10.286866614049 monoacylglycerol-lipase-western-ready-control MGL; MAGL hormone-sensitive lipases HSL kidney spleen heart liver testis stomach brain lung adrenal gland keletal muscle adipose tissue neurochemistry 10.286866614049
10230 (+)-Muscarine (iodide salt) 24570-49-8 ≥95% 2010-05-06 0.801602209944 -muscarine-iodide-salt neurochemistry 300-54-9 2438-77-9 poisonous mushroom acetylcholine G proteins Alzheimer's disease signal transduction L-muscarine Amanita muscaria 0.801602209944
13667 Muscimol 2763-96-4 ≥98% 2010-05-28 14.333144396698 muscimol Pantherine; Agarin γ-aminobutyric acid GABA neurotransmitters GABAA GABAC GABAB agonists benzodiazepines memory neurochemistry neuroscience GABA-A Receptor alpha Subunit GABA Benzodiazepine Receptors GABA A Receptor gamma Subunit GABA A Receptor delta Subunit GABA A Receptor alpha Subunit GABA Benzodiazepine Receptor GABA A Receptor beta Subunit Benzodiazepine-GABA Receptor Benzodiazepine GABA Receptor GABA-A Receptor rho Subunit GABA A Receptor rho Subunit Benzodiazepine Receptors Benzodiazepine Receptor Receptors Muscimol Receptors, Diazepam Muscimol Receptor Diazepam Receptor GABA A Receptors GABA-A Receptor GABA A Receptor 14.333144396698
10007704 N-(3-hydroxyphenyl)-Arachidonoyl amide Exclusive 183718-75-4 >98% ✓ 2007-02-02 9.847955801105 n-3-hydroxyphenyl-arachidonoyl-amide 3-HPAA neurochemistry neuroscience AM404 anologs N-(4-hydroxyphenyl)-arachidonoylamides AEA ethanolamides cycloxygenase-1 cyclooxygenase-2 COX-1 COX-2 inhibits inhibitors inhibition N-(3-hydroxyphenyl)-Arachidonoylamide 3-HPA cannabinoids cbs synthetic 9.847955801105
10014 N-Ac-Tyr-Val-Ala-Asp-CMK 178603-78-6 >98% 2004-04-13 53.466104972375 n-ac-tyr-val-ala-asp-cmk Ac-YVAD-CMK inhibitors inhibits interleukins neuroprotective cerebral ischemia inhibition selective irreversible interleukin-1.beta.converting enzyme ICE Caspase-1-IL-1.beth. IL1beta neuroprotective cerebral ischemia alaninamides neurochemistry chloromethyl ketones 53.466104972375
10009737 NAPE-PLD Blocking Peptide - 2007-04-16 0.640607734807 nape-pld-blocking-peptide peptides WB western blots blotting IHC immunohistochemistry ICC immunocytochemistry N-acylethanolamines NAEs inflammatory regulations apoptosis tissues degenerations biosynthesized membranes phospholipid-dependent pathway enzymes enzymatic hydrolysiscatalyzing phospholipases D subtypes mRNA and proteins activity brain kidney testis neuroscience neurochemistry 0.640607734807
11240 Naphyrone 1-naphthyl isomer (hydrochloride) New - ≥95% 2012-01-24 100.473730404707 naphyrone-1-naphthyl-isomer-hydrochloride designer drugs forensics pyrovalerone cathinones dopamine serotonin norepinephrine bath salts isomers hydrochloride HCl analogs party pills 100.473730404707
10517 Naphyrone (hydrochloride) 850352-11-3 ≥97% 2011-08-29 105.016779230112 naphyrone-hydrochloride O-2482; NRG-1; Naphpyrovalerone; β-Naphyrone analogs MDPV forensics sciences designer drugs 850352-53-3 pyrovalerones cathinones dopamine serotonins norepinephrines bath salts 105.016779230112
10158 N-Arachidonoyl-3-hydroxy-γ-Aminobutyric Acid - >98% 2004-03-04 5.788520564763 n-arachidonoyl-3-hydroxy-aminobutyric-acid NAG-3H-ABA amino acids bovines brains glycines congeners NAGly suppress responses pain NAG3HABA neurochemistry neuroscience 5.788520564763
90057 N-Arachidonoyl Dopamine 199875-69-9 >98% 15.214267955801 n-arachidonoyl-dopamine NADA analogs capsaicin arachidonic acids amides VR1 receptors vannilloids cannabinoids aada cb1 cb2 analgesic N-arachidonoyl-dopamine neurochemistry neuroscience 15.214267955801
10007431 N-Arachidonoyl Dopamine-d8 - ≥99% deuterated forms (d1-d8) 2005-08-10 10.190939226519 n-arachidonoyl-dopamine-d8 NADA-d8 deuterateds analogs capsaicin arachidonic acids amides VR1 receptors vannilloids cannabinoids ada cb1 cb2 analgesic arachidonoyl-dopamine neurochemistry neuroscience deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass 10007431 spectrometry cannabinoids cbs synthetic 10.190939226519
90065 N-Arachidonoyl-L-Alanine 401941-73-9 >98% 2004-04-19 11.440856353590 n-arachidonoyl-l-alanine NALA amino acids bovines brains glycines congeners NAGly suppress responses pain neurochemistry neuroscience 11.440856353590
10005455 N-Arachidonoyl-L-Serine 187224-29-9 >98% 2004-08-11 7.062702159718 n-arachidonoyl-l-serine ARA-S endocannabinoids antagonists cannabidiols neuroprotective neurotransmitters hypotensive effects antagonize antagonist neurochemistry neuroscience cannabinoids cbs synthetic 7.062702159718
10005537 N-Arachidonoyl Taurine Exclusive - >98% ✓ 2004-11-18 7.087296764009 n-arachidonoyl-taurine bovine brain NADA dopamine ARA-S ARAS N-arachidonoyl-L-serine lipidomics mass spectrometry MS rats N-fatty acyl amides amino acids neurochemistry neuroscience TRPV1 TRPV4 FAAH, cbs, cannabinoids, synthetic 7.087296764009
90067 N-Arachidonoyl-γ-Aminobutyric Acid 128201-89-8 >98% 2004-02-26 17.560849191732 n-arachidonoyl-aminobutyric-acid NAGABA amino acids bovines brains glycines congeners NAGly suppress responses pain neurochemistry neuroscience 17.560849191732
10007517 N-Arachidonyl Maleimide 876305-42-9 >98% 2006-07-31 18.778762430939 n-arachidonyl-maleimide NAM neurochemistry neuroscience 2-AG 2-arachidonoyl glycerol MGL MAGL monoacylglycerol lipase monoglycerol inhibition inhibits inhibitor pain inflammation anxiety endocannabinoids anandanides 2AG fatty acids CB1 CB2 central peripheral inhibitors cannabinoids cbs synthetic 18.778762430939
13718 Nav1.7 Sodium Channel Monoclonal Antibody (Clone S68-6) - 2009-12-04 0E-12 nav1-7-sodium-channel-monoclonal-antibody-clone-s68-6 antibodies channels ions western blots blotting immunoblotting immunoprecipitation WB IP immunocytochemistry ICC pain sensitivity insensitivity sodiums voltage-gated voltage gated 0E-12
10007739 N-Cyclohexanecarbonylpentadecylamine 702638-84-4 ≥98% 2006-08-04 6.760179558011 n-cyclohexanecarbonylpentadecylamine endocannabinoids neurons acidic PEAase palmitoyl ethanolamides amidases anandamides AEA fatty acyls inhibits inhibitors inhibition arachidonoyl neurochemistry neuroscience FAAH hydrolase cannabinoids inhibitors 6.760179558011
10008317 N-Cyclohexanecarbonyltetradecylamine - ≥98% 2006-08-16 6.668812154696 n-cyclohexanecarbonyltetradecylamine FAAH AEA anandamide PEAase inhibitors PEA palmitoylethanolamides ararchidonoyl acidic fatty acids amide hydrolases amidase inhibits inhibition cannabinoids 6.668812154696
10005851 N-Decanoyl p-Nitroaniline 72298-63-6 ≥98% 2004-12-07 7.204371546961 n-decanoyl-p-nitroaniline DepNA FAAH substrates anandamides hydrolases colorimetric cannabinoids aea para-nitroanalines fatty acids anandamide arachidonoyl ethanolamides neurochemistry neuroscience anilide 7.204371546961
10010574 N-Desmethyltrimebutine (hydrochloride) 294882-33-0 ≥99% 2008-04-14 2.513812154696 n-desmethyltrimebutine-hydrochloride SPI trimebutine metabolites anesthetics disorders spasmolytic gastrointestinal neurochemistry 2.513812154696
10007288 N-Docosanoyl Taurine - ≥98% 2005-12-29 0.491139502762 n-docosanoyl-taurine neurochemistry neuroscience depression anxiety arachidonoyls amino acids conjugates N-arachidonoyl dopamines NADA N-arachidonoyl-L-serines ARA-S bovine brains taurines fatty lipidomic spinal cord wild types hydrolases FAAH substrates oleoyl ethanolamides endocannabinoids TRPV1 TRPV4 FAAH cannabinoids cbs synthetic 0.491139502762
10004184 NESS 0327 Exclusive 494844-07-4 >98% ✓ 2008-05-27 34.593259668508 ness-0327 neurochemistry neuroscience cannabinoids antagonist CB1 CB2 SR 141716A rimonabant WIN 55212-5 pain obesity 34.593259668508
10007286 N-Lignoceroyl Taurine 807370-75-8 >98% 2005-12-21 0.529526440410 n-lignoceroyl-taurine neurochemistry neuroscience depression anxiety arachidonoyls amino acids conjugates N-arachidonoyl dopamines NADA N-arachidonoyl-L-serines ARA-S bovine brains taurines fatty lipidomic spinal cord wild types hydrolases FAAH substrates oleoyl ethanolamides endocannabinoids TRPV1 TRPV4 FAAH cannabinoids cbs synthetic 0.529526440410
10607 NMDA Receptor NR1 Subunit Monoclonal Antibody - 2009-10-26 0.635359116022 nmda-receptor-nr1-subunit-monoclonal-antibody inhibits inhibitors neurotransmitters WB western blots blotting receptors ion channels glutamate 0.635359116022
10608 NMDA Receptor NR2A Subunit Polyclonal Antibody - 2009-10-26 0.635359116022 nmda-receptor-nr2a-subunit-polyclonal-antibody inhibits inhibitors neurotransmitters WB western blots blotting receptors ion channels glutamate inhibition immunoprecipitation IP IHC Immunohistochemistry 0.635359116022
10009759 NMDA Receptor NR2B Subunit (Phospho-Tyr1252) Polyclonal Antibody - 2007-02-09 5.314917127072 nmda-receptor-nr2b-subunit-phospho-tyr1252-polyclonal-antibody antibodies WB western blots phospho-specific NMDA receptor NMDAR phosphorylation NR2B blotting immunoblotting 5.314917127072
10009760 NMDA Receptor NR2B Subunit (Phospho-Tyr1336) Polyclonal Antibody - 2007-02-09 5.314917127072 nmda-receptor-nr2b-subunit-phospho-tyr1336-polyclonal-antibody antibodies WB western blots phospho-specific NMDA receptor NMDAR phosphorylation NR2B blotting immunoblotting 5.314917127072
10009761 NMDA Receptor NR2B Subunit (Phospho-Tyr1472) Polyclonal Antibody - 2007-02-22 9.230662983425 nmda-receptor-nr2b-subunit-phospho-tyr1472-polyclonal-antibody antibodies WB western blots phospho-specific NMDA receptor phosphorylation NR2B blotting immunoblotting 9.230662983425
10609 NMDA Receptor NR2B Subunit Polyclonal Antibody - 2009-10-26 0.635359116022 nmda-receptor-nr2b-subunit-polyclonal-antibody N-methyl-D-aspartate Receptor inhibits inhibitors neurotransmitters WB western blots immunoblotting receptors ion channels glutamate IP IHC immunohistochemistry immunoprecipitation 0.635359116022
9001144 N,N-Dimethylcathinone (hydrochloride) New 10105-90-5 ≥98% 2011-12-12 31.894984335770 n-n-dimethylcathinone-hydrochloride Metamfepramone forensics cathinone phenylethylamine phenethylamine neuroscience dimethylpropion dimepropion rats psychotropic hydrochloride hcl 31.894984335770
10007287 N-Nervonoyl Taurine - >98% 2005-12-29 0.529526440410 n-nervonoyl-taurine neurochemistry neuroscience depression anxiety arachidonoyls amino acids conjugates N-arachidonoyl dopamines NADA N-arachidonoyl-L-serines ARA-S bovine brains taurines fatty lipidomic spinal cord wild types hydrolases FAAH substrates oleoyl ethanolamides endocannabinoids TRPV1 TRPV4 FAAH cannabinoids cbs synthetic 0.529526440410
360871 nNOS Blocking Peptide - 5.469613259668 nnos-blocking-peptide ncNOS; Neuronal Nitric Oxide Synthase; NOS I western blots bNOS synthases immunoblotting controls peptides constitutive antibodies 5.469613259668
360870 nNOS Electrophoresis Standard - >95% 5.317016574585 nnos-electrophoresis-standard ncNOS; Neuronal Nitric Oxide Synthase; NOS I western blots immunoblotting bNOS synthases standards constitutive antibodies neurochemistry 5.317016574585
160870 nNOS Polyclonal Antibody - 11.173204419889 nnos-polyclonal-antibody ncNOS; Neuronal Nitric Oxide Synthase; NOS I synthases Western blots brain bNOS neurotransmitters memory blotting constitutive human neurons antibodies WB ICC immunocytochemistry IHC immunohistochemistry antisera antiserum immunoprecipitation IP neurochemistry immunoblotting 11.173204419889
60870 nNOS (rat recombinant) - cell lysate 100,000 x g supernatant 9.891178637200 nnos-rat-recombinant ncNOS; Neuronal Nitric Oxide Synthase; NOS I neuronal enzymes constitutive nitric oxide synthase bNOS neurochemistry active 9.891178637200
60875 nNOS (rat recombinant) - Purified - >95% 15.263898973953 nnos-rat-recombinant-purified ncNOS; Neuronal Nitric Oxide Synthase; NOS I neuronal enzymes constitutive nitric oxide synthase bNOS neurochemistry active 15.263898973953
10009632 nNOS Western Ready Control - 2007-05-30 7.062909760589 nnos-western-ready-control NOS I; ncNOS Western blotting WB citrulline nomenclature tissue neuronal brain N-terminus PSD-95 PSD-96 PZD neurochemistry 7.062909760589
10115 N-Oleoyl Dopamine 105955-11-1 ≥98% 5.504001578531 n-oleoyl-dopamine ODA VR1 agonists CB1 receptors analogs vanilloids cannabinoids analgesic amides N-oleoyldopamine inhibits inhibitors inhibition 5-lipoxygenases 5-LOs binding selective FAAH hydrolases fatty acid neurochemistry neuroscience cbs synthetic 5.504001578531
90269 N-Oleoyl Glycine 2601-90-3 ≥98% 3.989834254144 n-oleoyl-glycine precursor oleoylamide fatty acids neurochemistry neuroscience oleoylglycine oleoyl-glycine 3.989834254144
13058 N-Oleoyl-L-Serine - ≥98% 2008-10-17 1.935911602210 n-oleoyl-l-serine lipids bones endogenous anabolic activity activities formation resorption cannabinoids cbs synthetic 1.935911602210
10005609 N-Oleoyl Taurine Exclusive 52514-04-2 ≥98% ✓ 2005-01-05 7.001404235727 n-oleoyl-taurine endocannibinoids fatty amides oleamides taurines amino-acyls lipidomics profiling fatty acids neurochemistry neuroscience TRPV1 TRPV4 FAAH cannabinoids cbs synthetic 7.001404235727
9001142 Norsufentanil Exclusive New 61086-18-8 ≥95% ✓ 2012-04-27 186.638524395619 norsufentanil R 30451 noralfentanil R30451 R-30451 opioids metabolites forensics cytochromes P450 CYP450 pain anesthesia synthetics sufentanil livers isoforms 186.638524395619
9001143 Norsufentanil-d3 Exclusive New 1204688-16-3 ≥99% deuterated forms (d1-d3) ✓ 2012-04-27 161.351168073780 norsufentanil-d3 R 30451-d3 deuterateds deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS noralfentanil R30451 R-30451 opioids metabolites forensics cytochromes P450 CYP450 pain anesthesia synthetics sufentanil livers isoforms P-450 P 450 161.351168073780
781001 NOS Activity Assay Kit - 125.224198895027 nos-activity-assay-kit iNOS eNOS nNOS nitric oxide synthases activity radiolabeled arginine inducible neuronal endothelial citrulline kits assays 125.224198895027
10007697 N-Palmitoyl Dopamine 136181-87-8 >98% 2005-11-23 5.079447513812 n-palmitoyl-dopamine PALDA N-acyls fatty anologs N-araachidonoyl NADA N-oleoyl ODA bovine brains amides palmitic acids hybrids anandamides neurotransmitter pathways inactive vanilloid receptors 1 VR1 ligands hyperalgesics nocifensives responses in vivo entourage effects neurochemistry cannabinoids cbs synthetic 5.079447513812
10009020 N-Palmitoyl Glycine 2441-41-0 ≥98% 2009-12-01 2.330883977901 n-palmitoyl-glycine N-Hexadecanoyl-Glycine; PalGly pain inflammation AEA anandamides DRG nociception calcium influx arachidonoyl amides glycines 2.330883977901
10005611 N-Palmitoyl Taurine 83982-06-3 >98% 2005-02-16 6.738441199684 n-palmitoyl-taurine endocannabinoids fatty amides oleamides bovine brain lipidomics rat amino-acyl neurochemistry, cannabinoids cbs synthetic 6.738441199684
70590 NS-398 123653-11-2 >98% 140.299861878453 ns-398 cyclooxygenases inhibitors NSAIDs COX-2 nonsteroidal anti-inflammatory drugs cox2 pghs2 pghs-2 prostaglandins synthases synthase-2 inhibits selective ns398 selectivity neurochemistry 140.299861878453
10005610 N-Stearoyl Taurine 63155-80-6 >98% 2005-02-09 6.968275453828 n-stearoyl-taurine endocannabinoids fatty amides oleamides amino-acyl bovine brain rat lipidomics neurochemistry neuroscience TRPV1 TRPV4 FAAH cannabinoids cbs synthetic 6.968275453828
10032 N-(α-Linolenoyl) Tyrosine 259143-19-6 >98% 17.163414364641 n-linolenoyl-tyrosine NALT neurochemistry neuroscience fatty acids neurotransmitters dopamine CNS central nervous system anti-Parkinson's anti-Parkinsons diseases endocrinology 17.163414364641
80587 Nω-propyl-L-Arginine 137361-05-8 >98% 24.332803867403 n-propyl-l-arginine nNOS NOS selective inhibitors arginine nitric oxide synthase neurochemistry 24.332803867403
10006803 O-1602 317321-41-8 >98% 2005-09-12 11.877928176795 o-1602 abnormal cannabidiols CB1 CB2 receptors vasorelaxation neurochemistry neuroscience central cannabinoids peripheral selective antagonists nonendothelium-dependant vasodilation nitric oxides NOs inhibits inhibitors inhibition vasorelaxant cannabinoids cbs synthetic 11.877928176795
10006804 O-1821 35482-50-9 >97% 2005-09-12 26.649907918968 o-1821 abnormal cannabidiol central cannabinoids peripheral CB1 CB2 receptors vasorelaxation neurochemistry neuroscience antagonists synthetic regioisomer endothelium dependent vasodilation cannabinoids cbs synthetic 26.649907918968
10004914 O-1918 536697-79-7 >98% 2005-09-09 11.646172059984 o-1918 antagonists abnormal cannabinoids cannabidiols cannabidiol-mediated synthetic regioisomers CB1 CB2 responsiveness psychotropics activity induces endothelium-dependent vasodilations NO-independent nitric oxides mechanisms analogs endothelial receptors inhibits inhibition inhibitors vasorelexants in vitro blocks induced activations PI3-kinases Akt pathway umbilical vein cells neuroscience neurochemistry O1918 0-1918 cannabinoids cbs synthetic 11.646172059984
10009195 O-2545 (hydrochloride) - ≥98% 2007-07-12 5.521546961326 o-2545-hydrochloride cannabinoids water soluble agonists receptors CB1 CB2 lipophilic surfactants 874745-42-3 murine models intravenously IV 02545 intracerebroventricularly endocrinology neurochemistry cannabinoids cbs synthetic 5.521546961326
91050 O-Arachidonoyl Ethanolamine (hydrochloride) 443129-35-9 >98% 35.874988950276 o-arachidonoyl-ethanolamine-hydrochloride Virodhamine; O-AEA; Arachidonic Acid-(2-aminoethyl)-ester endocannabinoids anandamides tetrahydrocannabinoids THC CB1 CB2 receptors arachidonoyl ethanolamides ligand ethanolamines neurochemistry neuroscience esters antagonists cannabinoids cbs synthetic 35.874988950276
10010547 O-Arachidonoyl Glycidol Exclusive 439146-24-4 >98% ✓ 2008-03-31 19.853933701658 o-arachidonoyl-glycidol 2-AG 2-arachidonoyl glycerol 2-oleoylglycerol N-arachidonoylethanolamine anandamide AEA FAAH endocannabinoid obesity pain neurodegenerative diseases monoacylglycerol lipase inhibits inhibitors inhibitions MAGL MGL cannabinoids 19.853933701658
90265 Oleoyl Ethanolamide 111-58-0 ≥98% 19.863959484346 oleoyl-ethanolamide Oleic Acid Ethanolamide; OEA cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides cbs synthetic 19.863959484346
10007823 Oleoyl Ethanolamide-d2 - ≥99% deuterated forms (d1-d2) 2006-03-06 17.913535911602 oleoyl-ethanolamide-d2 OEA-d2; Oleic Acid Ethanolamide-d2 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides cbs synthetic 17.913535911602
9000552 Oleoyl Ethanolamide-d4 Exclusive - ≥99% deuterated forms (d1- d4) ✓ 2010-01-12 10.248737174428 oleoyl-ethanolamide-d4 Oleic Acid Ethanolamide-d4; OEA-d4 cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides deuterateds deuteriums MS mass spectrometry CBs LC-MS OEAs LC/MS GC/MS G-MS standards PPAR brain tissue neurochemistry neuroscience synthetic 10.248737174428
10005459 Oleoyl Ethyl Amide Exclusive 85075-82-7 >98% ✓ 2004-07-21 22.870906077348 oleoyl-ethyl-amide N-Ethyloleamide; OEtA endocannabinoids analogs FAAH fatty acid amide hydrolase analgesic inhibitors inhibitor inhibition acyl PEAase anxiolytic inhibits selective selectivity neuroscience neurochemistry cannabinoids cbs synthetic 22.870906077348
71650 Oleoyl Oxazolopyridine 288862-58-8 >98% 6.240812154696 oleoyl-oxazolopyridine CAY10400 FAAH fatty acid amide hydrolases inhibitors inhibition inhibits hydrolysis hydrolyze CAY-10400 neuroscience neurochemistry 6.240812154696
62640 Oleyl Trifluoromethyl Ketone 177987-23-4 ≥98% 0.034806629834 oleyl-trifluoromethyl-ketone OTK; Heptadecyl Trifluoromethyl Ketone Trifluoromethyl ketone inhibitors inhibits analogs oleic fatty acids neurochemistry neuroscience 0.034806629834
90262 Olvanil 58493-49-5 ≥98% 6.452605893185 olvanil NE 19550; N-Vanillyloleamide capsaicin capsicum vanilloids receptors agonists cannabinoids analgesia anandamides analgesic vanillylamines amides analogs neurochemistry neuroscience 6.452605893185
10171 OMDM-1 - ≥98% 2004-02-05 12.754530386740 omdm-1 (S)-N-oleoyl Tyrosinol endocannabinoids inhibitors AEA lipids anandamides analogs selective selectivity inhibits inhibition R-tyrosinol amides (R)-tyrosinol oleic acid reuptake OMDM1 neurochemistry neuroscience cannabinoids inhibitors 12.754530386740
10179 OMDM-2 - ≥98% 2004-02-05 10.203624309392 omdm-2 (R)-N-oleoyl Tyrosinol endocannabinoids inhibitors AEA lipids anandamides analogs selective selectivity inhibits inhibition R-tyrosinol amides (R)-tyrosinol oleic acid reuptake OMDM2 neurochemistry neuroscience cannabinoids inhibitors 10.203624309392
300000 Optineurin (C-Term) Blocking Peptide - 11.317154696132 optineurin-c-term-blocking-peptide NRP; FIP-2 western blots blotting WB peptides controls FIP2 apoptosis OPTN c-terminus 14.7k interacting protein-2 TNFalpha TNF.alpha. TNF-alpha TNF-.alpha. tumornecrosis factor neurochemistry neuroscience 11.317154696132
100000 Optineurin (C-Term) Polyclonal Antibody - 25.259585635359 optineurin-c-term-polyclonal-antibody NRP; FIP-2 apoptosis signaling transduction signalling 14.7k interacting protein-2 nemo-related proteins WB western blots blotting cell death glaucoma IOP intraocular pressure neurochemistry neuroscience CTerm ophthalmology immunoblotting 25.259585635359
300002 Optineurin (INT) Blocking Peptide - 2.625276243094 optineurin-int-blocking-peptide NRP; FIP-2 receptors controls peptides antibodies FIP2 WB western blot blotting 14.7K interacting protein-2 neurochemistry neuroscience 2.625276243094
100002 Optineurin (INT) Polyclonal Antibody - 16.567707182320 optineurin-int-polyclonal-antibody NRP; FIP-2 apoptosis signaling transduction signalling neurochemistry neuroscience fip2 tumor necrosis factors tnf glaucoma IOP intraocular pressure WB western blots blotting cell death 14.7k interacting protein-2nemo-related ophthalmology immunoblotting 16.567707182320
600240 Orexin 1 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-03-31 10.428937998772 orexin-1-receptor-step-reporter-assay-kit-luminescence OX1R hypercretins 1 orexins 2 A orexin-2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists 10.428937998772
600250 Orexin 2 Receptor STEP Reporter Assay Kit (Luminescence) Exclusive - ✓ 2010-03-31 9.883163122942 orexin-2-receptor-step-reporter-assay-kit-luminescence OX2R hypercretins 1 orexin 2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists 9.883163122942
10008642 oxy-Arachidonoyl Ethanolamide - >98% 2007-09-06 13.338195211786 oxy-arachidonoyl-ethanolamide oxy-Anandamide; oxy-AEA oxyanadamide arachidonylethanolamide AEA THC marijuana CB1 CB2 endocannabinoids receptors cannabinoids inhibitors 13.338195211786
90350 Palmitoyl Ethanolamide 544-31-0 ≥98% 13.010110497237 palmitoyl-ethanolamide Palmidrol; PEA endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic 13.010110497237
9000551 Palmitoyl Ethanolamide-d4 Exclusive - ≥99% deuterated forms (d1-d4) ✓ 2010-01-20 6.165601157590 palmitoyl-ethanolamide-d4 Palmidrol-d4; PEA-hydroxyethyl-1,1,2,2-d4 endocannabinoids CB2 neurotransmitters receptors ligands PEAs N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines LC-MS GC-MS mass spetrometry standards deuterateds deuterium MS LC/MS GC/MS cannabinoids cbs synthetic 6.165601157590
10007824 Palmitoyl Ethanolamide-d4 Exclusive 1159908-45-8 ≥99% deuterated forms (d1-d4) ✓ 2006-03-06 12.649668508287 palmitoyl-ethanolamide-d4 Palmidrol-d4; PEA-7,7,8,8-d4 GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cyclic cAMP ethanolamides anandamides AEA fatty acids neurochemistry ethanolamines cannabinoids cbs synthetic 12.649668508287
9000573 Palmitoyl Ethanolamide-d5 Exclusive - ≥99% deuterated forms (d1-d5) ✓ 2010-03-04 5.393704726826 palmitoyl-ethanolamide-d5 PEA-15,15,16,16,16-d5; Palmidrol-d5 endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines LC-MS GC-MS mass spetrometry standards deuterateds deuterium MS LC/MS GC/MS CBs synthetic 5.393704726826
91354 Palmitoyl N-Isopropylamide 189939-61-5 >98% 5.645082872928 palmitoyl-n-isopropylamide PIA cannabinoids FAAH fatty acid amide hydrolase inhibits inhibitors inhibition ethanolamides palmitoyl-n-isopropylamide PEA neurochemistry neuroscience synthetic analogs hydrolysis ethanolamines 5.645082872928
62175 Palmitoyl Serinol 126127-31-9 >98% 21.019765193370 palmitoyl-serinol endocannabinoids 2PG CB1 receptors synthases FAAH fatty acids amides analogs hydrolases 2-PG glycerols adenyl cyclase inhibits inhibition re-uptake reuptake neurochemistry neuroscience cannabinoids cbs synthetic 21.019765193370
62650 Palmityl Trifluoromethyl Ketone 141022-99-3 >98% 43.213038674033 palmityl-trifluoromethyl-ketone PTK; Pentadeca Trifluoromethyl Ketone ketones inhibitors analogs palmitic fatty acids inhibits inhibition lipoxygeanses LOs neurochemistry neuroscience 43.213038674033
11345 Paxilline New 57186-25-1 ≥98% 2012-03-01 10.565642497180 paxilline (+)-Paxilline Paxicillin Paxillin inhibitors inhibits inhibitions channels K+ blockers potassium BKCa cells signaling smooth muscle vascular cardiovascular neuronal neuroscience 10.565642497180
11347 Penitrem A New 12627-35-9 ≥98% 2012-03-05 16.753229974160 penitrem-a Tremortin A; NSC 354845 12679-82-2 inhibitors inhibits inhibition channels blockers potassium BKCa cells signaling smooth muscles vascular cardiovascular neuronal neuroscience SLO1 Maxi-K fungal fungus toxins 16.753229974160
9000746 Pentylone (hydrochloride) 17763-01-8 ≥98% 2011-04-20 69.778877351744 pentylone-hydrochloride mephedrone MDMA ecstasy neuroscience forensics designer drugs MDPV valerophenone 1-pentanone pentanone 698963-77-8 69.778877351744
13279 PF-3845 1196109-52-0 ≥98% 2010-01-27 43.794327808471 pf-3845 fatty acids hydrolase FAAH N-acyl ethanolamines NAEs endocannabinoids N-arachidonoyl ethanolamine anandamide AEA inhibitors inhibits inflammation pain PF3845 PF 3845 cannabinoids cbs synthetic Antibodies Monoclonal Monoclonal Antibodies 43.794327808471
10010907 PF-622 898235-65-9 >98% 2008-03-26 6.130267743306 pf-622 FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain fatty acids amides hydrolases neurochemistry 6.130267743306
10010908 PF-750 959151-50-9 >98% 2008-03-25 11.054506215470 pf-750 FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain neurochemistry 11.054506215470
9000849 Phenazepam 51753-57-2 ≥98% 2011-02-14 109.638796807857 phenazepam Fenazepam; BD 98 benzodiazepine agonists GABAA receptors anxiolytic sedative anticonvulsive anti-convulsive anti convulsive hypnotic tranquilizers 109.638796807857
11203 Phenylpiperazine (hydrochloride) New 4004-95-9 ≥98% 2012-02-22 2.352272203382 phenylpiperazine-hydrochloride NSC 38914; NSC 150847 EINECS 218-646-9 NSC38914 NSC-38914 ST088126 92-54-6 chloride AC1L2O6F AC1Q38T6 AR-1C5346 AR1C5346 NSC150847 NSC-150847 101-3441 forensics designer drugs 5-HT serotonin piperazines NSC 38914 NSC 150847 2.352272203382
71655 PHOP 288862-83-9 >98% 2005-02-02 8.605465666929 phop Phenyl hexanoyl oxazolopyridine; CAY10402 FAAH fatty acids amides hydrolases inhibits inhibitors inhibition cannabinoids CB1 CB2 hydrolysis hydrolyze CAY-10402 TGH triacylglycerols neurochemistry neuroscience cbs synthetic 8.605465666929
9001155 Piperlonguminine New 5950-12-9 ≥98% 2012-03-01 13.498262095450 piperlonguminine N-Isobutylpiperamide; NSC 125178 piperlonguminin alkaloids antifungals anticancers antihyperlipidemic anti-inflammatory amyloid β peptides Alzhaimer’s diseases alkaloids humans neuroblastoma cells proteins 13.498262095450
10525 PK 11195 New 85532-75-8 ≥98% 2012-03-30 130.000000000000 pk-11195 RP 52028 85340-56-3 ligands benzodiazepine neuroscience receptors GABA central peripheral proteins TSPO cerebellum spinal cord tissues RP-52028 RP52028 PK-11195 PK11195 BRN 4264456 130.000000000000
589751 Prion Protein EIA Kit - 8.628683241252 prion-protein-eia-kit Prion Protein ELISA Kit proteins mad cow diseases bovine spongiform scrapie Creutzfeldt-jakob neurodegeneration measures kits eias enzyme encephalopathy immunoassays ELISAs BSE spi-bio spibio A05201 assays 8.628683241252
10009034 Prion Protein Monoclonal Antibody (BAR 221) - 2006-07-11 4.092081031307 prion-protein-monoclonal-antibody-bar-221 PrP proteins antibodies antisera antiserum spi-bio spibio A03222 WB western blots blotting immunoblotting EIA enzyme immunoassays FC flow cytometry IHC immunohistochemistry 4.092081031307
10009030 Prion Protein Monoclonal Antibody (Clone 11C6) - 2006-07-11 3.836325966850 prion-protein-monoclonal-antibody-clone-11c6 PrP proteins antibodies antisera antiserum spi-bio spibio A03212 WB western blots blotting immunoblotting EIA enzyme immunoassays FC flow cytometry 3.836325966850
189710 Prion Protein Monoclonal Antibody (Clone 12F10) - 9.393646408840 prion-protein-monoclonal-antibody-clone-12f10 PrP proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob A3221 neurodegeneration antibodies antisera antiserum neurochemistry neuroscience spi-bio spibio WB western blots blotting immunoblotting IHC immunohistochemistry 9.393646408840
189760 Prion Protein Monoclonal Antibody (Clone 8G8) - 5.208563535912 prion-protein-monoclonal-antibody-clone-8g8 PrP proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antisera antiserum antibodies WB western blots blotting IHC immunohistochemistry neurochemistry neuroscience spi-bio spibio A03220 immunoblotting 5.208563535912
10009035 Prion Protein Monoclonal Antibody (Clone BAR 224) - 2006-07-11 24.924493554327 prion-protein-monoclonal-antibody-clone-bar-224 PrP proteins antibodies antisera antiserum spi-bio spibio A03211 WB western blots blotting immunoblotting EIA enzyme immunoassays FC flow cytometry IHC immunohistochemistry 24.924493554327
10009036 Prion Protein Monoclonal Antibody (Clone BAR 233) - 2006-07-11 4.092081031307 prion-protein-monoclonal-antibody-clone-bar-233 PrP proteins antibodies antisera antiserum spi-bio spibio A03223 WB western blots blotting immunoblotting EIA enzyme immunoassays FC flow cytometry 4.092081031307
10009037 Prion Protein Monoclonal Antibody (Clone BAR 236) - 2006-07-11 4.092081031307 prion-protein-monoclonal-antibody-clone-bar-236 PrP proteins antibodies antisera antiserum spi-bio spibio A03224 WB western blots blotting immunoblotting EIA enzyme immunoassays FC flow cytometry 4.092081031307
189750 Prion Protein Monoclonal Antibody (Clone Pri 308) - 4.162292817679 prion-protein-monoclonal-antibody-clone-pri-308 PrP proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum neurochemistry neuroscience spi-bio spibio A03200 WB western blots blotting immunoblotting IHC immunohistochemistry 4.162292817679
189720 Prion Protein Monoclonal Antibody (Clone SAF 32) - 18.810082872928 prion-protein-monoclonal-antibody-clone-saf-32 PrP proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt- jakob neurodegeneration antibodies antisera antiserum saf32 neurochemistry neuroscience spi-bio spibio A03202 WB western blots blotting immunoblotting IHC immunohistochemistry Enzyme-linked immunosorbent assays FC flow cytometry 18.810082872928
189730 Prion Protein Monoclonal Antibody (Clone SAF 53) - 4.162292817679 prion-protein-monoclonal-antibody-clone-saf-53 PrP proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum saf53 neurochemistry neuroscience spi-bio spibio A03203 Enzyme-linked immunosorbent assays FC flow cytometry 4.162292817679
189740 Prion Protein Monoclonal Antibody (Clone SAF 54) - 4.162292817679 prion-protein-monoclonal-antibody-clone-saf-54 PrP proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum saf54 neurochemistry neuroscience spi-bio spibio A03204 IHC immunohistochemistry 4.162292817679
189755 Prion Protein Monoclonal Antibody (Clone SAF 61) - 4.162292817679 prion-protein-monoclonal-antibody-clone-saf-61 PrP proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum saf61 neurochemistry neuroscience spi-bio spibio A03205 Enzyme-linked immunosorbent assays FC flow cytometry 4.162292817679
189765 Prion Protein Monoclonal Antibody (Clone SAF 83) - 6.254834254143 prion-protein-monoclonal-antibody-clone-saf-83 PrP proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum saf83 neurochemistry neuroscience spi-bio spibio A03207 WB western blots blotting immunoblotting Enzyme-linked immunosorbent assays FC flow cytometry 6.254834254143
189775 Prion Protein Monoclonal Antibody (Clone SAF 84) - 15.671270718232 prion-protein-monoclonal-antibody-clone-saf-84 PrP proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum saf84 neurochemistry neuroscience spi-bio spibio A03208 WB western blots blotting immunoblotting IHC immunohistochemistry 15.671270718232
189770 Prion Protein Monoclonal Antibody (SAF-70) - 5.208563535912 prion-protein-monoclonal-antibody-saf-70 proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt- A03206 jakob neurodegeneration antibodies SAFTO WB western blots blotting antisera antiserum neurochemistry neuroscience spi-bio spibio immunoblotting 5.208563535912
13621 Pristimerin Exclusive 1258-84-0 ≥98% ✓ 2010-03-08 49.274348855564 pristimerin Celastrol methyl ester; NSC 99281 monoacylglycerol lipases MAGLs monoglycerol MGLs cannabinoids 2-arachidonoyl glycerol 2-AG inhibitor 2-Picenecarboxylic acids cannabinoids cbs synthetic Triterpenes 49.274348855564
500940 Progranulin (human) EIA Kit - 2011-04-26 31.976145346366 progranulin-human-eia-kit PGRN autocrine growth factor embryonic development tissues repair tumorigenesis inflammation signaling pathways cells cycles progressions motility precursor proteins secreted glycosylated forms proteolytic cleavages extracellular proteases peptides granulins GRNs paragranulin secretory leukocytes inhibitors SLPI periphery regulates regulation inflammatory cascade anti-inflammatory pro-inflammatory tumors necrosis factors receptors TNFRs TNF-alpha TNF-.alpha. TNF-a TNF-α TNFalpha TNF.alpha. TNFa TNFα pathogenesis arthritis mice mouse serum visceral obesity plasma glucose dyslipidemia central nervous systems CNSs neurotrophic activity neuroinflammation mutations genes chromosomes 17 frontotemporal lobar degeneration FTLD dementia marker chronic ELISAs EIAs enzymes immunoassays immunometrics assays cultures supernatants 31.976145346366
500950 Progranulin (mouse) EIA Kit - 2011-04-26 38.552602823818 progranulin-mouse-eia-kit murine mice PGRN autocrine growth factor embryonic development tissues repair tumorigenesis inflammation signaling pathways cells cycles progressions motility precursor proteins secreted glycosylated forms proteolytic cleavages extracellular proteases peptides granulins GRNs paragranulin secretory leukocytes inhibitors SLPI periphery regulates regulation inflammatory cascade anti-inflammatory pro-inflammatory tumors necrosis factors receptors TNFRs TNF-alpha TNF-.alpha. TNF-a TNF-α TNFalpha TNF.alpha. TNFa TNFα pathogenesis arthritis mice mouse serum visceral obesity plasma glucose dyslipidemia central nervous systems CNSs neurotrophic activity neuroinflammation mutations genes chromosomes 17 frontotemporal lobar degeneration FTLD dementia marker chronic ELISAs EIAs enzymes immunoassays immunometrics assays cultures supernatants 38.552602823818
12010 Prostaglandin D2 41598-07-6 ≥99% 162.543959850903 prostaglandin-d2 PGD2 Vasodilation prostaglandins brain sleep platelets aggregation. H-PGDS synthases mast cells hematopoietic allergic allergy asthmatic anaphylaxis hypotension inhibits inhibitors inhibition beta-trace .beta.-trace b-trace neurochemistry 162.543959850903
12015 Prostaglandin D2-1-glyceryl ester 309260-52-4 >95% (as a 9:1 mixture of the 1- and 2-glyceryl esters) 2004-08-05 35.810524861878 prostaglandin-d2-1-glyceryl-ester PGD2-1-glyceryl ester endocannabinoids anandamides 2AG fatty acids porcine brain isomerase moiety cannabinoids cbs synthetic 35.810524861878
312010 Prostaglandin D2-d4 - ≥99% deuterated forms (d1-d4) 52.674930939227 prostaglandin-d2-d4 PGD2-d4 GC/MS deuterium isotopes PGD2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience 52.674930939227
10007272 Prostaglandin D2-d4 Lipid Maps MS Standard - ≥99% deuterated forms (d1-d4) 2009-02-26 45.215165745857 prostaglandin-d2-d4-lipid-maps-ms-standard PGD2-d4 GC/MS deuterium isotopes PGD2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience MS mass spectrometry standards 45.215165745857
10010123 Prostaglandin D2-d9 - ≥99% deuterated forms (d1-d9) 2007-10-25 46.889442425124 prostaglandin-d2-d9 PGD2-d9 GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience allergy asthma 46.889442425124
512031 Prostaglandin D2 EIA Kit - 2010-07-19 203.609714548802 prostaglandin-d2-eia-kit PGD2 ELISA Kit PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions 203.609714548802
12012 Prostaglandin D2 Ethanolamide 398138-28-8 >96% 29.410055248619 prostaglandin-d2-ethanolamide PGD2-EA anandamides ethanolamides cannabinoids PGD2 prostaglandins AEA neurochemistry neuroscience ethanolamines prostamides 29.410055248619
10007203 Prostaglandin D2 Ethanolamide Lipid Maps MS Standard 398138-28-8 >96% 2008-10-29 29.459463299131 prostaglandin-d2-ethanolamide-lipid-maps-ms-standard PGD2-EA anandamides ethanolamides cannabinoids PGD2 prostaglandins AEA neurochemistry neuroscience ethanolamines prostamides GC LC mass spectrometry MS standards 29.459463299131
512041 Prostaglandin D2 Express EIA Kit - 2010-07-19 105.423217169570 prostaglandin-d2-express-eia-kit PGD2 Express ELISA Kit PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions 105.423217169570
10192 Prostaglandin D2 serinol amide - >98% 2004-05-13 38.065237569061 prostaglandin-d2-serinol-amide PGD2-SA PGD2 vasodilation prostaglandins brain sleep platelets aggregation anandamides serinols amides cannabinoids AEA 38.065237569061
10006593 Prostaglandin D Synthase (hematopoietic-type; human recombinant) - ≥95% 2005-02-16 27.636114180479 prostaglandin-d-synthase-hematopoietic-type-human-recombinant Hematopoietic-PGDS; H-PGDS; PGD Synthase (hematopoietic-type; human recombinant) prostaglandins synthases PGDs PGD2 HPGDS H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators active 27.636114180479
10009625 Prostaglandin D Synthase (hematopoietic-type; human recombinant) Western Ready Control - 2007-07-19 21.429212707182 prostaglandin-d-synthase-hematopoietic-type-human-recombinant-western-ready-control Hematopoietic-PGDS; H-PGDS western blot WB PGH2 lipocalin-type hematopoietic peripheral tisses antigen-presenting cells mast megakaryocytes allergic HPGDS H-PGDS inflammatory diseases inhibits inhibitor inhibition E. coli 21.429212707182
10004347 Prostaglandin D Synthase (hematopoietic-type; mouse recombinant) Exclusive - ≥85% ✓ 2008-06-05 33.375506445672 prostaglandin-d-synthase-hematopoietic-type-mouse-recombinant H-PGDS; Hematopoietic-PGDS PGH2 lipocalin-type .beta.-trace prostaglandins hematopoietic enzymes PGD2 proteins recombinant inflammation activity high throughput screening inhibitors inhibits inhibition assays HPGDS H-PGDS active 33.375506445672
10007684 Prostaglandin D Synthase (lipocalin-type; human) EIA Kit Exclusive - ✓ 2008-06-09 14.145262430939 prostaglandin-d-synthase-lipocalin-type-human-eia-kit Lipocalin-PGDS ELISA Kit; L-PGDS EIA Kit EIAs ELISAs Assays sandwich immunometric homodimer glycosylation catalyzes prostaglandins PGH2 PGD2 carrier proteins lipid-like molecules neurochemistry retinoids thyroid hormones body fluids cerebrospinal seminal plasma PTGDS beta-trace b-trace .beta.-trace betatrace btrace lpgds l-pgds assays 14.145262430939
10004342 Prostaglandin D Synthase (lipocalin-type; human) Monoclonal Antibody (Clone 10A5) - 2004-03-04 6.002923572744 prostaglandin-d-synthase-lipocalin-type-human-monoclonal-antibody-clone-10a5 Lipocalin-PGDS; L-PGDS prostaglandins inhibitors renal failure synthases lpgds antibodies antisera antiserum wb ihc western blots blotting immunohistochemistry b-trace beta-trace .beta.-trace l-pgds immunoblotting 6.002923572744
10006788 Prostaglandin D Synthase (lipocalin-type; human recombinant) - ≥95% 2005-03-23 38.766714022625 prostaglandin-d-synthase-lipocalin-type-human-recombinant L-PGDS; Lipocalin-PGDS prostaglandins synthases PGDs PGD2 H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators neurochemistry lpgds l-pgds active 38.766714022625
10009741 Prostaglandin D Synthase (lipocalin type; human) Western Ready Control - 2007-04-30 1.697615101289 prostaglandin-d-synthase-lipocalin-type-human-western-ready-control L-PGDS; Lipocalin-PGDS GST lpgds l-pgds western blot WB neurochemistry hL-PGDS hLPGDS 1.697615101289
10004344 Prostaglandin D Synthase (lipocalin-type; mouse) Polyclonal Antibody - 2004-03-10 2.135950276243 prostaglandin-d-synthase-lipocalin-type-mouse-polyclonal-antibody L-PGDS; Lipocalin-PGDS prostaglandins inhibitors renal failure synthases antibodies antisera antiserum wb ihc western blots blotting immunohistochemistry lpgds l-pgds immunoblotting 2.135950276243
10006787 Prostaglandin D Synthase (lipocalin-type; mouse recombinant) - ≥95% 2005-03-23 42.061845953851 prostaglandin-d-synthase-lipocalin-type-mouse-recombinant L-PGDS; Lipocalin-PGDS prostaglandins synthases PGDs PGD2 H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators neurochemistry lpgds l-pgds active 42.061845953851
160003 Prostaglandin D Synthase (lipocalin-type) Polyclonal Antibody - 27.542111724984 prostaglandin-d-synthase-lipocalin-type-polyclonal-antibody L-PGDS; Lipocalin-PGDS antibodies human pgds synthases western blots blotting prostaglandins pgd2 antisera antiserum wb lpgds l-pgds immunoblotting 27.542111724984
10010548 Prostaglandin D Synthase (lipocalin-type; rat recombinant) Exclusive - ≥95% ✓ 2008-07-01 40.950246493837 prostaglandin-d-synthase-lipocalin-type-rat-recombinant L-PGDS; Lipocalin-PGDS prostaglandins PGH2 beta-trace b-trace proteins assays neurochemistry rL-PGDS rlPGDS .beta.-trace beta-trace b-trace recombinant human cerebrospinal fluid PGs CSF GST-tags GST-tagged N-terminal lpgds l-pgds active 40.950246493837
13012 Prostaglandin E1 Ethanolamide 210976-81-1 ≥98% 38.187998772252 prostaglandin-e1-ethanolamide PGE1-EA; Alprostadil Ethanolamide anandamides ethanolamides cannabinoids PGE1 prostaglandins AEA neurochemistry neuroscience ethanolamines prostamides 38.187998772252
10140 Prostaglandin E2-1-glyceryl ester 37497-47-5 >98% (as a 85:15 mixture of the 1- and 2-glyceryl esters) 50.722817679558 prostaglandin-e2-1-glyceryl-ester PGE2-1-glyceryl ester Prostaglandins PGE2-1-GE esters 2-AG 2-arachidonyl-glycerol metabolites COX-2 PGHS-2 cycloxygenases synthases PGE2-2-GE COX2 PGHS2 cannabinoids cbs synthetic 50.722817679558
14012 Prostaglandin E2 Ethanolamide Exclusive 194935-38-1 >98% ✓ 43.989917127072 prostaglandin-e2-ethanolamide PGE2-EA; Dinoprostone Ethanolamide; Prostamide E2 anandamides ethanolamides cannabinoids PGE2 prostaglandins AEA analogs neurochemistry neuroscience ethanolamines prostamides 43.989917127072
10007212 Prostaglandin E2 Ethanolamide Lipid Maps MS Standard 194935-38-1 >98% 2008-11-05 33.395580110497 prostaglandin-e2-ethanolamide-lipid-maps-ms-standard Dinoprostone Ethanolamide; Prostamide E2; PGE2-EA anandamides ethanolamides cannabinoids PGE2 prostaglandins AEA analogs neurochemistry neuroscience ethanolamines prostamides GC-MS GC/MS LC-MS LC/MS mass spectromatory standards 33.395580110497
10193 Prostaglandin E2 serinol amide Exclusive - ≥98% ✓ 2004-03-03 36.179234411997 prostaglandin-e2-serinol-amide PGE2-SA PGE2SA cannabinoids agonists CB1 receptors analogs 2-glyceryl neurochemistry neuroscience 36.179234411997
10139 Prostaglandin F2α-1-glyceryl ester 43042-79-1 >98% (as a 9:1 mixture of the 2- and 1-glyceryl esters) 17.860110497238 prostaglandin-f2-1-glyceryl-ester PGF2α-1-glyceryl ester Prostaglandins PGF2alpha-1-GE PGF2.alpha.-1-GE esters 2-AG 2-arachidonoyl-glycerol COX-2 metabolites cyclooxygenases PGHS-2 synthases PGHS2 COX2 PGF2alpha-2-GE PGF2.alpha.-2-GE PGFa-2-GE PGF2a-1-GE cannabinoids cbs synthetic 17.860110497238
10194 Prostaglandin F2α serinol amide - >98% 2004-02-23 14.588425414364 prostaglandin-f2-serinol-amide PGF2α-SA PGF2alphaSA PGF2.alpha.SA PGF2alpha-SA PGF2.alpha.-SA cannabinoids agonists CB1 recptors analogs 2-glyceryl esters amides neuroscience 14.588425414364
160630 Prostaglandin I Synthase Monoclonal Antibody (Clone isn-1) - Protein-A purified 4.454613259668 prostaglandin-i-synthase-monoclonal-antibody-clone-isn-1 Prostacyclin Synthase; PGIS; PGI Synthase synthases endothelium PGI2 prostaglandins antibodies antisera antiserum Bovine PGI synthase atherosclerosis neurochemistry IP immunoprecipitation IHC immunohistochemistry 4.454613259668
100023 Prostaglandin I Synthase (murine) Polyclonal Antibody - 2004-06-30 14.377154696132 prostaglandin-i-synthase-murine-polyclonal-antibody PGIS; Prostacyclin Synthase; PGI Synthase antibodies antisera antiserum western blots blotting wb IHC immunohistochemistry prostaglandins prostacyclins synthases receptors atherosclerosis immunoblotting 14.377154696132
160640 Prostaglandin I Synthase Polyclonal Antibody - 8.655893186003 prostaglandin-i-synthase-polyclonal-antibody Prostacyclin Synthase; PGIS; PGI Synthase PGIS prostacyclin synthases endothelium Western blots PGI2 prostaglandins blotting antisera antiserum immunoprecipitation IP antibodies atherosclerosis WB immunoblotting 8.655893186003
10011435 PSD95 Monoclonal Antibody (Clone 6G6) - 2008-05-07 0.317679558011 psd95-monoclonal-antibody-clone-6g6 Postsynaptic Density Protein 95 antibodies ICC WB western blots immunocytochemistry proteins neurochemistry neurons memory learning neuronal AMPA immunoblotting autism TARPs blotting 0.317679558011
10011436 PSD95 Monoclonal Antibody (Clone 7E3) - 2008-05-07 0.635359116022 psd95-monoclonal-antibody-clone-7e3 Postsynaptic Density Protein 95 antibodies WB western blots proteins neurochemistry neuronal neurons synapse memory learning PSD-95 immunoblotting receptors TARPs AMPA autism PSD 95 blotting 0.635359116022
10009506 PSD95 Polyclonal Antibody - 2007-01-03 0.392265193370 psd95-polyclonal-antibody Postsynaptic Density Protein of 95 antibodies WB western blot PDZ domain glutamate receptors signaling proteins synapse NMDAR phosphorylation proteins signalling blotting immunoblotting 0.392265193370
10008594 PSN632408 Exclusive 857652-30-3 ≥98% ✓ 2006-08-01 16.772696132596 psn632408 GPR119 SNORF25 agonists oleoylethanolamide OEA obesity appetite food intake GPCR G protein-coupled receptors PSN632408 weight gain pancreas gastrointestinal tract brain endocrinology neurochemistry 16.772696132596
10817 Pyrovalerone Exclusive 3563-49-3 ≥95% ✓ 2011-05-25 36.642393687258 pyrovalerone Thymergix; Centroton; Valerophenone inhibitors neurotransmitters dopamine norepinephrine controlled substances forensic analysis forensics bath salts 10836 valerophenone 36.642393687258
10836 Pyrovalerone (hydrochloride) 1147-62-2 ≥95% 2011-05-24 43.955073284603 pyrovalerone-hydrochloride Centroton; Thymergix; Valerophenone inhibitors neurotransmitters dopamine norepinephrine controlled substances forensic analysis forensics bath salts inhibition 10817 free base inhibits 3563-49-3 43.955073284603
90070 R-1 Methanandamide 157182-49-5 >98% 21.729305445934 r-1-methanandamide (R)-(+)-Arachidonyl-1'-Hydroxy-2'-Propylamide; AM356 cannabinoids neurotransmitters ligand AEA lipids CB1 CB2 receptor anandamide analogs agonists neurochemistry neuroscience 21.729305445934
10004281 R-1 Methanandamide Phosphate - >98% 2004-08-20 21.225856353591 r-1-methanandamide-phosphate R-1MAP; (R)-(+)-Arachidonyl-1'-Hydroxy-2'-Propylamide Phosphate endocannabinoids neurotransmitters ligands AEA lipids CB1 CB2 receptors anandamides analogs agonists phosphates LPA lysophatidic acids neurochemistry neuroscience R1 cannabinoids cbs synthetic 21.225856353591
90074 R-2 Methanandamide - >98% 11.043190607734 r-2-methanandamide (R)-(-)-Arachidonyl-2'-Hydroxy-1'-Propylamide cannabinoids neurotransmitter AEA lipids CB1 CB2 receptors anandamide analogs neurochemistry neuroscience 11.043190607734
10491 (R)-AM1241 Exclusive 444912-51-0 ≥98% ✓ 2010-05-27 38.796531659228 -r-am1241 (+)-AM1241 cannabinoids CB2 receptors CB1 agonists inverse agonists antinociception pains SR144528 rimonabant CBs 38.796531659228
10645 RCS-4 - ≥98% 2010-11-24 116.736971034073 rcs-4 cannabinoids receptors JWHs 018 CB1 CB2 cannabimimetics forensics CBs neurochemistry cannabinoids cbs synthetic 116.736971034073
10865 RCS-4 2-methoxy isomer Exclusive - ≥98% ✓ 2011-06-15 48.632737799022 rcs-4-2-methoxy-isomer synthetic cannabinoids forensics receptors herbal spices incense JWH 250 JWH-250 JWH250 RCS4 RCS 4 analogs CB1 CB2 cannabimimetic indoles CBs 48.632737799022
10866 RCS-4 3-methoxy isomer Exclusive - ≥98% ✓ 2011-06-15 45.077700937744 rcs-4-3-methoxy-isomer cannabinoids receptors JWH 018 CB1 CB2 CBs cannabimimetics forensics synthetic bath salts JWH-018 JWH018 45.077700937744
10798 RCS-4-C4 homolog Exclusive - ≥98% ✓ 2011-04-21 42.903849575109 rcs-4-c4-homolog BTM-4; SR-19; OBT-199; E-4 cannabinoids cannabimimetic metabolites CB1 CB2 receptors agonists spice forensics synthetics smoking urinary urine serum JWH018 JWH 018 JWH-018 JWH18 BTM4 BTM 4 E4 E 4 OBT199 OBT 199 SR19 SR 19 42.903849575109
10513 RCS-4-d9 - ≥99% deuterated product 2011-09-12 34.954514656230 rcs-4-d9 cannabinoids receptors JWHs 018 CB1 CB2 cannabimimetics forensics sciences CBs neurochemistry synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS 34.954514656230
10935 RCS-4 N-(5-hydroxypentyl) metabolite Exclusive - ≥98% ✓ 2011-06-17 48.680381189597 rcs-4-n-5-hydroxypentyl-metabolite cannabinoids cannabimimetic metabolites CB1 CB2 CBs receptors agonists spices forensics synthetic smoking urinary urine RCS4 RCS 4 JWHs glucuroconjugate forensics sciences neuroscience 48.680381189597
10636 RCS-8 - ≥98% 2010-11-02 98.138615251861 rcs-8 SR-18 cannabinoids receptors JWH 250 CB1 CB2 cannabimimetics forensics cannabinoids cbs synthetic Rabbit Aorta Contracting Substance A2 Thromboxane Thromboxane A2 98.138615251861
10012554 Resolvin D1 Exclusive 872993-05-0 ≥95% ✓ 2008-06-06 256.332392917195 resolvin-d1 RvD1; 17(S)-Resolvin D1 EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins 10007848 256.332392917195
70255 (R)-Flurbiprofen 51543-40-9 ≥99% 2004-06-11 8.886160220994 -r-flurbiprofen E-7869; Tarenflurbil; Flurizan cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits inhibition neurochemistry 8.886160220994
10009411 Ribosomal S6 Kinase 2 Polyclonal Antibody - 2006-11-28 0.435082872928 ribosomal-s6-kinase-2-polyclonal-antibody RSK2 wb western blotting blots antibodies p90 kinases RSK1 RSK2 RSK3 RSK4 downstream members extracellular signal-regulated ERK/MAPK cascade humans Coffin-Lowry syndrome mental retardation growth deficits defects tonic regulation GPCRs G protein-coupled signalling immunoblotting 0.435082872928
9000484 Rimonabant 168273-06-1 ≥98% 2009-06-17 74.152900552486 rimonabant SR141716 SR 141716A SR141716A CB1 inverse agonists anti-obesity immunomodulation anti-proliferation appetite suppressants receptors weight control medication cannabinoids anti-proliferative immunodulatory cbs sythetic 74.152900552486
10011132 Rolipram 61413-54-5 ≥98% 2008-12-16 11.059300184162 rolipram ZK 62711; SB 95952 inhibits inhibitor inhibition phosphodiesterase PDE4 cAMP inflammation leukocyte LPS TNF monocytes C5a LTC4 eosinophil neurons bones loss 11.059300184162
90353 R-Palmitoyl-(1-methyl) Ethanolamide 142128-47-0 >98% 5.322567435814 r-palmitoyl-1-methyl-ethanolamide R-1 PMA PEA AEA ethanolamides R-1-PMA cannabinoids analogs (R)-methyl ethanolamines inhibitors inhibits CB2 receptors neurochemistry neuroscience 5.322567435814
90357 R-Palmitoyl-(2-methyl) Ethanolamide 179951-56-5 >98% 5.091187845303 r-palmitoyl-2-methyl-ethanolamide RP-2ME PEA cannabinoids analogs anandamides methanandamides CB2 receptors ethanolamides inhibits inhibitors (R)-N-(2-hydroxypropyl)-hexadecanamide FAAH fatty acids hydrolases agonists neurochemistry neuroscience ethanolamines 5.091187845303
10009227 (R)-SLV 319 656827-86-0 ≥98% 2007-09-05 0.254419889503 -r-slv-319 CB1 CB2 receptors cannabinoids antagonists inflammation 0.254419889503
90072 S-1 Methanandamide - >98% 11.043190607734 s-1-methanandamide (S)-(-)-Arachidonyl-1'-Hydroxy-2'-Propylamide cannabinoids neurotransmitters ligand AEA lipids CB1 CB2 receptors anandamides analogs agonists neurochemistry neuroscience 11.043190607734
90076 S-2 Methanandamide - >98% 20.952053406998 s-2-methanandamide (S)-(+)-Arachidonyl-2'-Hydroxy-1'-Propylamide cannabinoids neurotransmitter ligand AEA lipid CB1 CB2 receptors anandamide analogs agonists neurochemistry neuroscience 20.952053406998
13603 S-Adenosylhomocysteine 979-92-0 ≥98% 2010-04-22 15.222591160220 s-adenosylhomocysteine SAH; AdoHcy amino acids derivatives cysteine methyl cycle biosynthesis risk factors metabolic pathways cancers by-products by products neurodegenerative diseases Adenosylhomocysteine, S S-Adenosylhomocysteine S Adenosylhomocysteine 15.222591160220
11487 Salvinorin A New 83729-01-5 ≥98% 2012-05-16 164.444444444444 salvinorin-a Divinorin A hallucinogens drugs abuse forensics science κ opioids receptors selective agonists terpenoids Salvia divinorum plants serotonin 164.444444444444
11488 Salvinorin B New 92545-30-7 ≥98% 2012-05-02 164.444444444444 salvinorin-b Divinorin B salvinorin A hallucinogens drugs abuse forensics science κ opioids receptors selective agonists terpenoids metabolites Salvia divinorum plants depression mania 5-HT2A serotonin 164.444444444444
10490 (S)-AM1241 Exclusive 444912-53-2 ≥98% ✓ 2010-05-27 41.957847151487 -s-am1241 (-)-AM1241 cannabinoids CB2 receptors CB1 agonists inverse agonist antinociception pains SR144528 rimonabant CBs 41.957847151487
10096 SB 242084 (hydrochloride) 1049747-87-6 ≥98% 2010-06-29 1.280536700867 sb-242084-hydrochloride 181632-25-7 serotonins 5-hydroxytryptamines 5-HT neurotransmitters neuroscience receptors gut central nervous system antagonists 5-HT2C dopamine adrenergic receptors brain anxiolytic neurochemistry CNS Antigens HLA-SB Antigens HLA-PL Antigens HLA-DP HLA-SB Antigens HLA-PL Antigens HLA-DP Antigens HLA SB Antigens HLA PL Antigens HLA DP Antigens HLA-SB HLA-PL HLA-DP 1.280536700867
11019 SB 366791 472981-92-3 ≥98% 2011-10-13 9.380497237569 sb-366791 pain TRPV1 antagonists hyperalgesia receptors neurons central peripheral nerves terminals thermal mechanical hyperalgesia bone cancers ganglion SB366791 SB-366791 9.380497237569
14060 SC-19220 19395-87-0 >96% 61.538110497237 sc-19220 PGE2 antagonists antinociceptives EP1 receptors selective prostaglandins SC19220 SC 19220 61.538110497237
10767 SETD2 (human recombinant) New - ≥95% 2012-01-19 10.685672191528 setd2-human-recombinant p231HBP; Huntington Interacting Protein B; KMT3A; HYPB epigenetics histones methyltransferases SET-domains containing SETD-2 SETD 2 huntingtin interacting proteins b HYBP trimethylation H3K36me3 mouse fibroblasts cells mono-methylation di-methylation WW hyperphosphorylation RNA polymerase II regulation diseases 10.685672191528
13332 (S)-Glycyl-H-1152 (hydrochloride) Exclusive 913844-45-8 ≥98% ✓ 2010-01-27 83.825403314916 -s-glycyl-h-1152-hydrochloride Rho Kinase Inhibitor IV Rho kinases ROCK-I p160ROCK ROCK-II G protein Rho cytoskeletons adhesions proliferation smooth muscles contraction stem cells inhibitors inhibition inhibited Fasudil hydrochloride ROCK IV h1152 h-1152 h 1152 83.825403314916
10009312 SKF-96365 (hydrochloride) 130495-35-1 ≥98% 2007-01-19 47.533237569061 skf-96365-hydrochloride calcium antagonists voltage-gated inhibits inhibitors inhibition acetylcholine-induced depolarization smooth muscles platelets neutrophils SFK9635 Ach-induced HCl neurochemistry 47.533237569061
10009226 (±)-SLV 319 Exclusive 362519-49-1 ≥98% ✓ 2007-01-16 25.542371440714 -slv-319 CB1 CB2 Receptors Cannabinoids Antagonists Inflammations inflammatory neurochemistry lipophilic ligands cannabinoids cbs synthetic 25.542371440714
10006518 S-Nitrosylated Protein Detection Kit - 2005-11-29 153.615633312871 s-nitrosylated-protein-detection-kit SNO Detection NOs nitric oxides synthases oxidation oxidative reactive nitrogen species RNS thiol SH groups signalling proteins kits measures measurements S-nitrosation nitrosation S-nitrosylation nitrosylation assays 153.615633312871
700330 Sphingomyelinase Inhibitor Screening Assay Kit - 2010-02-09 42.857868184608 sphingomyelinase-inhibitor-screening-assay-kit SMase assays kits measures measuring measurementsphingomyelinases SMases hydrolases enzymes sphingolipids metabolisms DNase I superfamily phosphocholines ceramides cellular cells stress pathophysiological lysosomal digestion ceramide-mediated signal transductions cytokine-induced apoptosis differentiation immune inflammatory lipoproteins aggregation vessels atherogenesis intracellular trafficking acidic neutral proliferation depressive disorders neurodegenerative disorders strokes Alzheimer's dementia diseases therapeutics cleavage conjugates free thiols 42.857868184608
9000491 SR 144528 192703-06-3 ≥98% 2009-08-05 72.405013812154 sr-144528 antagonist CB1 CB2 cannabinoids receptors inverse agonist inflammation leukocytes CP 55940 CP55940 55,940 CP55,940 pain initiation suppression immune activation sr144528 CBs synthetic 72.405013812154
10683 SR 16584 1150153-86-8 ≥95% 2011-11-17 41.539337016574 sr-16584 antagonists receptors nicotinic acetylcholine receptors neuroscience nAChRs ligands ion channels central peripheral nerves nervous system subtypes SR-16584 SR16584 α3β4 α4β2 α7 41.539337016574
10009022 (S)-SLV 319 Exclusive 464213-10-3 ≥98% ✓ 2007-08-16 0.254419889503 -s-slv-319 CB1 CB2 receptors cannabinoids antagonists inflammation obesity neurochemistry inflammatory neuro-inflammatory neuroinflammatory (S)-SLV319 disorders ligands 0.254419889503
90245 Stearoyl Ethanolamide 111-57-9 >98% 13.817389502762 stearoyl-ethanolamide Stearic Acid Ethanolamide; Ceramid anandamides N-acyl ethanolamines PLD fatty acids neurochemistry neuroscience ethanolamides 13.817389502762
11564 STS-135 Exclusive New 1354631-26-7 ≥98% ✓ 2012-03-28 242.522906592621 sts-135 N-adamantyl-1-fluoropentylindole-3-Carboxamide cannabinoids CBs herbals spices forensics CB1 CB2 receptors agonists designer drugs STS 135 STS135 fluoropentylindole AM2201 AM-2201 AM 2201 synthetics peripheral 242.522906592621
583751 Substance P EIA Kit - 304.806395027623 substance-p-eia-kit Substance P ELISA Kit solid plates Substance-P Sub-P neurokinin measures kits eias enzyme immunoassays ELISAs pain endocrinology neurochemistry neuroscience assays 304.806395027623
10606 Synapsin I Polyclonal Antibody - 2009-10-23 2.201657458563 synapsin-i-polyclonal-antibody gamma inhibits inhibitors neurotransmitters WB western blots blotting enzymes synthesis plasticity brain IHC IF IP immunohistochemistry immunoprecipitation immunofluorescence 2.201657458563
10605 Synapsin I Polyclonal Antibody (neat serum) - 2009-10-23 0.193370165745 synapsin-i-polyclonal-antibody-neat-serum gamma inhibits inhibitors neurotransmitters WB western blots blotting enzymes synthesis plasticity brain 0.193370165745
13830 Synthetic Cannabinoid HPLC Mixture I - ≥95% for each compound 2010-05-13 40.045118847375 synthetic-cannabinoid-hplc-mixture-i cannabinoids CBs endocannabinoids cannabidiols CP-47,497 cp 47,497 47,497-c8-homolog CP-47,497-C8 homolog analog CP-55,940 cp47,497 cp55,940 cp 55,940 HU-331 HU331 HU 331 HU308 HU 308 HU-308 JWH-015 jwh015 jwh 015 jwh 018 jwh018JWH-018 JWH-200 jwh200 jwh 200 jwh 250 jwh250 JWH-019 Win-55212-2 Jwh-250 win 55212-2 win55212 2 synthetic spices mixes synthetic 40.045118847375
13850 Synthetic Cannabinoid HPLC Mixture II - ≥95% for each compound 2010-12-21 44.388457144890 synthetic-cannabinoid-hplc-mixture-ii cannabinoids CBs synthetics mixtures receptors agonists synthetic 44.388457144890
11335 Synthetic Cannabinoid HPLC Mixture III New - ≥95% for each compound 2012-03-20 75.250490689850 synthetic-cannabinoid-hplc-mixture-iii cannabinoids CBs synthetics mixtures receptors agonists JWHs AMs RCS 75.250490689850
11336 Synthetic Cannabinoid HPLC Mixture IV New - ≥95% for each compound 2012-05-03 100.564303915699 synthetic-cannabinoid-hplc-mixture-iv cannabinoids CBs synthetics mixtures receptors agonists JWHs AMs 100.564303915699
11337 Synthetic Cannabinoid HPLC Mixture V (AM Series) New - ≥95% for each compound 2012-02-02 40.873690480371 synthetic-cannabinoid-hplc-mixture-v-am-series AM series AM-2201 AM-1220 AM-630 AM-1241 AM-694 AM-2233 AM2201 AM1220 AM630 AM1241 AM694 CBs cannbinoids mixtures AM2233 40.873690480371
70240 Tacrine (hydrochloride) 1684-40-8 >98% 5.510773480662 tacrine-hydrochloride Romotal; Cognex acetylcholinesterase inhibitors Alzheimer's disease serotonin noradrenalin AChE enzyme immunoassay reagents neurochemistry neuroscience 5.510773480662
10009911 Tangeritin 481-53-8 ≥98% 2008-12-16 11.780883977900 tangeritin Ponkanetin; NSC 618905; NSC 53909 flavone cancers tumors cholesterol atherosclerosis ERKs p38 MAPKs JNKs AKTs LDLs triacylglycerol estradiol MDR1 pregnane X receptors IL-1 IL1 IL 1 melanoma insulinoma 11.780883977900
11190 Termitomycamide B New 1254277-89-8 ≥97% 2012-01-31 0E-12 termitomycamide-b mushrooms extracts ER stress apoptosis endoplasmic reticulum neuroscience proteins misfolding Parkinson’s diseases Alzheimer’s prions fatty acids cells death termites termitomycamides Termitomyces titanicus Neuro2a 0E-12
11191 Termitomycamide E New 1177258-62-6 ≥98% 2012-01-27 0E-12 termitomycamide-e 2'-Deoxotermitomycamide A mushrooms extracts ER stress apoptosis endoplasmic reticulum neuroscience proteins misfolding Parkinson’s diseases Alzheimer’s prions neuronal calcium homeostasis Termitomyces titanicus termites 0E-12
10011127 Thioperamide Maleate 148440-81-7 ≥98% 2009-03-26 0.202209944751 thioperamide-maleate histamines H3 receptors antagonists seizures GABA 110-16-7 106243-16-7 selective croses blood-brain barrier 0.202209944751
11144 TMA-2 Exclusive New 1083-09-6 ≥95% ✓ 2012-04-03 78.225577811970 tma-2 2,4,5-Trimethoxysmphetamine TMA2 TMA 2 22199-15-1 designer drugs psychedelic amphetamines hallucinogen 5-HT2 sertonin receptors forensics 78.225577811970
13623 Topiramate 97240-79-4 ≥98% 2010-08-17 5.831491712707 topiramate TPM; Topamax®; RWJ 17021; McN 4853; Epitomax anticonvulsants seizures epilepsy migraines headaches McN-4853 McN4853 RWJ-17021 RWJ17021 epitoma topamac topimax topina topomax 1103510-60-6 administered orally sulfamates anti-convulsants prevention Instituto Farmacologico Brand of Fructose Fresenius Kabi Brand of Fructose Grifols Brand of Fructose Plast Apyr Levulosa Mein Bieffe Brand of Fructose Baxter Brand of Fructose Levulosado Bieffe Medit Braun Brand of Fructose Ern Brand of Fructose Levulosa Fleboplast Fleboplast Levulosa Levulosado Vitulia Levulosado Braun Levulosa Grifols Levulosa Baxter Levulosa, Apir Levulosa Braun Levulosa Mein Levulosa Ibys Apir Levulosa Levulosa Ife Levulose Levulosa Fructose 5.831491712707
11120 TPPU Exclusive 1222780-33-7 ≥98% ✓ 2011-10-26 5.145469613259 tppu soluble epoxide hydrolase sEH inflammation hypertension cardiovascular disease neuroscience inhibitors inhibits inhibition pharmacokinetics 5.145469613259
10011659 Trolox 53188-07-1 ≥98% 2008-12-02 311.238232044199 trolox 6-hydroxy-2,5,7,8-tetramethylchroman-2-Carboxylic Acid antioxidants vitamins E oxidative injury injuries neurodegeneration aging cancers adjunctive 311.238232044199
10009398 Tryptophan Hydroxylase (Phospho-Ser260) Polyclonal Antibody - 2006-12-18 0.655248618784 tryptophan-hydroxylase-phospho-ser260-polyclonal-antibody TPH TPH260 hydroxylases catalyzes 5-hydroxylation biosynthesis indoleamines serotonin melatonin brain mammals neurons Raphe nuclei pineal gland neurotransmitter phosphorylation cyclic AMP cAMP-dependent kinases PKA Ca2+/calmodulin kinase II CaM K II phosphorylates antibodies antisera antiserum WB western blots blotting proteins diseases phospho-specific immunoblotting 0.655248618784
10009397 Tryptophan Hydroxylase (Phospho-Ser58) Polyclonal Antibody - 2006-12-18 0.836095764272 tryptophan-hydroxylase-phospho-ser58-polyclonal-antibody TPH TPH58 hydroxylases catalyzes 5-hydroxylation biosynthesis indoleamines serotonin melatonin brain mammals neurons Raphe nuclei pineal gland neurotransmitter phosphorylation cyclic AMP cAMP-dependent kinases PKA Ca2+/calmodulin kinase II CaM K II phosphorylates antibodies antisera antiserum WB western blots blotting proteins diseases phospho-specific immunoblotting 0.836095764272
10009396 Tryptophan Hydroxylase Polyclonal Antibody - 2006-12-13 2.395580110497 tryptophan-hydroxylase-polyclonal-antibody TPH hydroxylases catalyzes biosynthesis serotonin melatonin brain mammals neurons Raphe nuclei pineal gland antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry frozen sections proteins diseases immunoblotting 2.395580110497
10559 Tubastatin A (trifluoroacetate salt) Exclusive - ≥95% ✓ 2011-02-08 38.988967541436 tubastatin-a-trifluoroacetate-salt HDAC6 inhibitors histones deacetylases neuroprotection neurons epigenetics TFA inhibition inhibited neuronal protection α-tubulin alpha tubulin .alpha.tubulin a-tubulin tubastatin-A Acids Hydroxamic Hydroxamic Acids Acid Hydroxamic Hydroxamic Acid 38.988967541436
10009412 Tyrosine Hydroxylase (Phospho-Ser19) Polyclonal Antibody - 2006-11-28 0.435082872928 tyrosine-hydroxylase-phospho-ser19-polyclonal-antibody TH wb western blotting blots if immunofluorescence ihc immunohistochemistry antibodies rate-limiting enzymes synthesis catecholamines dopamine norepinephrine markers dopaminergic noradrenergic neurons depression schizophrenia parkinson's diseases drug abuse signaling phosphorylation phospho-specific regulation cells identification immunoblotting 0.435082872928
10009413 Tyrosine Hydroxylase (Phospho-Ser31) Polyclonal Antibody - 2006-11-28 0E-12 tyrosine-hydroxylase-phospho-ser31-polyclonal-antibody TH wb western blotting blots if immunofluorescence ihc immunohistochemistry antibodies rate-limiting enzymes synthesis catecholamines dopamine norepinephrine markers dopaminergic noradrenergic neurons depression schizophrenia parkinson's diseases drug abuse signaling phosphorylation phospho-specific regulation cells identification phospho-specific immunoblotting 0E-12
10009414 Tyrosine Hydroxylase (Phospho-Ser40) Polyclonal Antibody - 2008-07-07 1.740331491713 tyrosine-hydroxylase-phospho-ser40-polyclonal-antibody TH wb western blotting blots if immunofluorescence ihc immunohistochemistry antibodies rate-limiting enzymes synthesis catecholamines dopamine norepinephrine markers dopaminergic noradrenergic neurons depression schizophrenia parkinson's diseases drug abuse signaling phosphorylation phospho-specific regulation cells identification immunoblotting 1.740331491713
10604 Tyrosine Hydroxylase Polyclonal Antibody - 2009-10-23 0.193370165745 tyrosine-hydroxylase-polyclonal-antibody TH gamma inhibits inhibitors neurotransmitters WB western blots blotting enzymes synthesis dopamine norepinephrine immunoblotting IHC immunohistochemistry IF immunofluorescence 0.193370165745
10010245 U-83836E 137018-55-4 ≥98% 2008-07-08 0.386740331492 u-83836e antioxidant anti-oxidant oxidative injury stress free radicals ischemia diabetes a-tocopherol .alpha.-tocopherol 122003-11-6 PNU-83836E PNU83836E 0.386740331492
10045 UCM707 390824-20-1 >98% 2004-01-30 24.558784530386 ucm707 cannabinoids neurotransmitter inhibitors AEA lipids CB1 UR1 receptors anandamide hydrolysis fatty acids neurochemistry neuroscience 24.558784530386
11502 UR-144 New 1199943-44-6 ≥98% 2012-04-02 409.791972624799 ur-144 KM-X1 cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetics UR144 UR 144 peripheral central KMX-1 KMX 1 KM X1 409.791972624799
13261 URB447 Exclusive 1132922-57-6 ≥98% ✓ 2009-06-18 35.040220994475 urb447 CB1 CB2 cannabinoids antagonists obesity SR 141716A SR141716A rimonabant blood brains barrier URB appetite suppressant receptors URB-447 URB blocking peptides 447 cannabinoids cbs synthetic 35.040220994475
10046 URB597 546141-08-6 >98% 47.222456052235 urb597 FAAH fatty acid amide hydrolases inhibitors URB-597 anandamides lipids inhibition selective selectivity AEA inhibits hydrolysis hydrolyze arachidonoyl cannabinoids ethanolamides neuroscience neurochemistry 47.222456052235
10007457 URB602 565460-15-3 >98% 2005-09-06 40.775469613259 urb602 monoglycerol lipase MGL inhibition inhibits inhibitors rat brain enzymes enhanced stress-induced analgesia novel drugs pain stress management CNS central nervous system monoacylglycerol neuroscience neurochemistry cannabinoids cbs synthetic 40.775469613259
10007691 URB754 86672-58-4 >98% 2005-11-04 33.701977900552 urb754 neurochemistry neuroscience 2-AG 2-archidonoyl glyerol MGL monoacylglycerol lipase monoglyceride lipase endocannabinoids FAAH fatty acid amide hydrolase inhibitors inhibition inhibits monoglycerol MAGL neurochemistry cannabinoids 33.701977900552
10674 URB937 Exclusive 1357160-72-5 ≥95% ✓ 2011-03-08 15.000916206261 urb937 FAAH anandamide AEA inhibitors peripheral pain Cannabinoids 15.000916206261
700620 Urea Fluorometric Assay Kit - 2011-08-31 130.586222923792 urea-fluorometric-assay-kit kits assays measures measurements carbamide cycle protein amino acids aa metabolisms catabolism deaminated ammonia livers N-acetylglutamate blood kidneys urine nitrogen countercurrent exchange systems nephrons kidneys creatinine prerenal hperuremia cardiac decompensation water depletion renal glomerulonephritis chronic nephritis polycystic nephrosclerosis tubular necrosis urinary tract toxic metabolites ammonium hyperammonemia plasma detoxification neurological brain neuroprotection serum urease hydrolysis carbon dioxide CO2 detector fluorescence fluorescent 130.586222923792
10006731 VDM11 313998-81-1 >98% 2005-07-13 9.313609576427 vdm11 analogs arachidonoyls ethanolamides AEA anadamides potentiates activity inhibits inhibition reuptake neurons FAAH fatty amides acyls hydrolases transport CB1 CB2 cannabinoids VR1 vanilloid receptors AM404 glutamergic synaptic transmission hippocampal mechanisms sodium channels neurochemistry neuroscience 9.313609576427
9000976 Vigabatrin 68506-86-5 ≥95% 2011-05-04 5.829033149171 vigabatrin γ-Vinyl GABA; Sabril™ 60643-86-9 neurotransmitters γ-aminobutyric acids GABA inhibitors seizures epilepsy neuroscience gamma-vinyl-gamma-aminobutyric gamma vinyl aminobutyric gamma-vinyl-GABA Sabrilex Sabril 5.829033149171
9001204 WIN 54461 Exclusive New 166599-63-9 ≥98% ✓ 2012-04-11 92.324171225580 win-54461 6-Bromopravadoline cannabinoids CBs receptors CB1 CB2 antagonists neuroscience forensics WIN-54461 WIN54461 mimetics WIN 55212-2 WIN 552122 WIN-55212-2 WIN55212-2 aminoalikylindoles WIN 54,461 10009023 10763 vas deferens inhibition inhibits inhibitors 92.324171225580
10009023 (+)WIN 55212-2 (mesylate) 131543-23-2 ≥98% 2006-10-05 59.227790192713 -win-55212-2-mesylate WIN-2 agonists cannabinoids CB1 CB2 neurons rat glutamates SR141716A IP3 Xestospongin C 55212-3 WIN-3 inflammatory neuropeptides CGRP trigeminal neurochemistry ganglions TG exocytosis WIN55,212-2 endocrinology WIN55212-2 cannabinoids cbs synthetic 59.227790192713
10736 (±)WIN 55212 (mesylate) New 137795-17-6 ≥98% 2012-01-11 46.514430542014 -win-55212-mesylate cannabinoids CB1 CB2 receptors pain neuroscience agonists antagonists aminoalkylindole CBs enantiomers (+)WIN 55212-2 (-)WIN 55215-3 SR144528 SR-144528 SR 144528 racemic mesylate central peripheral 46.514430542014
10011213 WWL70 Exclusive 947669-91-2 >97% ✓ 2008-04-15 17.513604972375 wwl70 serine hydrolase ABHD6 inhibitors inhibits inhibition 2-AG endocannabinoids .alpha./.beta. a/b alpha/beta neurochemistry cannabinoids inhibitors 17.513604972375
10790 Xanomeline oxalate 141064-23-5 ≥98% 2011-06-14 0.443784530386 xanomeline-oxalate Lumeron; Memcor; LY246708 agonists muscarinic receptors acetylcholine psychosis antipsychotic memory neurotransmitters neurological Alzheimer’s diseases M1-preferring 0.443784530386
11565 XLR11 Exclusive New 1364933-54-9 ≥98% ✓ 2012-04-10 391.634701678218 xlr11 cannabinoids CBs cannabimimetic receptors CB1 CB2 designer drugs forensics neuroscience XLR-11 XLR 11 central peripheral 391.634701678218
11688 XLR11 N-(4-pentenyl) analog Exclusive New - ≥98% ✓ 2012-05-08 299.757058969709 xlr11-n-4-pentenyl-analog UR-144 N-(4-pentenyl) analog cannabinoids CBs CB1 CB2 forensics spices herbals neuroscience XLR-11 XLR 11 AM2201 MAM2201 AM 2201 AM-2201 MAM 2201 MAM-2201 analogs 11565 central peripheral receptors K2 UR144 UR 144 UR-144 pentenyl analog 10707 9001219 299.757058969709
80340 α-Guanidinoglutaric Acid 73477-53-9 ≥98% 4.408514426028 -guanidinoglutaric-acid GGA nitric oxide synthase inhibitors nNOS NO seizure brain neurochemistry 4.408514426028
78050 (−)-(α)-Kainic Acid 487-79-6 >98% 2004-04-08 107.091823204420 -kainic-acid neuroexcitatory seizures neuroexcitotoxics epileptogenics alga algae neurochemistry neuroscience 107.091823204420
90215 α-Linolenoyl Ethanolamide Exclusive 57086-93-8 >98% ✓ 9.920122336227 -linolenoyl-ethanolamide cannabinoids neurotransmitters ethanolamides fatty acids CB alpha-linolenoyl .alpha.-linolenoyl cannabinergic neurochemistry neuroscience ethanolamines, cbs, synthetic 9.920122336227
9001195 α-Pyrrolidinobutiophenone (hydrochloride) Exclusive New 13415-54-8 ≥95% ✓ 2012-01-27 47.605683573834 -pyrrolidinobutiophenone-hydrochloride α-PBP 13415-82-2 hydrochloride HCl forensics phenethylamines amphetamines cathinones designer drugs butyrophenones ketones MPBP party pills synthetic anti-psychotic anti-emetic antipsychotic antiemetic anti psychtic anti emetic α-pyrrolidinobutyrophenone 47.605683573834
9001083 α-Pyrrolidinopentiophenone (hydrochloride) Exclusive 5485-65-4 ≥98% ✓ 2011-10-11 90.620199780421 -pyrrolidinopentiophenone-hydrochloride α-PVP; 2-(1-pyrrolidinyl)-Valerophenone; O-2387 14530-33-7 designer drugs forensics pyrovalerone bath salts inhibits inhibitors inhibition transporters neurotransmitters dopamine norepinephrine uptake monoamine analogs alpha PVP APVP hydrochloride HCl psychoactive stimulant a-pvp apvp alpha-pyrrolidinopentiophenone 90.620199780421
Other Resources
Management Team Company Profile Company History ChemAssistant Tools FAQs Cayman Europe Cayman Pharma CaBRI Cayman Gear Press Releases Illustrations and Charts Key Research Area Posters Article Library Analysis Tools Conference Schedule Order Terms Browser Recommendation Privacy Statement Site Map

Cayman Chemical Company · 1180 East Ellsworth Road · Ann Arbor, Michigan 48108 · USA

Toll Free: (800) 364-9897 (USA and Canada Only) · Fax: (734) 971-3640

Copyright 2012 Cayman Chemical Company

Lost password?